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The Academy of Science of South Africa (ASSAf) was inaugurated in May 1996. It 
was formed in response to the need for an Academy of Science consonant with 
the dawn of democracy in South Africa: activist in its mission of using science and 
scholarship for the benefit of society, with a mandate encompassing all scholarly 
disciplines that use an open-minded and evidence-based approach to build 
knowledge. ASSAf thus, adopted in its name the term ‘science’ in the singular as 
reflecting a common way of enquiring rather than an aggregation of different 
disciplines. Its Members are elected based on a combination of two principal 
criteria, academic excellence and significant contributions to society. 
The Parliament of South Africa passed the Academy of Science of South Africa 
Act (No 67 of 2001), which came into force on 15 May 2002. This made ASSAf the 
only academy of science in South Africa officially recognised by government 
and representing the country in the international community of science academies 
and elsewhere. 
 
 
This report reflects the proceedings of Global Mental Health in an Era of Sustainable 
Development: Research and Policy Priorities Symposium Proceedings 
 held at St George’s Hotel, Pretoria. 
Views expressed are those of the individuals and 
not necessarily those of the Academy nor a consensus view of the Academy 
based on an in-depth evidence-based study. 
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DAY 1: 30 MAY 2019 
 
SESSION 1: WELCOMING AND OPENING ADDRESS 
Facilitator: Prof Rita Thom, Department of Psychiatry, University of the Witwatersrand, 
South Africa 
 
Welcome remarks (Mr Stanley Maphosa, International and National Liaison Manager, 
Academy of Science of South Africa) 
 
Mr Maphosa opened the meeting and welcomed everyone. The Academy of Science of 
South Africa (ASSAf) has almost 600 members, who are selected on merit. ASSAf brings its 
members together as a consortium or ‘think tank’ of top scientists to offer evidence-based 
science policy advice to government. ASSAf has realised this mandate through the many 
studies that it has conducted.  
 
In August 2013, ASSAf entered into a partnership with the German National Academy of 
Sciences Leopoldina by signing a bilateral memorandum of understanding (MoU), which 
was renewed for a further five years in April 2018. The partnership with Leopoldina has 
resulted in several joint activities, including: 
• Symposium on Technological Innovations for Low Carbon Societies (October 2012); 
• Symposium on Environment and Health (June 2015); 
• Symposium on Mathematics (March 2016); 
• Symposia on Infectious Diseases (October 2016 and April 2018); 
• Science-Business-Society Dialogue Conference (December 2016 and November 
2017); 
• Symposium on Air Pollution and Health (June 2019);  
• ASSAf and the Leopoldina worked together with the Network of African Science 
Academies (NASAC) (2015–2018). 
 
The present symposium was associated with a study on Mental, Neurological and 
Substance use (MNS) disorders that ASSAf would shortly be publishing as part of its science 
advice to government. 
 
The partnership with Leopoldina had enabled both academies to partner with many 
science academies in other African countries and had opened doors to some academies 
in BRICS (Brazil, Russia, India, China and South Africa) and G20 countries, as well as the 
InterAcademy Partnership (IAP). Together with Leopoldina, ASSAf is striving to do work that 
has national, regional and global impact. 
 
Welcome remarks (Prof Frank Rösler, Leopoldina Board Member and Senior Professor, 
Biological Psychology and Neuropsychology, University of Hamburg, Germany) 
 
Prof Rösler welcomed everyone on behalf of the German National Academy of Sciences 
Leopoldina. ASSAf and the Leopoldina are key partners in pursuing the goal of 
strengthening scientific cooperation between the African continent and Germany. Based 
on the MoU, Leopoldina and ASSAf had deepened their cooperation through joint 
symposia and workshops on a range of different topics. The present joint symposium was 
the fifth on a series of events pertaining to health issues. This symposium was not just a 
bilateral event between ASSAf and Leopoldina but involved other BRICS countries apart 
from South Africa, namely Brazil, India and China.  
 
Mental disorders belong to the most frequent chronic diseases. The World Health 
Organisation (WHO) estimates the worldwide prevalence of depression to be as high as 
300 million patients, bipolar disorders 60 million, schizophrenia 23 million and dementia 50 
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million. Mental health conditions also include developmental and substance use 
disorders. These conditions not only result in severe suffering of patients and their families, 
but also carry a heavy economic burden for societies, whether high, middle or low 
income. 
 
Throughout the world, the burden of mental disorders continues to grow, with significant 
impacts on health, social, economic and human rights consequences. Between 1990 and 
2010, the prevalence of MNS disorders increased by 41%; these disorders now account for 
one in every ten lost years of health globally. Mental disorders and diseases are a pressing 
problem globally, and extreme effort must be invested in research to fight this epidemic. 
Basic research is required to delineate the epidemiology of the various diseases, and 
applied research to develop and improve treatments. Strategies have to be developed 
to absorb the severe economic consequences. The motivation to make progress in this 
field is equally high in high-, middle- and low-income countries.  
 
In Germany, for example, one in four adults is diagnosed with a mental health disorder 
every year. In recent years, a new group of patients have become salient in Europe: one 
quarter of migrants experience post-traumatic stress disorder symptoms, because of 
adverse experiences in their countries of origin or on their hazardous odyssey to Europe. 
Low-income countries are disproportionately burdened with MNS disorders; 75% of global 
MNS disorders occur in low-income countries, and service users of mental health services 
in these countries are far less likely to get access to proper treatment than in high-income 
countries.  
 
The determinants of mental health and mental disorders in low-income countries include 
not only biological predisposition, but also social, cultural, economic, political and 
environmental factors which are often more salient than in high-income countries, 
including extreme poverty, civil wars, political repression, violence, and oppressive family 
and social structures. 
 
One of the most fundamental problems in addressing mental diseases is that there are at 
present no comprehensive aetiological models for the development and manifestation 
of any of the psychiatric disorders. Many biological, social and psychological factors that 
contribute to the manifestation of mental diseases, including biological factors such as 
genetic predisposition, transmitted deficits, psychological factors such as stressful life 
events and family conditions, and social factors such as stressful work conditions have 
been delineated. However, what is missing is a convincing model that integrates all these 
factors in a mechanistic way in order to understand the most important risk factors, how 
they interact, and how efficient treatments can be developed. One reason for this is that 
mental diseases are primarily defined by the psychological phenomenology of symptoms 
according to the International Classification of Diseases (ICD). However, 
phenomenological symptomatology is not unique for any of the mental diseases, and 
there is considerable overlap of symptoms for different diagnostic categories. Even more 
problematically, a single psychological symptom may be caused by a multitude of 
biological deficits. This conclusion follows from genome-wide association studies as well as 
brain-imaging results.  
 
Another important topic is how effective treatment can be guaranteed for patients in low- 
and middle-income countries (LMICs), and how public health initiatives can be 
established and funded. A critical question in this regard is how effectively and how soon 
after onset a mental disorder can be diagnosed. Mental diseases often appear as 
comorbidities with other severe somatic diseases (e.g. AIDS which is particularly prevalent 
in sub-Saharan Africa). Patients tend to seek help initially to cure their somatic symptoms 
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but not their psychic symptoms; however, where psychic symptoms exist, they also have 
to be treated.  
 
A critical question is how interventions can be improved so that many people benefit, not 
only in cities but also in rural areas. This is not only a question of basic or applied research, 
but has political implications, as human resources and funds are required to overcome 
the bottlenecks in treatment supply.  
 
These brief questions and many more will be addressed during this symposium.  
 
Prof Rösler acknowledged and thanked the many parties that had made the event 
possible: the South African Department of Science and Technology for supporting the 
bilateral cooperation of ASSAf and the Leopoldina; the organisers (Prof Crick Lund, Mr 
Stanley Maphosa and Dr Siyavuya Bulani for ASSAf, and Dr Jan Nissan and Dr Marina Koch-
Krumrei for Leopoldina); and the speakers. Prof Rösler was proud that the bilateral 
cooperation between ASSAf and Leopoldina had won the support of prominent 
researchers from South Africa, BRICS countries and Germany working in the field of 
psychiatry and mental illness. 
 
Addressing mental health disorders in the African Region (Dr Steven Shongwe, Acting 
Director, Non-communicable Diseases, World Health Organisation Regional Office for 
Africa) 
 
Mental health is an integral and essential component of health. There is no health without 
mental health. According to the constitution of the WHO, “Health is a state of complete 
physical, mental and social well-being and not merely the absence of disease or infirmity”. 
The determinants of mental health include biological, socioeconomic and environmental 
factors. The range of mental and behavioural disorders includes depression, bipolar 
affective disorders, schizophrenia, anxiety disorders, dementia, substance use disorders, 
intellectual disabilities and other disorders. Globally, 14% of the burden of disease is 
attributed to these disorders. Seventy-five per cent of people with these disorders in many 
low-income countries do not have access to the treatment they need. The Lancet 
Commission on Global Mental Health and Sustainable Development estimated that up to 
1.1 billion people globally are affected by mental disorders, and human rights violations 
are common. Many people with mental health disorders find themselves in unfortunate 
and degrading positions; some are imprisoned or physically abused in care facilities. 
Access to treatment is often limited, or the quality of care is very poor. 
 
The determinants of mental and substance use disorders include:  
• Underlying socioeconomic challenges including poverty, unemployment and 
illiteracy; widespread social stigma related to mental health; and humanitarian 
situations due to natural or human-made disasters. 
• Underlying medical conditions including HIV/AIDS, cardiovascular disease and 
cancer. The problems are exacerbated by health system-related barriers to accessing 
early detection, diagnosis, treatment, rehabilitation and palliative care. 
• Other factors include the experience of discrimination, human rights violations, 
conflict, natural disasters and humanitarian situations. 
 
Recognising the high burden of mental health, the World Health Assembly in 2013 
adopted the comprehensive Mental Health Action Plan, which has been extended until 
2020 and aligned with the Sustainable Development Goals (SDGs), especially SDG 3 
(Good Health and Well-being) and SDG 5 (Gender Equality). The Mental Health Action 
Plan is a commitment by member states to take specified actions to improve mental 
health and to contribute to the attainment of agreed global health targets. Targets and 
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strategies have been developed for each of the objectives of the Mental Health Action 
Plan, namely: 
• To strengthen effective leadership and governance for mental health;  
• To provide comprehensive, integrated and responsive mental health and social care 
services in community-based settings; 
• To implement strategies for promotion and prevention in mental health; 
• To strengthen information systems, evidence and research for mental health. 
 
The WHO policy plans and programmes for mental health are guided by the main 
principles of universal health access, human rights, deinstitutionalisation, integration of 
mental health into general healthcare (especially primary healthcare), and community-
based care. Another principle is that strategic documents should be produced in close 
collaboration with all relevant stakeholders. 
 
 
Figure 1: WHO service organisation pyramid for an optimal mix of services for mental 
health. 
 
According to the WHO model for an optimal mix of services for mental health (Figure 1), it 
is essential to integrate mental healthcare into primary healthcare, which should be 
supported by other levels of care including community-based and hospital services 
(secondary and tertiary levels of care). There is certainly an important role for psychiatric 
hospital for specialised services, but the role of such institutions should be minimised. It is 
fundamental to empower people for self-care. 
 
The WHO Mental Health Gap Action Programme (mhGAP) is aimed at scaling up services 
for MNS disorders, especially for LMICs. The programme entails task-shifting, capacity 
building at all levels, training of non-specialised health workers and mental health 
professionals, supportive supervision, and exploring opportunities for the review and 
development of curricula. 
Legislation is another important component for dealing with mental health in order to 
ensure that people with mental health disorders are respected. Laws should be aligned 
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to international standards such as the United Nations (UN) Convention on the Rights of 
Persons with Disabilities as well as optional protocols. 
 
With respect to progress in implementing the Mental Health Action Plan and other related 
initiatives, health systems especially for mental health are weak in most countries in the 
African Region. Thirty-eight of the 47 member states in Africa have mental health policies 
and 18 have mental health legislation, but there are challenges with implementation and 
enforcement. The challenges include late diagnosis, poor coordination, insufficient 
trained human resources, poor data, high costs and inaccessible medicines and 
technologies, the financial burden to individuals and systems, and low prioritisation of 
mental health. The number of psychiatrists in the African Region is very low in comparison 
with other regions of the world and is declining even further due to the brain drain and 
migration. Sub-Saharan Africa has only 1 823 psychiatrists for a continent of one billion 
people. In many countries of the Africa Region with a population of five million or more, 
there may be only one psychiatrist or none at all. Currently in the region, the number of 
psychiatrists is 0.06 per 100,000 population, whereas in high-income countries the number 
of psychiatrists is 6.6 per 100,000 population. 
 
The challenges in reducing the treatment gap in the Africa Region include low 
prioritisation of mental health and insufficient funding, weak health systems, insufficient 
trained health workers, inadequate mental health facilities in terms of health facilities and 
at community level, access to medicines, poor quality of care, and persistent stigma and 
discrimination. 
 
Some current mental health strengthening initiatives of the WHO include: 
• Humanitarian emergencies: WHO and partners provide health and psychosocial 
support in such situations. Tools for clinical management of MNS disorders in 
humanitarian situations include the mhGAP Humanitarian Intervention Guide. 
• Programme for Improving Mental Healthcare (PRIME): This involves a consortium of 
research institutions and ministries of health in five countries (India, Nepal, Ethiopia, 
South Africa and Uganda). The goal is to generate world-class research evidence on 
the implementation and scale-up of treatment programmes for priority mental 
disorders. 
• QualityRights Initiative: This is a WHO global initiative to improve the quality of care of 
mental health services, promote human rights and address the physical, sexual and 
emotional abuse of those with mental health disorders. The initiative provides online 
training and works at multiple levels including changing mindsets and practices, 
transforming services, building civil society and reforming policy and law.  
 
The recommendations include: 
• Mobilising resources: Member states should mobilise financial, human and material 
resources to scale up mental health programmes, services and interventions.  
• Policies, plans and legislation: Member states should accelerate the development 
and implementation of mental health policies, plans and legislation.  
• Capacity building and training: Member states should scale up the training of mental 
health professionals including psychiatrists, psychologists, social workers, nurses and 
counsellors. 
• Integration of services: Member states should integrate mental health, alcohol and 
substance use disorders into primary healthcare. 
• Deinstitutionalisation: Capacity should be built for deinstitutionalisation and 
community-based care. 
• Scaling up innovations including the use of ICT, task shifting of psychosocial 
interventions, and strengthening health information systems and surveillance on 
mental health and substance use disorders. 
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Global mental health and the Sustainable Development Goals: aligning the research 
and policy agendas (Prof Crick Lund, Alan J Flisher Centre for Public Mental Health, 
Department of Psychiatry and Mental Health, University of Cape Town) 
 
The presentation drew on the work of the Lancet Commission on Global Mental Health 
and Sustainable Development, in which Prof Lund had been involved for the last three 
years. The commission involved a number of different countries and published its report in 
October 2018.  
 
The SDGs were launched by the UN in September 2015 as a big agenda with targets to 
be achieved by 2030. In his address at the time of the launch, the UN Secretary-General, 
Ban Ki-Moon, said: “We have a big bold agenda before us – now we must work to make 
it real in people’s lives.” The targets and indicators for the SDGs have been worked out by 
UN agencies working in collaboration with governments around the world. The SDGs are 
shaping the policy agenda of many governments around the world particularly in sub-
Saharan Africa, not only for the health sector but also for other development priorities 
related to education, climate change, the environment, sustainable cities and 
communities and others. 
 
For the first time, the importance of mental health has been acknowledged and included 
in an agenda of this magnitude. Mental health was not mentioned in the Millennium 
Development Goals (2000–2015), which preceded the SDGs. Mental health is addressed 
in SDG 3 (Good Health and Well-being): 
• Target 3.4. “By 2030, reduce by one third premature mortality from non-communicable 
diseases through prevention and treatment and promote mental health and well-
being.” 
• Target 3.5. “Strengthen the prevention and treatment of substance abuse, including 
narcotic drug abuse and harmful use of alcohol.” 
 
As countries move towards trying to establish universal health coverage, it is vital to ensure 
that mental health is included in the package of services. South Africa, for example, is in 
the process of formulating the National Health Insurance, and it will be critical to ensure 
that mental health is included in the core package of services funded by universal health 
coverage. 
 
Within broader global development policy, mental health has been growing as a field 
with a number of seminal publications from the early 1990s onwards: 
• Caracas Declaration of Mental Health and Human Rights (1990), which emphasised 
the need for developing psychiatric care closely linked to primary care through 
community-based services and advocated the need to anchor the restructuring of 
the services in a legal framework, and to assure proper safeguards for the human and 
civil rights of patients. 
• World Mental Health Report (1995), which highlighted the large and growing burden 
of mental disorders in low-income countries, their strong association with social 
determinants (such as poverty, displacement and violence), and the pervasive lack 
of care and abuse of human rights.  
• WHO World Health Report (2001), which focused on mental health for the first time and 
presented a public health perspective on mental health along with providing 
practical guidance to policymakers. 
• WHO Mental Health Atlas (2001, 2005, 2011, 2014, 2018), which for the first time provided 
comparable data from the majority of countries on some basic indicators of mental 
health services and systems. 
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• Lancet Global Mental Health (2007), the first in the series, which emphasised the large 
treatment gaps for mental disorders in LMICs and called for services for mental 
disorders to be scaled up, guided by the evidence of cost-effective interventions and 
respect for human rights. 
• Movement for Global Mental Health (2007), a virtual alliance of people affected by 
mental disorders and practitioners of global mental health that was formed to 
collectively champion the attainment of the call to action. 
• UN Convention on the Rights of Persons with Disabilities (2007), which promotes, 
protects and ensures full and equal enjoyment of all human rights and fundamental 
freedoms by all people with disabilities, and promotes respect for their inherent dignity. 
The convention was adopted, quickly signed and ratified by most countries in the 
world and came into force in 2008.  
• WHO mhGAP (2008), which committed WHO to providing evidence-based guidance 
and assistance to countries for scaling-up care for MNS disorders. Over the next 10 
years, the initiative assisted more than 100 countries. 
• Grand Challenges in Global Mental Health (2011), which was the most comprehensive 
priority-setting exercise to guide research in global mental health. It identified 
implementation questions as the leading priority, ushering in a wave of new funding 
for global mental health research. 
• WHO Mental Health Action Plan (2013), which was adopted with the highest level of 
political commitment by all 194 ministers of health in the World Health Assembly. The 
global action plan has clear objectives, actions, indicators and targets for eight years. 
• SDGs (2015), which recognised the promotion of mental health, prevention of mental 
and substance use disorders, and universal health coverage as targets of the health 
goal. 
• Disease Control Priorities (2016), which published recommendations for cost-effective 
packages of care for the prevention, treatment and care of mental disorders that are 
feasible for delivery through a range of platforms (from the community to the 
specialist) and can be prioritised as the mental health component of universal health 
coverage. 
• Out of the Shadows meeting and declaration (2016) in which the World Bank and WHO 
recognised mental health not just as a global health priority, but as a global 
development priority. 
• Lancet Commission on Global Mental Health and Sustainable Development (2018), 
which proposed a reframing of mental health to concurrently address the prevention 
and quality gaps alongside the treatment gap (for both clinical and social care 
interventions) in order to reduce the global burden of mental disorders.  
 
A substantial body of evidence has grown. There are robust measures of the burden of 
disease (although these could be improved), the extent of service provision, and the 
available resources and policies. The statistics show the rising burden of mental and 
substance use disorders. Between 1991 and 2016, the percentage of total disability-
adjusted life years (DALY) increased globally from 6.6% to 9.4%. The trend is similar for all 
countries, but the actual figures are higher in high-income countries. Mental health and 
substance use disorders are not evenly distributed across the life course. Many such 
disorders peak in adolescence and early adulthood, which is a critical risk period. 
Alzheimer’s disease and other dementias peak in later life. It is necessary to be aware of 
these changes in considering prevention and promotion across the life course.  
 
The high burden of mental and substance use conditions has major economic 
consequences, especially since their effect is felt more by disability than by mortality. 
Mental health conditions are projected to cost the global economy US$16.1 trillion by the 
year 2030, which is more than cancer, diabetes and respiratory diseases combined. This is 
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not just a problem for the economies of high-income countries, as the economies of LMICs 
are also significantly impacted. 
 
Despite this burden and the associated economic costs, the coverage of minimally 
effective treatment rates for depression, anxiety and substance use disorders is negligible. 
Only about 2% of people living with an anxiety disorder, 4% with a major depressive 
disorder and 1% with substance use disorder in LMICs receive minimally effective 
treatment. The situation is somewhat better, although still inadequate, in high-income 
countries, where only 14% of people with an anxiety disorder, 22% with a major depressive 
disorder and 10% with substance use disorder receive minimally effective care. 
Development assistance for mental health is pitiful and does not compare with assistance 
for conditions such as HIV/AIDS, maternal and neonatal health, malaria or tuberculosis 
(TB). 
 
In countries around the world, people with mental health disorders, especially those with 
severe mental illness, sometimes live in shocking conditions and are subjected to human 
rights abuses such as being chained or caged. 
 
In the context of reframing mental health and setting research priorities, the Lancet 
Commission on Global Mental Health and Sustainable Development recommended three 
important changes that are required in the approach to the field, namely: 
 
1. Mental health exists on a spectrum, ranging from day-to-day wellness to long-term 
disabling conditions. There is a need to move away from categorical measures of 
mental disorders towards a more dimensional understanding of mental health. There 
is a continuum from diffuse non-specific mental distress, to the development of full-
blown syndromes. There is a high level of comorbidity between conditions, especially 
in the early stages. Efforts should be focused on prevention and early-stage 
identification. Research should be directed at understanding the aetiology of mental 
health conditions as multiple and often overlapping determinants, rather than trying 
to develop sophisticated classification systems of how symptoms present themselves 
in a clinical setting. The Lancet Commission developed a framework for understanding 
the social determinants of mental health and categorised these across five main 
domains, namely demographic, economic, neighbourhood, environmental events, 
and social and cultural domains. A large systematic review was undertaken, and a 
range of distal and proximal factors were identified that influence the mental health 
of individuals across the life course and interact with a range of genetic risk factors. 
Many of these social determinants are strongly linked to the SDGs. It was possible to 
identify how particular SDGs are relevant to certain social and economic domains. 
The Lancet Commission’s report developed a number of indicators that are important 
to track as potential determinants of population mental health.  
 
2. Childhood and adolescence are key moments shaping lifelong mental health. 
Plasticity deteriorates over the life course. There is a period of pruning and differential 
maturation of neuronal cells in adolescence and early adulthood. Senescence in later 
life provides high risk for dementia and other neurocognitive deterioration. Early 
childhood and adolescence are critical. The environment shapes neuronal 
development across the life course and is reflected in the incidence of mental and 
substance use disorders. In considering mental health strategies from the population 
perspective, it is important to develop interventions that target key developmental 
stages and try to identify problems and intervene as early as possible. The current 
symposium provides an opportunity for scientists in a range of fields to meet, including 
neuroscience, genetics, social epidemiology, clinical psychiatry and clinical 
psychology. This is encouraging, because a convergence approach is required in 
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order to understand the biological and social determinants and the ways in which 
they influence the presentation of phenotypes across the life course and the 
developmental trajectory of the human brain. 
 
3. Mental health is a fundamental human right. People living with mental ill health should 
be at the centre of planning services and challenging stigma. The Lancet Commission 
report goes into some detail on the UN Convention on the Rights of Persons with 
Disabilities and its relevance to people with mental health. The Lancet Commission 
emphasised youth leadership and especially the participation of young people 
affected by mental health conditions, resulting in the launch of the 
‘MyMindOurHumanity’ social media campaign to fight stigmatisation. 
 
The Lancet Commission set out a number of priority interventions, building on the 
approach of understanding the life course and the dimensional approach to mental 
health. The interventions firstly need to identify those at risk, promote mental health in 
those who are well, identify key risk factors and opportunities for intervention for those at 
risk, and provide a set of interventions for those who suffer from poor mental health, 
especially early in their life course. These can be delivered across a number of different 
platforms, from school-based to community-based and digital platforms, as well as 
primary care and health sector platforms. The Lancet Commission set out what the 
priorities should be for policy, plans and law for primary, secondary and tertiary healthcare 
in low-, middle- and high-resource settings. 
 
The key messages and recommendations emerging from the work of the Lancet 
Commission include: 
• Mental health should be reframed using a dimensional, life-course approach that is 
founded on human rights and in alignment with the SDG. 
• Mental healthcare should be an essential component of universal health coverage. 
As countries move towards universal health coverage and national health insurance, 
it is important to ensure that mental health is included in specific packages of care, 
and scientific evidence is used to strengthen health systems and adopt task-sharing 
approaches to deliver mental healthcare through non-specialists. 
• Public policies should be used to protect mental health and implement the WHO 
action plan. 
• It is important to listen to and engage people with lived experience so that they 
become part of the research and policy agenda. 
• Mental health requires far greater investment, especially given the compelling 
evidence that pharmacological and psychosocial mental health interventions yield 
economic improvements in LMICs.  
• Research should be used to guide innovation and implementation. The current 
workshop presents an opportunity to consider the research agenda and priorities. 
• Monitoring and accountability need to be strengthened. 
 
 
Keynote address (Dr Yogan Pillay, DDG: Health Programmes, Department of Health, 
South Africa) 
 
The Friendship Bench project has received considerable international publicity, including 
a bench in the exhibition area at the 2019 World Health Assembly. This is an evidence-
based intervention developed in Zimbabwe to bridge the mental health treatment gap. 
The mission is to enhance mental well-being and improve quality of life through the use of 
problem-solving therapy delivered by trained lay health workers. The intervention focuses 
on people who are suffering from common mental disorders, such as anxiety and 
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depression. This innovation is pertinent to improving mental health interventions in the 
context of task-shifting and involving communities.  
 
Another intervention that could be used to mobilise communities around mental health 
and mental illness is the example of a US high-school teacher who put up a board in class 
with rows showing the mood of learners, on the spectrum from ‘I’m happy’ to ‘I’m feeling 
sad’. Learners were encouraged each morning to place stickers on the spectrum with 
their names at the back. The teacher would then have one-to-one conversations with the 
learners. This is a creative way of checking on the mood of the classroom and doing 
something about it. 
 
The National Department of Health (DoH) would like to see such innovations emerging 
from symposia such as the present one. Too often, meetings result only in talk without 
follow-up action. Dr Pillay was interested to see what would come out of the work of the 
Lancet Commission, how it would be ensured that the recommendations were 
implemented, and who would hold people accountable.  
 
Advocates for every medical condition all concur that there is no health without mental 
health. There is thus no ready answer to the question of what will distinguish mental health 
from conditions such as HIV, eye healthcare or oral care. Dr Pillay was hoping that this 
symposium would help to answer this question.  
 
Dr Pillay’s presentation would focus on the situation in South Africa. The release of the 
South African Human Rights Commission (SAHRC) Report of the National Hearing on the 
Status of Mental Healthcare in South Africa on 28 March 2019 should cause us to pause 
and reflect on what we have done to provide quality rights-based mental health services 
for the people of the country. A blog on the South African College of Applied of 
Psychology website, entitled ‘The shocking state of mental health in South Africa in 2018’, 
noted that as many as one in six South Africans suffer from anxiety, depression or 
substance-use problems; 40% of people living with HIV in South Africa have a diagnosable 
mental disorder; 41% of pregnant women are depressed, and when crime and motor-
vehicle accidents are taken into consideration, up to six million South Africans could suffer 
from post-traumatic stress disorder. Only 27% of South Africans who report severe mental 
illness ever receive treatment. This means that nearly three-quarters of these sufferers are 
not accessing any form of mental healthcare at all. These statistics are poor and reflect 
high levels of comorbidities, and significant lack of integration in services. 
 
This bleak picture is found not only in academic journals, but also in the media. In 2014, 
The Sunday Times published a report entitled ‘South Africa’s sick state of mental health’ in 
which the authors noted that one third of South Africans suffer from mental illness, but only 
25% of these receive treatment. These circumstances were exacerbated by the Esidimeni 
tragedy. While there is an imperative to deinstitutionalise psychiatric patients and provide 
community-based mental health services, this clearly needs to be done with much more 
care and by ensuring that non-governmental organisations to which patient care is 
entrusted have the capacity to provide good quality care. There are both local and 
global lessons to be learnt from this tragedy.  
 
The situation around mental health in South Africa is troubling, and clearly urgent action is 
needed. Dr Pillay looked forward to this symposium to indicate what we need to do more 
of, and what we should stop doing because the evidence suggests that it makes no 
difference to mental health or helping people with mental illness, and in the context that 
there are never sufficient resources. 
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The lack of access as well as the quality of mental health services is not unique to South 
Africa. It is a global problem and therefore needs a global movement to deal with it. The 
question is whether the Lancet Commission report has generated such a global 
movement. This was not evident from the World Health Assembly. The Lancet Commission 
report makes the global neglect of mental health clear, stating that “the global burden 
of disease attributable to mental disorders has risen in all countries in the context of major 
demographic, environmental, and socio-political transitions.” If the importance of these 
three factors is undermined, we will not succeed in having the robust interventions we 
need. 
 
The Lancet Commission report notes that human rights violations and abuses of mental 
health patients persist, and the quality of services for mental health is routinely worse than 
the quality of services for physical health. Government investment in developing 
assistance remains pitifully small. Collective failure to respond to the global mental health 
crisis results in monumental loss of human capacities and avoidable suffering.  
 
These views reflected in the Lancet Commission report are echoed in the report of the 
SAHRC. The report is an indictment but sets out what needs to be done in specific 
timeframes. The report points to neglect, mismanagement and underfunding of mental 
health services in South Africa. While the report understandably locates its findings within 
a human rights context, it fails to carefully document the broader context of mental health 
or illness in South Africa. If South Africa is indeed a sick society, we need to understand the 
social determinants of health, as well as the need for mental health services. 
 
Despite a number of studies showing the poor status of mental health in South Africa, 
mental health and mental illness do not appear to be a priority. A four-country study in 
2011 that included South Africa suggested that there were three categories of reasons for 
under-investment in mental health, namely, not having the data to convince policy-
makers that mental health is a priority; not being able to articulate what needs to be done 
to strengthen mental health; and not being able to mobilise support for a response.  
 
In terms of what needs to be done, the reports of both the Lancet Commission and the 
SAHRC include a host of recommendations. The SAHRC locates its findings and 
recommendations within a human rights context. We need to consider how to correct the 
stigma and abuse of people with mental health challenges. Using the law is clearly not 
sufficient, as we have seen with HIV and TB. There is internalised and externalised stigma 
in relation to both HIV and TB. The South African National AIDS Council (SANAC) 
conducted a study of the stigma associated with HIV and TB using the Joint United Nations 
Programme on HIV and AIDS (UNAIDS) tool and found that there is still more stigma 
associated with TB than with HIV in South Africa, and there is more internalised than 
externalised stigma for both of these conditions. 
 
The DoH had commissioned a team of researchers to calculate how much is spent on 
providing mental health services in the public sector. More than R7.8 billion was spent on 
in-patient and out-patient mental health services in 2016/17, which represents 4.6% of total 
healthcare expenditure in the public sector (excluding expenditure in the private sector). 
Of this total, 14% was spent on out-patient services and 86% on in-patient services. In-
patient services are thus clearly prioritised, which means waiting for patients to become 
really ill before intervening, whereas the Lancet Commission urges greater focus on 
prevention and primary and secondary intervention. Only 8% was spent on primary mental 
health services, while 44% was spent on psychiatric hospital services. Psychiatric hospital 
services should not be minimised, because this might undermine the services that some 
patients would require. This issue should be approached by considering the correct 
number of beds in the context of the epidemiology of a particular country. 
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After determining what is spent on mental health in the public sector, it is then necessary 
to determine what should be spent. The DoH is working with colleagues from the University 
of Cape Town (UCT) and the South African Medical Research Council (SAMRC) to 
develop an investment case for mental health in order to demonstrate the levels of 
investment required and the expected return on the investment in terms of health. 
Investment cases had been developed for TB and malaria and had succeeded in 
securing conditional grants. In developing the case for mental health, one of the key 
questions is not only the size of investment but also the nature of the delivery platform (i.e. 
what services should be delivered and where). The DoH had also acknowledged the 
need for a more robust model for the provision of community-based mental health 
services. Using donor funding, the department had engaged a team from the University 
of KwaZulu-Natal (UKZN) to develop models for review around community-based mental 
health services. In addition, the DoH had commenced the provision of refresher courses 
for mental health medical officers and nurses. Since the start of 2019, 383 doctors and 
nurses, largely from district hospitals, had been retrained to deal with acute psychiatric 
conditions. Many of the doctors and nurses working in district hospitals had been found to 
be poorly equipped to deal with acute psychiatric patients. There is nowhere else to send 
such patients, as the psychiatric hospitals are full, and psychiatric patients end up filling 
medical wards in local hospitals. The training has an associated app with links to specialist 
physicians and psychiatrists, so that online consultation is available in real time. The DoH 
would evaluate the implementation of these measures.  
 
The DoH acknowledges that mental health services in South Africa need radical 
transformation. The department is committed, together with its partners, to providing 
significantly improved access and quality of care to patients and the population at large. 
This alliance with the global movement towards universal health coverage provides an 
opportunity to strengthen mental health services. This opportunity has to be seized by 
knowing what services should be provided at each level of care, at what cost, by whom, 
and how they will be held accountable. Practically, this means that as the National Health 
Insurance system is designed, there is a need for agreement on the package of mental 
health services to be provided, focusing on prevention as well as wellness. We need to 
ensure that this package is fully funded, with the right mix of health providers equipped to 
provide the best possible quality of care. Equally, as noted in the Lancet Commission 
report, we need to deal with the social determinants of mental illness with an inter-sectoral 
focus on reducing levels of poverty and inequity, increasing gender equity, improving 
access to employment and educational opportunities, and decreasing levels of 
interpersonal violence.  
 
There is much to be done. Dr Pillay hoped that the present symposium would help prioritise 
what has to be done, and the sequence of activities required to achieve the end result 
of more coverage, better quality care and greater impact on the lives of people. 
 
Discussion 
 
Ms Scott (Wits): Does the Lancet Commission report deal with infant mental health? There 
is considerable research being published on infant mental health, especially on the 
formation of attachments and the immunity that assists with emotional regulation. 
Borderline personality disorder, which tends to be referred to hospitals, is often the result 
of complex trauma from infancy and difficulty in attachments. Interventions tend to start 
from primary school age and later, but not in infancy. Simple things such as helping a 
mother to connect and make eye contact with her infant, and helping her to regulate 
emotions and attachments, could easily be done but are generally ignored in broader 
policy interventions. 
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Prof Lund (UCT): This is an important area. The Lancet Commission report has a section 
dealing with interventions across the life course, and a section on infancy and pregnancy. 
There are opportunities, for example, for routine screening for antenatal and postnatal 
depression. The Perinatal Mental Health Project at UCT does a lot of work in this area.  
 
Dr Pillay (DoH): There is also a need to look at what happens before conception and in 
utero. The in utero experience has been shown to be important for conditions such as 
diabetes and hypertension in later life. 
 
Ms Scott (Wits): It is easier to put relational psychological interventions, such as parent 
infant psychotherapy, in place from birth than to intervene at the level of genetics before 
conception or during pregnancy. 
 
Dr Pillay (DoH): Improved maternal nutrition alone would have very positive effects. 
 
Dr Allen (Lentegeur Psychiatric Hospital): I work on the ground as a psychiatrist, providing 
services for two substructures in areas with the poorest and least insured group of the 
population in the Western Cape. The mental health gap is well recognised, as described 
in the Lancet series of papers. The question is why implementation has not followed the 
research findings. One of the factors seems to be the assumption that those responsible 
for implementation are trained well enough to understand systems and what needs to be 
done. There is a current study on the core competencies of those who are meant to 
implement interventions that are considered important. The Lancet Commission on 
Medical Education looked at medical education for the 21st century and why education 
systems have not changed in order to implement what research shows is required. Despite 
the well-developed body of research on what needs to be done, universities do not have 
training programmes that reflect what research shows is required. The Lancet Commission 
on Medical Education found that medical students are not being trained to be leaders in 
mental health. We expect medical graduates, who have been trained largely to practice 
in first-world countries, to take up the challenge in LMICs and make a difference. They are 
unlikely to do so, because they have not been trained to do so, do not understand the 
systems, and do not have the leadership skills to do what needs to be done. 
 
Prof Lund (UCT): Agreed with these concerns. There is a need to develop public mental 
health competency among medical health professionals, and to shift the roles from 
providing individual clinical care to patients, to also taking on the roles of training, 
supervising and supporting non-specialist health providers to deliver mental healthcare. 
There are fewer than one psychiatrist to two million people in sub-Saharan Africa. The 
treatment gap can thus not be filled by just providing care using specialists. The curriculum 
would have to be changed in order to change the core competencies of mental health 
professionals to understand the system within which they deliver care, and to take on 
additional roles of providing training, supervision and support to non-specialists. 
 
Prof Thom (Wits): Another key issue is where people are trained. If the training platform is 
primarily in specialised hospitals, we will not achieve what we want.  
 
Prof Petersen (UKZN): In considering general health issues, integration is required. It is 
therefore important to include public mental health in the curricula for mental health 
specialist trainers as well as the general healthcare cadre, especially those who will be in 
management positions, as well as in public health master’s programmes. If mental health 
is to be integrated into general healthcare systems, it cannot stand outside it. If we 
develop a district healthcare plan, the only way it will actually be implemented is if it is 
integrated into the district plan as a whole. We need to orientate general public 
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healthcare managers with respect to the importance of mental health and how to 
integrate it. 
 
Prof Thom (Wits): Infant mental health is more likely to be implemented by nurses in a 
postnatal clinic than by mental health specialists. Those who are implementing general 
healthcare therefore need to integrate the mental health component in their particular 
area into the work that they do. 
 
Dr Pillay (DoH): Healthcare workers tend to think only of major mental disorders (e.g. 
schizophrenia or major depression) in the context of mental health. We therefore need to 
change the narrative related to how we talk of mental illness and mental health in order 
to promote these ideas, and so that they feel that these aspects are part of their job on a 
daily basis. The reality at healthcare facilities on the ground is very different from what one 
would hope healthcare workers would be doing. People are working in silos at all levels of 
the healthcare system. Integration is important, but we need to consider how to make it 
happen. The DoH has been talking of integration for many years, but it is not taking place. 
The written words we use might mean something to us, but they do not seem to resonate 
with those responsible for implementation. We have to change the narrative and the way 
in which we think about some of the concepts. 
 
Prof Duncan (UCT): The conceptual frameworks that inform policy, such as the ICD and 
the Diagnostic and Statistical Manual of Mental Disorders (DSM) have been mentioned. 
The International Classification of Functioning, Disability and Health (ICF) should also be 
considered with respect to integrated and intersectoral mental health policy and services. 
For example, the Mental Health Policy Framework and Strategic Plan and the Framework 
and Strategy for Disability and Rehabilitation do not talk to each other. If they did then 
community-based rehabilitation including habilitation, psychosocial rehabilitation and 
work rehabilitation as strategies for community development would be strengthened. 
Making the ICF and community-based rehabilitation (CBR) part of mental health policy 
will go a long way towards disability prevention. The way in which the rehabilitation 
professions are optimally utilised has implications for the human resource mix at district 
level, and for task-shifting to and task-sharing with community workers. The district health 
system plans confine rehabilitation professionals to clinic level. This is short-sighted because 
they are a ready workforce that is equipped to address the functioning and disability 
dimensions of mental disorders through intersectoral CBR. Based on the ICF, the WHO is 
working on the International Classification of Health Interventions. This is a significant 
opportunity to position disability inclusive mental health strategies and interventions at 
grassroots level.  
 
Dr Pillay (DoH): In developing a new package of interventions for the National Health 
Insurance (NHI), the DoH is looking at the coding systems being used. At present, the 
public health sector uses only ICD-10. The private sector has been using other coding 
systems, and in primary healthcare various systems have been used. The DoH is trying to 
convene a meeting with medical schemes to consider the coding system to be used. The 
way in which we code illnesses and diseases is related to how we think about them and 
what we do about them. With the introduction of the NHI, South Africa has a unique 
opportunity to look at issues such as the skills mix, who does what, and how services are 
paid for. The key question is how to collectively engage in this debate.  
 
Prof Lund (UCT): In relation to the community health service model that Dr Pillay 
mentioned, the integrated role of community rehabilitation workers, for example, could 
be considered. With a primary focus on functioning, one could consider caring for the old, 
for multiple comorbidities, and for loss of intellectual functioning and a range of other 
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functioning. CBR workers could offer a more integrated, low-cost and effective approach, 
using a functioning approach rather than an ICD approach.  
 
Prof Thom (Wits): The South African Association of Psychiatrists has two vocational groups, 
namely the private and the public sector. The private sector psychiatrists have organised 
themselves very well and have been able to engage with funders and get recognition for 
psychiatric disorders; the situation has greatly improved over the last ten years, although 
it is still not optimal. The society is trying to develop the public sector group to be more 
effective and to become advocates for patients and their families. There are efforts to try 
to develop partnerships between private and public sector psychiatrists. One of the areas 
that private sector psychiatrists have been looking at is the concept of value-based care 
and different models of reimbursement, which would speak to what the NHI is looking at. 
It is important for people to be aware that the private sector is not just interested in 
maintaining a fee-for-service model that is cost-ineffective but is also considering different 
models. 
 
Prof Kagee (SU): I agree with the speakers about the importance of prevention. What are 
your thoughts on the evaluation of prevention efforts in terms of mental health, and would 
these be funded? 
 
Prof Lund (UCT): Prevention is a critical area. We need to consider how we measure the 
effect of promotion and prevention interventions. The classical approach would be to 
look at the incidence of mental disorders over time by tracing a cohort of individuals. This 
type of design would require large numbers. It is also necessary to develop a more robust 
understanding of the ways in which prevention impacts on conditions such as depression, 
substance use or anxiety disorder, but there is much that we do not know in this regard. In 
considering mental health as a continuum, we need to develop more robust and 
culturally valid ways of measuring mental health as a positive construct, not just as a 
means of detecting mental illness. This is an area of research that could be usefully 
explored. A low-hanging fruit would be to take this approach during early life with infants, 
children and adolescents, as they present the best opportunity to change life-long 
trajectories and potentially show an impact. 
 
Prof Rösler (University of Hamburg): Some of these issues are related to the problem of the 
strong distinction between mental health issues and other health issues. Many mental 
health problems are not recognised early enough because of stigmatisation in all 
societies. Mental health practitioners need to be sensitised that any patient that consults 
them might have mental health problems. In that way they could play a role in prevention. 
To separate mental health and somatic health issues is an outdated way of thinking about 
health. As a biological psychologist, I do not see these differences, but the distinction 
between physical and mental health is very strongly established among the general 
public.  
 
Dr Pillay (DoH): In considering the investment case for mental health, it will be necessary 
to determine how much should be invested at primary, secondary and tertiary care levels, 
and what outcomes could be achieved. There were similar difficulties in making the 
investment case for HIV, for example. The focus has thus been on the question of what it 
would take, knowing what we know now about what works based on the best evidence 
we have, to (1) reduce incidence and (2) reduce mortality. We could only find evidence 
for biomedical interventions to do those two things. It is easier to address this question in 
relation to HIV than mental health, so it is a simplistic example. We say a lot about structural 
issues related to HIV, but the evidence of what works in dealing with structural, personal 
and interpersonal issues is lacking in order to justify including such aspects in the model. I 
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suspect there might be similar difficulties with the investment case for mental health, but 
we should at least try. 
 
Dr Allen (Lentegeur Psychiatric Hospital): At a conference in Durban, a speaker from the 
UK spoke about how to use data, especially economic data, to advocate for spending 
on preventative mental health programmes and why this is important from a financial 
perspective. Do we use health economists to help determine where we should be 
spending money? How do we take decisions on cost utility and how to get the most 
benefit from expenditure? Decisions are often made on the basis of crude measures, for 
example that people tend to die from conditions such as HIV and TB but not from mental 
health disorders. Allocations for health are done at provincial level, but many of the 
provinces do not have a line item for mental health, and mental health is captured within 
the budget for chronic diseases. Budgets are determined based on historical precedent 
(i.e. escalation of the allocation from the previous year increased by the inflation 
percentage). It is not possible to determine what the impact would have been if there 
had been expenditure on preventative programmes, because the discourse is not 
informed in a rational way. Economists do not consider health economics. When we 
devise policy and consider policy priorities, we need to look at integrating a range of 
different disciplines such as education and social development. We need experts to 
consider how much to spend on prevention because of the benefits of saving expenditure 
later, and we need to take this approach routinely as a matter of course. 
 
Prof Thom (Wits): The agenda for research that will come out of this symposium is already 
starting to become clear. 
 
Unidentified speaker: The science related to prevention is poor. The research is driven by 
agendas other than whether an approach can work in systems. Much of the research 
done in South Africa, largely in academic departments of psychology, tends to focus 
narrowly on validating a particular scale in a sample without any intention for wider 
application. The evidence is poor on whether intervention works, which makes it difficult 
to demonstrate impact so as to motivate investment. The research agenda needs to be 
revisited. Research that is not related to implementation should be self-funded. 
 
Prof Rietschel (Central Institute of Mental Health, Germany): A project was conducted in 
Germany in 2000 to systematically evaluate cities (Wuerzburg and Nuremberg) to 
establish whether arising public awareness for depression and implicating practitioners in 
endeavours could lead to reduction in depression and suicide. The study continued over 
several years, and it was shown that suicide was reduced. These findings have influenced 
many ongoing local activities in Germany. Such a study could be used as an example to 
support the need for prevention.  
 
Prof Lund (UCT): Taking a population-level approach is an interesting idea, which would 
entail looking at the key levers of how a particular intervention might influence population 
outcomes such as preventing suicide or the onset of depression, anxiety or substance 
abuse, and then considering all the system-level changes that would have to be in place 
to bring about those outcomes. The key challenge at population level is to have two 
comparable populations. If a study were conducted in two different cities, for example, 
they would have to be comparable, as there could be confounding factors such as 
labour migration and economic development that might drive the mental health 
outcomes. Developing a research agenda around a population approach could be 
informative for policymakers. 
 
Prof Thom (Wits): The discussion raises the issues of how university departments decide 
what research they will conduct. This might require more conversation among 
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policymakers to establish what research they need, so that universities can respond and 
provide useful information. 
 
Prof Chiliza (UKZN): Would Dr Pilllay elaborate on his comment that researchers need to 
know what to stop doing if it is not working, and what implications this has for the research 
agenda? Young researchers need guidance in what areas to focus on. 
 
Dr Pillay (DoH): In the context of limited resources, it is necessary to decide where to spend. 
The DoH has think tanks related to HIV, TB and maternal and child health, and the 
department recently created a think tank for mental health. The role of the think tanks is 
to brainstorm and inform the officials who are responsible for advising the Minister of Health 
on policy issues. Those invited to participate in the think tanks do not represent any 
particular constituency. Dr Pillay had raised the following issues for consideration by the 
think tank on mental health: 
• Whether South Africa’s psychiatric hospitals are as efficient as they could be (i.e. what 
they are doing that makes a difference, and what they should be doing differently 
including what they should stop doing); 
• Whether South African community mental health services are as efficient as they could 
be; 
• How much South Africa is spending on psychiatric drugs, whether there is rational 
prescription of such drugs, and whether the right drugs are being used to treat various 
mental health conditions. 
 
The DoH had had been addressing similar to questions related to HIV. HIV is a relatively 
new condition compared to mental health, but receives far more expenditure. The DoH 
was starting to ask in relation to HIV what things it should stop doing on the basis of the 
evidence. Research is required to consider what works and what does not work under 
certain conditions. Anecdotally, there are many things that are not working on which 
expenditure should not continue. Another issue is to determine the role that district 
hospitals should play in managing acute psychiatric patients, in terms of whether such 
patients should be admitted to such hospitals, and who should do what. At present 
psychiatric patients are being admitted to district hospitals, but they are not receiving 
quality care. There is a need for operational research to answer some of these questions.  
 
Dr Card (UJ): Part of my research is to understand how public healthcare workers at 
primary and community health centres understand mental ill health, and where patients 
are referred to. It was difficult to gain access to clinics in order to conduct this research. 
The study found that nurses do not have much access to mental healthcare training. Only 
21% of their training covers mental ill health. When they are confronted with patients 
experiencing trauma, they do not know how to deal with them and tend to refer them to 
district hospitals. There seems to be a gap between policy and implementation by people 
on the ground. 
 
Dr Pillay (DoH): The nursing curriculum is being revised, providing an opportunity to 
increase the focus on mental health. There have been many mistakes in the current 
nursing curriculum, and the integrated four-year course is not working in several areas, 
including mental health, obstetrics and gynaecology.  
 
The DoH has tried to address issues of access by establishing district mental health teams. 
The concept is sound, but there are not enough suitable people to make them workable. 
The idea was that local teams of psychiatrists, psychologists and social workers would 
address the planning of services, the quality of care and access. The district mental health 
teams were modelled on the district clinical specialist teams, which looked specifically at 
maternal and child health as well as TB and HIV. The challenges are that the mental health 
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teams lack the authority they need; many teams lack a full complement; not every district 
has such a team; and some of the teams do not have the capacity to deal with the issues 
(since clinicians may be ill equipped to address planning and issues of epidemiology). The 
DoH will have to rethink who is put in place in teams and in what capacity.  
 
Prof Lund (UCT): This is a useful conversation. We need to focus far more on operational 
research with the agenda set by policymakers. In the example of district mental health 
teams, there seem to be key gaps in their capacity to plan services at the population level 
for mental health. A useful piece of research might entail how to support, train and 
supervise district mental health teams as they are established in provincial health services, 
and evaluate their competencies. This could have a significant public health impact in 
terms of access to care. 
 
Prof Petersen (UKZN): The Southern African Research Consortium for Mental Health is 
evaluating the scale-up of the mental health integration project, which evolved from the 
model developed for the PRIME and was scaled up in KZN. The capacity-building 
component was driven by the National Institutes of Health (NIH) as the funder with the aim 
of capacitating programme managers with implementation science. It was possible to 
negotiate with the provincial authorities in KZN, involving the mental health directorate as 
well as mental health coordinators from each district. An implementation science 
capacity development programme was co-developed for skills including developing a 
district mental healthcare plan and integrating it into the district plan, and using 
continuous quality improvement to integrate, implement and evaluate the plan. Between 
policy and ground level, there is a need to provide a tool kit and a programme to drive 
integration at district level. 
 
SESSION 2: NEUROSCIENCE AND GENETICS 
Facilitator: Prof Bongani Chiliza, Head, Department of Psychiatry, University of KwaZulu-
Natal, South Africa 
 
Mental health research priorities in South Africa: Should we include neurogenetics? (Prof 
Dan Stein, Head, Department of Psychiatry and Mental Health, University of Cape Town, 
South Africa) 
 
The South African context could be summarised as follows: 
• 1800s: Psychiatric asylums were established as early as the 1800s. Robben Island, where 
Nelson Mandela and other political prisoners were imprisoned under apartheid, had 
been an asylum. 
• 1950s: University departments of psychiatry started to be established. 
• 1960s: Researchers at the University of the Witwatersrand published papers on 
behavioural therapy. 
• 1970s: Opposition to apartheid led to the academic boycott. 
• 1990s: Academic collaboration with researchers abroad began after the end of 
apartheid.  
• 2000s: Biological psychiatry began in the 2000s, including the first functional magnetic 
resonance imaging and neurogenetics. 
• 2010s: In the last ten years, the major focus of international collaboration has been 
global mental health. 
 
The 10/90 gap in research means that 90% of all research is done in places where only 10% 
of the world’s population lives. The budget allocation by the SAMRC for mental health 
research is smaller than for other health conditions. 
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Africa is the Cradle of Humankind. We are thus all Africans, since all Homo sapiens 
originated in southern Africa. Genetic evidence shows that genetic diversity is highest in 
Africa and lowest in places populated by small isolated groups, such as Iceland. Artefacts 
from a cave near Cape Town provide some of the oldest evidence of the creation of art 
dating back 125,000 years. 
 
With respect to research priorities, the 2012 Ekurhuleni Declaration on Mental Health 
reached consensus on what research needed to be done in the South African context. 
There is an ongoing debate on whether the national priorities in psychiatry and mental 
health research in a low- or middle-income country context such as South Africa should 
focus more on discovery or on implementation.  
 
The Grand Challenges in Global Mental Health (2011) differed from prior consensus 
documents on research in covering the whole gamut of both discovery and 
implementation science. This document identified the grant challenges as follows, thus 
informing some of the funding for mental health: 
• Identifying root causes, risk and protective factors; 
• Advancing the prevention and implementation of early interventions; 
• Improving treatments and expanding access to care; 
• Raising awareness of the global burden; 
• Building human resource capacity; 
• Transforming health-system and policy responses. 
 
The opportunities for research collaboration between Germany and South Africa include: 
• South Africa’s unique plant kingdom and rich floral system, which creates various 
psychotropic drugs that have been used for millennia. For example, the South African 
endemic plant Sceletium tortuosum has a long history of traditional use as a medicine 
by San and Khoikhoi people and subsequently by European colonial farmers as a 
psychotropic in tincture form, and research using MRI scans has found it to be an 
anxiolytic. There are many opportunities to conduct basic research on psychotropics. 
• Unique animal populations in Africa include large colonies of vervet monkeys and 
chacma baboons. There is a long tradition of ethologists over more than 100 years 
understanding primates in their local context. The naked mole rat is valuable for studies 
of ageing.  
• Unique societal features, including negative aspects such as high rates of gender-
based violence and social inequality; positive aspects such as high rates of cell phone 
penetration and large antiretroviral programmes; and interesting aspects such as 
rapid transformation from apartheid society to liberal democracy.  
• Unique clinical populations including: 
o Among the highest global prevalence of HIV. Mother-to-child transmission of HIV 
had been stopped; however, children who had been exposed to HIV but were 
uninfected were still cognitively affected. This presents a major issue for the 
research agenda. 
o The world’s highest rate of foetal alcohol syndrome (possibly with the exception 
of Native Americans in the USA).  
o High rates of methamphetamine-induced psychosis, accounting for one in four 
admissions to some hospitals. 
o Unique African genetic signature. 
 
Prof Stein raised the issue of whether the transition could be made in mental health from 
the bench to the bedside and to bundu (i.e. the community). In the USA, China and the 
European Union, there has been considerable research funding to give effect to this 
notion. Many people trained in public health are very sceptical whether this is possible 
and ask whether this has ever happened before or whether it is just a pipe dream. In 
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response to the question of whether this has ever happened before, it can be attested 
that it has already been done, and in South Africa. It is not widely known that Joseph 
Wolpe, who developed the technique of systematic desensitisation, was a South African 
and conducted his initial research based on cat behaviour at the University of the 
Witwatersrand. Arnold Lazarus, one of Wolpe’s young colleagues, coined the term 
‘behaviour therapy’ for this type of intervention. Behaviour therapy has since been 
transformed into cognitive therapy, which is the dominant intervention in psychotherapy 
throughout the world. 
 
Can cognitive behavioural therapy be taken from the bench to the clinic? Some of the 
earliest research on understanding community medicine comes from South Africa. Sydney 
Kark and his wife developed community health projects in KZN in the 1940s, involving task-
shifting and evidence-based interaction with communities. Their protégé was Mervyn 
Susser, who left South Africa during apartheid and established the influential Gertrude H 
Sergievsky Center within the Columbia Mailman School of Public Health, which integrated 
clinical, epidemiological and genetic research.  
 
On the issue of taking therapies from the clinic to the community, the Global Mental 
Health in Practice series recently published Global mental health and psychotherapy: 
adapting psychotherapy for middle- and low-income countries. The challenge is now to 
adapt and apply psychotherapy in the low-income context in which most people in the 
world live. Prof Stein considered this to be one of the most cutting-edge research areas in 
psychotherapy.  
 
Accepting the idea that research will help development is essential for making progress 
in genetic research, or indeed any other kind of research. There are good data to show 
that development is dependent on research. The Lancet Commission on Global Mental 
Health and Sustainable Development showed the importance of both discovery and 
implementation research for sustainable development.  
 
One of the challenges to be addressed is the genetics research gap. Genomic research 
is failing on diversity, in that only 18% of the research is done on non-Caucasian people. 
The statistics are even worse for the field of neurogenetic mental health research, where 
only 4% of the research is done on people of non-Caucasian ancestry.  
 
The next challenge is to show that understanding a person’s genetic make-up can lead 
to successful treatment. Cardiologists, for example, have developed new drugs based on 
their understanding of new genes. The Psychiatric Genomics Consortium is working to 
translate the findings of genome-wide association studies into new therapeutics for 
psychiatry.  
 
South Africa has very few neurogeneticists, and therefore needs to make progress through 
collaboration. Good collaborative models are required for neurogenetic collaboration; 
the sound models developed for collaboration in the field of public health could be used 
in this regard. 
 
One of the problems of genetic research is that it leads to reification and stigmatisation of 
mental illness conditions (e.g. through the simplistic reduction of a complex condition such 
as schizophrenia, and lack of taking the social determinants into account).  
 
Good examples of addressing the neurogenetic gap include: 
• Neuropsychiatric Genetics of African Populations (NeuroGAP) study, which was 
launched to address global disparities in neuropsychiatric genetic research, 
particularly in Africa. The study is being conducted in Kenya, Ethiopia, South Africa and 
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Uganda, and aims to collect 10,000 samples of DNA. This is one of the largest genetic 
studies in Africa.  
• ENIGMA Consortium, which is investigating the relationships between genetics and 
brain imaging through collaboration that involves Germany and South Africa, among 
others. 
• Drakenstein Child Health Study, which studies child development, including mental 
health from infant to prepubescent by integrating social determinants, genetics, 
epigenetics, gene expression, poverty, food insecurity and breast feeding. 
 
The rest of the world has something to learn from Africa. Africa, especially South Africa, 
presents interesting opportunities to integrate neuroscience and global mental health 
perspectives. 
 
Breakthrough in understanding the molecular causes of psychiatric disorders (Prof 
Markus Nöthen, Director, Institute of Human Genetics, University Hospital of Bonn, 
Germany) 
 
Genetics has grown as a bridge between research and clinical application, and the 
presentation will raise some arguments in favour of this. 
 
With respect to the genetic contribution to mental disorders, psychiatric illnesses 
frequently occur in families, as observed over centuries; for example, schizophrenia has a 
1% incidence among the general population but 10% among those with a first degree 
relative with the condition; bipolar disorder has a 2% incidence among the general 
population but 10–15% among those with a first degree relative with the condition; 
depressive disorder has a 10–15% incidence among the general population but 20–30% 
among those with a first degree relative with the condition. On the basis of twin studies, 
the genetic component (heritability) of the likelihood of developing the disease has been 
estimated: schizophrenia 70–80%, bipolar disorder 70% and depressive disorder 30–40%. It 
should be borne in mind that the estimated heritability is an average value, and no 
statement concerning individual cases is possible. 
 
The number of genes that contribute to psychiatric disorders is determined by the two 
main dimensions of biological complexity (in that the brain is the human organ with the 
greatest complexity) and heterogeneity as seen in the clinical variability of patients, since 
different functions of the brain can be affected leading to different symptoms in various 
diagnostic categories. The frequency of risk variants in the population that predispose 
towards a psychiatric disorder is determined mainly by selection pressure. If the untreated 
disorder causes reduced reproduction, there will be a larger number of rare mutations 
than in the case of a disorder that does not affect the reproduction rate. It has been 
shown, based on a population approach, that there is a reduced reproduction rate for 
most psychiatric disorders, particularly for schizophrenia and to a lesser degree for some 
other disorders. Not only rare variants but also common variants contribute strongly to 
psychiatric disorders, which might be explained by subclinical manifestations with 
favourable effects that cause selective advantage. There may be simultaneous 
contrasting effects for particular disorders favouring different parts of the spectrum of 
mutations.  
 
The understanding of the genetics of multifactorial disorders has profited enormously from 
the general understanding of the human genome starting with the first draft of the human 
genome in 2001, and especially from the systematic understanding at a population level 
of the genomic variability of common and rare variants across individuals. If a genetic 
variant is identified, the functional consequences or functional annotation of that genetic 
variation are still not known. Research on this aspect is ongoing. 
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The most commonly applied way of identifying the genetic risk factors for psychiatric 
disease is to use a genome-wide association approach. This approach uses patient DNA 
and controlled DNA from a large number of individuals, which is investigated for common 
variants with an array-based technology that allows the characterisation of common 
variation across the human genome. This technique is performed at the relatively low cost 
of €30, having come down from the previous cost of €300 several years ago. The 
identification of rare variants is more expensive. The first window into rare variants was 
offered by applying data generated by the arrays used for the analysis and using intensity 
data. This allows the efficient characterisation of genomic deletions or duplications if the 
variants have a certain size in the human genome. The future perspective is sequencing 
of the complete genome, the price for which is expected to come down over the next 
few years (currently US$1000 for genome-wide sequencing) to the extent that it is 
affordable not only for major research but also for many other projects. 
 
The understanding of the genetic contribution to a polygenic disorder, or a group of 
polygenic disorders such as psychiatric disorders, was only possible through large 
international collaboration, which was the key to success. The field of psychiatry is 
distinguished from many other fields by the extent and crucial role of international 
collaboration. The Psychiatric Genomics Consortium (PGC) was established in 2007. The 
consortium includes over 800 investigators from 38 countries. Data from more than 900,000 
individuals are currently in analysis. This is the largest biological experiment in the history of 
psychiatry. The initial focus of the project was on common single-nucleotide polymorphism 
(SNP) by investigating SNP arrays and later also including the characterisation of copy 
number variations (CNVs) based on the array data, as well as other rare genetic 
variations, with the perspective of obtaining whole genome sequences from many 
patients in the future.  
 
The PGC initially had a number of disease-specific working groups for Alzheimer’s disease, 
attention deficit hyperactivity disorder, anxiety, autism spectrum disorder, bipolar disorder, 
eating disorders, major depressive disorder, obsessive-compulsive disorder and Tourette 
syndrome, post-traumatic stress disorder, schizophrenia and substance use disorders. The 
PGC now has several cross-disorder working groups that are not bound to diagnostic 
categories, for example, copy number variation group, cross-disorder group and pathway 
analysis group.  
 
The Genome-Wide Association Studies (GWAS) in psychiatric disorders have been a 
continuing success story, for example: 
• For schizophrenia, the investigation of 40,675 cases and 64,643 controls resulted in the 
identification of 145 genome-wide significant loci.  
• For bipolar disorder, the investigation of 29,764 cases and 169,118 controls resulted in 
the identification 30 genome-wide significant loci, 
• For depressive disorder, the investigation of 135,458 cases and 344,901 controls resulted 
in the identification of 44 genome-wide significant loci. 
 
The BrainSTORM Consortium looked at shared aetiologies across diagnostic categories. 
Data for 158,028 cases and 365,993 controls were reported for ten psychiatric diseases in 
a paper in Science in 2018. Widespread sharing of genetic risk across psychiatric disorders 
was found.  
 
The GWAS of psychiatric diseases provided insights into biology. As with other multifactorial 
diseases, almost all GWAS findings are located in non-coding genomic regions, and not 
directly within a gene. It is therefore sometimes difficult to understand the functional 
consequences of the respective variants. The functional effects are most likely of a 
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regulatory nature, and the diseases are caused by complex influences on biological 
networks. If pathway-based analysis of the genomic regions implicated in the GWAS 
studies is conducted, some insight is gained into pathways that will most likely be involved 
in the disorders. The involvement of glutamatergic neurotransmission in schizophrenia, for 
example, has been identified. Individual rare variants have been found to make a 
relatively strong contribution to the development of schizophrenia in an individual, which 
has implications for diagnostics.  
 
Various large-scale exome and genome sequencing studies are under way, but it is 
difficult to implicate a single rare variant in the development of psychiatric disease, and 
requires large amounts of data. So far, only one gene has been implicated in such studies, 
but many more are expected to follow.  
 
It is not yet known whether common and rare risk variants explain total heritability in 
psychiatric diseases, but perhaps it is possible to learn from the latest results on other 
phenotypes. For example, pedigree heritability for height and body mass index (BMI) 
appear to be fully recovered from whole-genome sequence (WGS) data on 21,620 
unrelated individuals of European ancestry. The contribution of rare variants to narrow-
sense heritability is larger than expected under a neutral model, which reinforces previous 
observations that height and BMI have been under negative selection.  
 
With respect to translating genetic findings in psychiatric diseases into clinical practice, 
the findings provide the rational basis for the development of new drugs through proof of 
principle, for example, the GWAS for schizophrenia detects the D2 dopamine receptor 
(DRD2) gene, the most prominent drug target in treating psychotic diseases in the genetic 
study. In recent years, it has been possible to integrate the polygenic contribution into 
polygenic risk scores (PRSs). In considering prevention, it is essential to think in terms of risk 
stratification of patients or individuals at risk. A typical proxy that is used in practice is family 
information. It is now possible to base this on molecular data and reach far more precise 
estimates of risk based on PRSs. However, the use of PRSs may exacerbate health 
disparities when translated into clinical practice. The PRSs available today are several 
times more accurate in individuals of European ancestry than other ancestries. This is an 
inescapable consequence of Eurocentric biases in genome-wide association studies. To 
realise the full and equitable potential of PRS, greater diversity must be prioritised in 
genetic studies. As a matter of urgency, data will have to be generated for every 
population as a prerequisite for applying these new technologies, which will require 
investment.  
 
The first step in integrating genetics into diagnostic procedures for psychiatric disorders will 
be the detection of CNVs, which are rare but contribute strongly to the development of 
disease in an individual. CNVs are also associated with other clinical features. Patients 
must be seen in a multidisciplinary context and followed up over a number of years in 
order to ensure that they are always treated in the most appropriate way. There is general 
agreement that this will be the first application of genetic diagnostics in psychiatry. There 
are still a number of open issues, including indication criteria, detection methods, data 
interpretation, communication of genetic findings, the impact on clinical care in terms of 
precision medicine, and showing that these diagnostic procedures indeed provide 
advantages for patients and their families. 
 
One of Prof Nöthen’s colleagues in his department, Dr Franziska Degenhardt, is organising 
a cost action at the European level, financed by the European Commission, on 
developing guidelines for the genetic counselling of psychiatric patients, and guidelines 
for genetic testing. Researchers worldwide are invited to contribute to the programme 
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and the development of standards in this field. There may be South African researchers 
who are interested in participating in this important field.  
 
The future outlook for understanding the molecular causes of psychiatric disorders will 
include: 
• Cohorts must be expanded to include ethnic groups that have been 
underrepresented.  
• The majority of the contributory genetic factors will by systematically identified through 
GWAS and in future also genome sequencing. This is a matter of biometric and systems 
biology interpretation to reach an understanding of the biological mechanisms that 
underlie the genetic contribution. In future, this should lead to the identification of 
aetiological subtypes and more therapeutic targets. 
• Gene–gene and gene–environment interactions have not been extensively 
addressed. 
• Genetic diagnoses and genetic predication will become more reliable.  
• In terms of functional biological analyses, every locus that is identified will be followed 
up by with many detailed.  
 
Prof Nöthen acknowledged the role of his colleagues, Dr Franziska Degenhardt (research 
group leader for schizophrenic disorders), Dr Andreas Forstner (research group leader for 
affective disorders) and in particular Prof Dr Peter Propping, the previous head of the 
department. Prof Propping was the founder of psychiatric genetics in Germany. The 
knowledge and integrity of Prof Propping overcame Germany’s historical burden given 
the abuse of genetic approaches in psychiatry during the Nazi period and allowed this 
field to be established in Germany from the 1970s onwards. 
 
China brain project and macaque models for biomedical research (Prof Mu-ming Poo, 
Director, Institute of Neuroscience, Chinese Academy of Sciences, China) 
 
The China Brain Project is a national project following international brain projects in the 
European Union, USA, Japan and Korea and other countries. This long-term project will 
extend over 15 years (2019–2035). The project is referred to as having ‘one body, two 
wings’. The key objectives of the core programme (the body) are (1) to understand the 
neural basis of cognitive functions, which comprises basic neuroscience research, (2) to 
develop a variety of brain research technology platforms for that purpose, and (3) to 
develop a mesoscopic connectome project, which will entail understanding and 
mapping out the neural connections at cellular level in various animal models, including 
zebra fish, mice and monkeys. This project will be initiated through international 
collaboration. The sub-objectives of the programme (the wings) are (1) to develop an 
effective approach in the diagnosis and interventions of brain disorders, especially early 
diagnosis, and (2) to develop brain–machine intelligence technologies, including the 
brain–machine interface; brain-inspired computing methods, devices and systems; and 
new machine learning.  
 
The presentation will cover the diagnosis and interventions of brain disorders ‘wing’ of the 
project, which focuses on developmental disorders, including autism, mental retardation 
and schizophrenia; psychiatric disorders, including depression and addiction; and 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s. In order to understand 
disease mechanisms, it is necessary to understand the genetic and epigenetic factors, 
and the pathological circuit dysfunctions associated with various diseases. Understanding 
disease mechanisms is a long-term project, and it may be possible to develop early 
diagnostic tools before fully understanding the disease mechanisms through genetic, 
molecular, imaging and cognitive (functional) markers for various diseases. This will require 
longitudinal studies of cognitive functions on large cohorts of normal human subjects as 
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well as diseases subjects. Once the markers have been identified, it will be possible to 
develop early intervention approaches; such interventions are traditionally 
pharmacological and physiological, but physical modulation is also believed to be an 
important approach. It would also be appropriate to develop new disease models using 
non-human primates including two types of macaque monkeys (cynomolgus and rhesus) 
as well as marmosets to supplement the widely used rodent models for disease.  
 
Prof Poo introduced the research on macaque monkeys to develop disease models. One 
approach several years ago was to introduce human genes into monkeys by using a 
lentivirus vector containing the human MeCP2 gene to express in the embryo. The MeCP2 
gene is known to be associated with autistic disorders; for example, Rett syndrome is 
caused by mutation of the MeCP2 gene, for which there is a rodent model. A macaque 
model was developed using overexpression of the human MeCP2 gene. The lentivirus 
injection into the mature oocyte was followed by intra-cytoplasmic sperm injection for in 
vitro fertilisation. The healthy developing embryo was implanted into a surrogate mother 
who gave birth to the transgenic monkey offspring that carry multiple copies of the human 
MeCP2 gene. Seven transgenic monkeys were produced several years ago. Each 
monkey had different copies of the transgenes in different chromosomes. The monkeys 
developed behavioural phenotypes that resembled the autistic phenotype, for example, 
repetitive stereotype circular locomotion. Transgenic monkeys showed higher than 
normal threat-related anxiety and reduced social interactions both with wild-type 
monkeys and with other transgenic monkeys in terms of play and grooming both in pairs 
and in groups. This social deficit is characteristic of autistic patients. The average scores 
for transgenic monkeys in cognition tests were close to those of wild-type monkeys, but 
their ability in various tests was highly variable. The transgenic monkeys seemed to learn 
tasks more slowly, but eventually reached similar levels to wild-type monkeys.  
 
A second generation of transgenic monkeys was bred, showing that germ-line 
transmission of MeCP2 is possible. The germ-line produced by one of the second-
generation male monkeys had various chromosome copies that were similar to those of 
the original donor. The progeny produced were variable in their expression of the 
transgene. They also showed lower social interaction than wild-type monkeys. The model 
resulted in a highly variable phenotype.  
 
A more advanced approach is to produce gene-edited macaque monkeys by 
CRISPR/Cas9 editing of in vitro fertilised monkeys. In this case, in vitro fertilisation is done by 
sperm injection. The fertilised embryo is then injected with a vector that carries out 
CRISPR/Cas9 editing on a specific gene (Bmal1). Ten embryos were implanted in a 
surrogate mother to produce the second generation. The Bmal1 gene that was targeted 
for editing is known as the circadian rhythm gene; a deficiency of this gene is associated 
with many disorders, including neurodegeneration, ageing, metabolic diseases and even 
cancer. Knocking this gene out could cause a variety of downstream disease symptoms. 
Complete knock out of Bmal1 expression was achieved in five of the gene-edited 
monkeys. Bmal1 expression has a cyclic circadian rhythm variation. The Bmal1 knock-out 
(KO) monkeys moved more and did not sleep as well as wild-type monkeys; in particular, 
Bmal1 knock-out led to reduced REM and non-REM sleep during regular dark/light 
patterns. When the Bmal1 KO monkeys were exposed to 24 hours of light for three days, 
the sleep disorder was more exaggerated. The Bmal1 KO and particle KO monkeys also 
showed circadian neuroendocrine dysregulation, with clear loss of the cyclic variation of 
hormones in their blood, including melatonin, testosterone, dehydroepiandrosterone 
(DHEA) and cortisol. For all the gene-edited monkeys, cortisol levels remained high 
throughout the day and night and showed stress, anxiety and depression phenotypes 
(e.g. hiding in the corner of the cage and avoiding social contact). Bmal1 knock-out also 
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resulted in a schizophrenia phenotype, thus producing psychiatric symptoms similar to 
humans. 
 
Gene editing through viral expression of transgenes resulted in random insertion of multiple 
copies. This method thus does not result in a model that is reliable or reproducible. The 
results of Bmal1 knock-out showed that CRISPR/Cas9 has low efficiency, with potential off-
target effects that researchers cannot control as well as mosaic expression in that not all 
the progeny showed the same extent of editing. The generation time of macaque 
monkeys is five years, unlike mice in which it is possible to breed a more uniform phenotype 
after only a few months by breeding successive generations. Non-uniform genetic 
backgrounds are the cause of variability in all the gene-editing approaches. It was 
therefore decided several years ago to produce monkeys through cloning by somatic cell 
nuclear transfer. The success of the cloning method was demonstrated in 1996 through 
Dolly, a female domestic sheep, the first mammal cloned from an adult somatic cell, using 
the process of nuclear transfer. The first cloned monkeys were produced at the end of 
2017. In these clones, the nuclear DNA is identical to that of the donor fibroblast, and the 
mitochondrial DNA is identical to that of the oocyte donor monkey. Having conducted 
successful cloning, the next step was the decision to clone the gene-edited monkey that 
clearly showed the depression and anxiety phenotype through Bmal1 knock-out. Using 
the fibroblast from a male Bmal1 KO monkey, five cloned monkeys were produced in 2019. 
The nuclear DNA was identical to that of the fibroblast donor, and the mitochondrial DNA 
was identical to that of the oocyte donor. Very early, while still in the incubator, one of the 
cloned monkeys demonstrated the same anxiety and depression phenotype as the 
fibroblast donor, which was already 1.5 years old (e.g. hiding in the corner, hugging the 
head). The work was published in two papers in 2019 in the National Science Review, a 
new broad-spectrum journal from China that publishes both reviews and research articles.  
 
There is debate in the field between those who believe that non-human primates could 
be valuable in developing models for therapies for human diseases, and those who 
believe that non-human primates should be used with care as opposed to using rodents, 
although the rodent model has proved not to be useful for the development of drugs for 
psychiatric disorders (e.g. the failure of the clinical trials for most drugs for Alzheimer’s’ 
disease).  
 
Non-human primates provide useful animal models because they can be used for 
studying the neural basis of higher cognitive functions that are most prominent in or unique 
to primate species (e.g. empathy, consciousness, complex social cooperative behaviour). 
The evolutionary origin of human intelligence needs to be understood. Gene-edited 
monkeys could serve as valuable models for human brain disorders, as demonstrated by 
the Bmal1 KO monkey that showed many psychiatric phenotypes that it is not possible to 
study in rodents.  
 
The key issue will be to establish rigorous ethical practices in monkey research, and to 
communicate the importance of non-human primate research to society. The intention 
within the next few years is to use non-human primate models to develop 
pharmacological drugs or physiological interventions for psychiatric disorders. 
 
Family studies from endogamous groups enable the elucidation of distinct predisposing 
pathways in dyslexia (Prof Subrata Sinha, All India Institute of Medical Sciences, New 
Delhi, India) 
 
Dyslexia or reading disability, a form of specific learning disability, is a 
neurodevelopmental disorder and refers to difficulty in reading and writing despite normal 
intelligence and adequate education. Its worldwide prevalence is estimated to be 
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around 5–10%. Dyslexia has recently been recognised by the government of India as a 
disability with specific characteristics, so that sufferers of dyslexia have legislative access 
to benefits similar to those received by the hearing-impaired, for example. Much remains 
to be done to implement the legislation. 
 
Dyslexia has definite environmental and biological components. Studies have been done 
on post-mortem brains, as well as subsequent neuroimaging studies, but the exact nature 
of the aberrant pathways are not clear. Like other mental health disorders, dyslexia is 
heterogeneous, with multifactorial aetiology. Dyslexia is likely to be a ‘basket’ of disorders, 
possibly different pathways leading to a broadly common phenotype. Research has not 
been able to identify a limited set of genes that play a preeminent role in susceptibility to 
dyslexia worldwide. It is hoped that the role of genetic analysis and complex phenotyping 
would be useful in identifying different endophenotypes resulting from distinct molecular 
and cellular pathologies. 
 
Dyslexia is characterised by dysregulated phonological processing; dyslexic patients have 
the basic ability to mentally manipulate and process speech and sound correspondences 
but deficits in other abilities such as word reading and decoding. Psychometric 
assessment batteries are used to ascertain dyslexia in research and clinical settings. 
 
India has a large number of reproductively isolated endogamous groups as a result of 
geographical, cultural (related to caste, tribes and arranged marriages), religious and 
ethnic isolation, and endogamous practices persist up to the present. In 1868, K McLeod 
of the Indian Medical Service observed “a peculiar ethnological and pathological value 
from the circumstance that all the subjects examined were natives of this district. So many 
cases of individuals, whose life and ancestry are confined within so small an area, can 
only be obtained amongst a people of stationary propensities not possessing facilities or 
inclination to migrate. The time when such records can be easily collected is rapidly 
passing away. Education and enlightenment, combined with increased facilities for 
migrating, will eventually break down the barrier.” 
 
A paper by Nakatsuka et al., (2017) published in Nature Genetics entitled ‘The promise of 
discovering population-specific disease-associated genes in South Asia’, reported on the 
identification of 81 unique groups, 14 of which had estimated census sizes of more than 
one million that descended from founder events more extreme than those in Ashkenazi 
Jews and Finns, both of which have high rates of recessive disease due to founder events. 
In such groups, recessive diseases are also likely to occur at an elevated rate, even in non-
consanguineous cases, because of recent shared ancestors. 
 
The comparative genetic similarity helped Prof Sinha’s research team to identify, with a 
comparatively modest research structure, certain susceptibilities that it would otherwise 
not have been possible to identify. Seventy-six members from three generations of a family 
of a particular caste were assessed. This multigenerational family constituted an 
endogamous group from west India. There were marriages from outside the family, but 
from the same group. It was found that there was an insertion present upstream of the 
BASP1 coding gene; this was a homozygous insertion in 12 out of 14 cases of dyslexia, 
whereas the heterozygous or wild type was present in 20 out of 24 cases among the 
controls without the dyslexic phenotype.  
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Figure 2: Overlapping region between BASP1 and LOC285696. 
 
The overlapping region between BASP1 and LOC285696 (hitherto named BASP1-AU1) is 
599 bp long (Figure 2). Insertion is present at 350 bp downstream from the start site of 
mRNA of BASP1-AU1. LOC285696 encodes an uncharacterised long non-coding RNA in 
the overlapping region. This is a divergent lncRNA pairing with a coding gene BASP1. 
Several genes are involved in neurite outgrowth and synapse formation. Co-expression of 
growth cone proteins GAP-43 and CAP-23 (BASP1) can elicit long axon extension by adult 
dorsal root ganglion (DRG) neurons. BASP1 overexpression stimulated neurite outgrowth in 
PC12E2 as well as in hippocampal neurons. The function of lncRNA is not yet known. 
Divergent lncRNA is known to regulate the corresponding coding gene. It is suspected 
that it helps to form a loop structure that is essential for the expression of the gene. The 
criteria for genomic looping are the presence of divergent CTCF sequences on looping 
points. CTCF protein (11-zinc finger protein or CCCTC-binding factor) binds on CTCF 
sequences. The Hi-C data of Rao and Huntley et al., (2014) were used for genomic looping 
analysis and the Juicebox tool was used to visualise looping at the BASP1 genomic locus. 
The BASP1-AU1, BASP1 and TCF12 complex links two loci associated with inherited dyslexia. 
The literature shows that there is a DYX1 locus on chromosome 15q21.2 that is highly 
replicated in dyslexia inheritance. The DYX1 locus has two genes, namely DYX1C1 and 
TCF12. The endogamous family in the study also had a GT insertion in chromosome 5p15.1. 
There is a single common pathway critical for neuronal differentiation. It is likely that the 
same phenotype may result from the effects of different molecular pathways.  
 
A second family (KA25) that was studied was a group that was geographically ethnically 
isolated. Whole exome sequencing and whole genome SNP array were conducted. A 
common set of genes was identified in both procedures. A set of 17 polymorphisms 
located across the 1.9 Mb region on chromosome 5q31.3 was identified, encompassing 
genes of the PCDHG cluster, TAF7, PCDH1 and ARHGAP26, dominantly inherited with 
dyslexia in this multi-incident family. The non-risk form of 17 variations of the PCDHG cluster 
are preponderant in the human lineage, while risk alleles are ancestral and conserved 
across Neanderthals to non-human primates. The observed association of PCDHG genes 
encoding neural adhesion proteins reinforces the hypothesis of aberrant neuronal 
connectivity in the pathophysiology of dyslexia. Additionally, the striking conservation of 
the identified variants indicates a role of PCDHG in the evolution of highly specialised 
cognitive skills critical to reading. The PCDHG haplotype was not present in other members 
of the community. Only four (0.1%) of the individuals possessed both the CNTN6 and 
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PCDHG haplotype together, while there was 100% co-segregation of these haplotype 
within the affected individuals in family KA25. 
 
A third family was studied with respect to comorbidity between dyslexia and attention 
deficit hyperactivity disorder (ADHD). Variants were filtered by comparing ADHD or 
dyslexia, or ADHD and dyslexia, with healthy individuals. Genes were prioritised on the 
basis of variants causing protein-altering changes or regulatory effects on gene expression 
or structure, brain expression, or those associated with the same or other neuropsychiatric 
disorders. Exome sequencing identified a 1.738 kb long haplotype in FAM43A (3q29) co-
segregating with dyslexia and/or ADHD. FAM43A is overexpressed in whole blood of the 
risk genotype. The FAM43A haplotype has been shown to be present in schizophrenia, 
intellectual disability and learning difficulties.  
 
Endogamous groups are a valuable genetic resource, because genetic similarity 
improves the possibility of identifying disease-associated variations. Better identification 
and understanding of aberrant pathways through the molecular heterogeneity of 
apparently similar phenotypes is well addressed by such groups. Markers for early 
diagnosis may be relevant to only one group, but some have large populations. 
Personalised or group-specific management could become possible. Novel insights into 
basic cellular processes can be gained, and researchers can generate feasible research 
questions. Africa and Asia have endogamous groups that are a rich research resource. 
Some of these groups may be over a million strong. 
 
Caution must be exercised in studying endogamous groups because the scientific findings 
will lack generalisability, although the findings of studies of such groups contribute to the 
literature on aberrant pathways. There could also be negative social risks of focusing on 
isolated groups, including stigmatisation and exploitation, and care is required not to 
identify the groups that have been studied. The criterion in using endogamous groups for 
research is whether the community could benefit. 
 
The laboratories that have collaborated in this work are the National Brain Research 
Centre/All India Institute of Medical Sciences, the Institute of Genomics and Integrative 
Biology, and the Regional Centre of Biotechnology. 
 
Discussion 
 
Dr Zawaira (Alexander Zawaira Consulting Scientists): Prof Nöthen’s work found a negative 
correlation between schizophrenia and intelligence. If one can question one’s sanity, one 
is probably not insane. The mathematicians John Forbes Nash Jr, Georg Cantor and Kurt 
Gödel are examples of people whose minds enlightened our understanding of the world 
of mathematics and physics and were schizophrenic. 
 
Prof Nöthen (University Hospital of Bonn): The studies can provide the first insight into 
phenotypes between the diseased and non-diseased population. The findings relate to 
correlation not causation. Expression of a particular phenotype is not responsible for the 
development of the other phenotype. With respect to the relationship between 
schizophrenia and intelligence, there is probably a continuum of contributing genes from 
mental retardation to autism and schizophrenia. Some types of schizophrenia are more 
likely to be caused by genes representing the overlap of the different phenotypes, which 
is of interest in understanding aetiology. The comment was based on a level of 
interpretation, which is difficult on the basis of the available data. 
 
Dr Zawaira (Alexander Zawaira Consulting Scientists): This response implies that the 
frequency of schizophrenia is likely to differ between major population clusters. Different 
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human populations have different levels of intelligence, although this is a controversial 
view.  
 
I agree with Prof Nöthen’s rule of thumb, which states that a condition that seems to 
reduce reproductive potential is probably associated with unique genetic variations, and 
furthermore, I agree that this rule of thumb is  useful in building hypotheses for experimental 
work (i.e. experimentally-testable hypotheses). Have you considered building a linked 
chain of hypotheses from this rule of thumb to formal Darwinism?  That is, have you 
considered formalising this rule of thumb? 
 
Prof Lund (UCT): In terms of developing interdisciplinary research agendas, it might be 
valuable for neurogeneticists to introduce social epidemiological elements in order to 
better understand interactions between genes and the environment in longitudinal 
studies. 
 
Prof Stein (UCT): One of the key messages is that phenotypes depend on the intersection 
of genetics and other factors. Heritability changes with environment. Any differences in 
intelligence are due to environment not genetics. Reductionist errors must be avoided, 
such as those made in the study of genetics in Nazi Germany and that continue to be 
made. GWAS shows how multiple genes are involved in multiple phenotypes.  
 
In South Africa, pneumonia is the biggest killer of children under the age of two. The 
Drakenstein Child Health Study looked at the relationship between genes that code for 
lung development and exposure to pollutants that give rise to pneumonia. There is no 
gene for asthma, for example. Asthma is very complex, involving a large number of genes 
that intersect with pollutants in complex ways. It is likely to become possible eventually to 
determine a polygenic risk score for an individual, thus showing a predisposition to a 
particular condition. It can then be recommended that they avoid a particular pollutant. 
 
Two interdisciplinary areas that are very important for genetics are philosophy in order to 
address deep ethical and conceptual issues, and statistics related to risk. 
 
Prof Nöthen (University Hospital of Bonn): I do not believe that polygenic risk analysis is far 
from implementation in clinical care. Medical practitioners already stratify the population 
in terms of disorders (e.g. coronary heart disease, lipid levels, blood pressure or other 
measurements) and dispense preventive measures based on that stratification. Genetic 
information could be included for more precise estimates in stratification and clinical care 
in the near future. In psychiatry, risk stratification is not established and will take longer, as 
it will need to be proved that the type of risk stratification that has been done extensively 
for other diseases makes clinical sense. 
 
Dr Zungu (HSRC): Is there any work in South Africa that focuses on genetic mutation in 
relation to mental health disorders?  
 
Prof Stein (UCT): The biggest study is NeuroGAP. Other work is being done at Stellenbosch 
University and the University of KwaZulu-Natal. 
 
Prof Duncan (UCT): Circadian modulation was well illustrated by Prof Poo’s research on 
cloned monkeys and could have links with social epidemiological data (as referred to by 
Prof Lund) and implications for activity and functioning. The UK National Health Service is 
moving towards social prescribing with respect to interventions related to how people 
spend their time each day in terms of functioning and activities. In this context, play as an 
activity and modulation for well-being might be worth considering as a dimension, for 
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example in the Drakenstein Child Health Study? The introduction of an activity programme 
has been shown to reduce depression, for example, in a study by Vikram Patel). 
 
Prof Stein (UCT): Circadian rhythms are interesting. It is clear that people generally need 
more sleep than they are getting and that the use of digital devices is interrupting sleep 
and causing a host of problems.  
 
SESSION 3: PUBLIC MENTAL HEALTH AND EPIDEMIOLOGY 
Facilitator: Prof Markus Nöthen, Director, Institute of Human Genetics, University Hospital 
of Bonn, Germany 
 
Common mental disorders among individuals seeking HIV testing (Prof Ashraf Kagee, 
Co-Director, Centre for Public Mental Health, University of Stellenbosch, South Africa) 
 
The prevalence of HIV is still high: 36.9 million people globally were living with HIV in 2017, 
of whom 35.1 million were adults and 1.8 million were children under the age of 15 years. 
HIV infection is associated with a range of mental health conditions. It has been assumed 
that an HIV-positive test causes people to become depressed, traumatised, or develop 
other mental health conditions. In a paper in 2004, Prof Melvin Freeman referred to the 
HIV pandemic as a “mental health disaster”.  
 
In 2008, Freeman published a prevalence study of 900 people living with HIV using the 
Composite International Diagnostic Interview (CIDI) and found that 43.7% had a 
diagnosable mental disorder: major depression 11.1%, mild depression 29.9%, alcohol 
abuse 12.4%, generalised anxiety disorder 0.4%, post-traumatic stress disorder (PTSD) 0.7%, 
PTSD (event HIV) 4.2%, and intermittent explosive disorder 3.9%. Mental health concerns in 
HIV affect the quality of life, adherence to antiretroviral therapy (ART) and therefore 
health outcomes, family functioning and adherence to infant-feeding guidelines among 
new mothers. 
 
Prof Kagee conducted a mental health and adherence study in which 101 ART users 
completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), PTSD scale 
and viral load tests. The odds of an association between high BDI scores and detectable 
viral load were high. Patients reporting elevated symptoms of depression on the BDI were 
more than three times as likely as non-depressed patients to have a detectable viral load. 
This raises several questions: whether mental health screening should be integrated during 
HIV testing; whether mental disorders are present prior to an HIV test; and whether routine 
screening for common mental disorders is a good idea.  
 
In order to try to answer these questions, participants were recruited by means of 
convenience sampling at five HIV testing sites in the Western Cape, South Africa. 
Temporary testing centres were set up in public areas such as shopping centre parking 
lots and public transport centres, and community members were invited to receive a free 
HIV test. The Structured Clinical Interview for the Diagnostic and Statistical Manual of 
Mental Disorders (Research Version) (SCID) was administered, as well as a range of self-
reporting measures including the BDI, BAI, Hopkins Symptom Checklist, Post-traumatic 
Stress Symptom Scale and Alcohol Use Disorders Identification Test (AUDIT). Five hundred 
people were recruited into the sample, including 49.1% males and 50.9% females, with a 
mean age of 36. Over a quarter of the participants had at least one form of mental 
disorder.  
 
The only significant differences between men and women were related to anxiety. In a 
number of cases, a common mental health disorder (CMD) existed prior to having an HIV 
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test. For those who later tested HIV positive, this result was clearly neither the cause nor the 
precipitant of the mental disorder. 
 
With respect to the question of whether routine screening is a good idea, screening 
measures are cost-effective, time-efficient, and easy to use, whereas diagnostic 
interviews such as SCID are resource- and time-intensive, and have to be administered by 
a trained professional. The performance of the self-reporting measures was assessed in 
determining the presence of CMDs, with the following findings: 
• BDI is effective in identifying non-cases of major depressive disorder (MDD), but less 
effective in identifying cases of MDD. 
• BAI is effective in identifying non-cases for generalised anxiety disorder (GAD), but less 
effective in identifying cases for GAD. 
• The PTSD Symptom Scale (PSS) is effective in identifying non-cases for PTSD, but less 
effective in identifying cases of PTSD. 
• AUDIT is well suited to identifying true non-cases of alcohol use disorder (AUD), but 
moderately effective in identifying true cases of AUD. 
 
The conclusion reached with respect to the advisability of transdiagnostic screening was 
that it is not practical or efficient in a public health setting to ask people to complete a 
lengthy battery of tests consisting of multiple screening instruments. It is also not feasible 
for clinic staff to have to score and interpret multiple disorder-specific screening 
instruments. 
 
The utility of a brief transdiagnostic instrument was then considered to identify persons who 
require further psychiatric assessment. The Hopkins Symptom Checklist (HSCL) was used. 
With respect to positive predictive value, there was a 57% probability that individuals who 
scored above 43 on the HSCL-25 would meet diagnostic criteria for a CMD. With respect 
to negative predictive value, there was an 80% probability that individuals scoring below 
43 would not meet the criteria for a disorder. HSCL-25 thus has some utility as a brief 
transdiagnostic screening tool to identify individuals who are likely to have a CMD, and is 
moderately accurate. 
 
The following conclusions were reached: 
• A positive screen does not necessarily mean caseness for a CMD. 
• Routine screening can generate a large number of false positives, with a high number 
of unnecessary psychiatric referrals, thereby placing a burden on the public health 
system. 
• A two-tiered approach to screening might be effective. In such an approach, 
individuals who score above the cut-off point on a screening instrument should be 
further assessed using a diagnostic interview to determine whether they are a true 
case for a CMD. This would help to avoid clinics being overloaded with false positives. 
• Screening may not be a panacea. 
• In using a screening approach, it is assumed that properly trained healthcare workers 
are available to provide treatment to those who need it. 
 
The next steps in this work are to adapt a transdiagnostic screening instrument using local 
idioms of distress that pertain to the subjective experiences of people in various 
communities. An observational cohort study of ART users would determine if screening 
and referral for treatment lead to the amelioration of mental health symptoms, improved 
mental health outcomes, improved ART adherence, retention in care and viral 
suppression. 
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Addressing the challenge of mental disorders: genetic approaches to nosology, 
aetiology, and treatment (Prof Marcella Rietschel, Scientific Director, Department of 
Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Germany), 
Faculty of Medicine Mannheim, University of Heidelberg 
 
All mental disorders are heritable, although there are differences with respect to 
heritability and frequency. For example, schizophrenia and bipolar disorder have a 
heritability of about 80% and a frequency of less than 1%, while alcohol dependence and 
major depressive disorders are the most common mental health disorders with frequency 
of over 10% and heritability of about 40%. It would be useful to identify the genetic factors 
that underlie these disorders, because there are no objective biological markers to help 
guide diagnosis or predict the cause of the disorder or response to medication. Unravelling 
these factors at a molecular level would foster better understanding of their aetiology and 
enable the development of better treatment. 
 
The most straightforward approach is to compare at genome-wide level the variance 
between the affected and non-affected population, or people sharing or not sharing 
various traits. This has been done with considerable success over the last decade with 
GWAS, which compare differences of common variants with allele frequencies of above 
1% in patients and controls. Common variants explain 30–50% of heritability estimated in 
families. Increasing numbers of genome-wide significant variants have been identified in 
relation to schizophrenia (over 40,000 patients) and bipolar disorder (over 20,000 patients), 
as well as in alcohol use disorder and major depressive disorder, requiring larger sample 
sizes. The GWAS data represent rich data sets, and their analyses is not limited to following 
up the genome-wide significant findings. The wealth of data below the threshold can be 
used to gain insight into the biology and characterise gene components. Understanding 
the biology is done by analysis at the gene and pathway levels, as well as the enrichment 
level.  
 
In schizophrenia, many variants associated with the condition have already been found, 
the most significant with markers in the major histocompatibility complex (MHC) region, 
namely expression of complement component factor C4-A. C4 proteins are responsible 
for pruning in which the brain sheds weak or redundant connections between neurons as 
it matures. During adolescence and early adulthood, this activity takes place primarily in 
the section of the brain where thinking and planning skills are centred, known as the 
prefrontal cortex. Given the implication of C4A in synaptic elimination during postnatal 
development, this finding provides robust genetic support to the longstanding theory of 
excessive synaptic pruning in schizophrenia, postulated in 1982. 
 
It was also reassuring that the DRD2 receptor, which is the target for all classical anti-
psychotics, was among the genome-wide significant findings. The findings support 
previous hypotheses with respect to dopaminergic neurotransmission, glutamatergic 
neurotransmission and postsynaptic density. The findings also point to hitherto unknown 
mechanisms in relation to histone methylation processes, acetylcholinesterase and 
calcium channel function. Most of the variants are enriched at enhancers active in the 
brain. Studies are being done to try to localise which loci are expressed in which gene 
regions, and when during the lifetime.  
The wealth of data can be used to estimate the heritability of complex psychiatric 
disorders. The variance explained by the tested variants is about a 30–50% of the 
heritability estimated by formal genetic studies. For alcohol use disorder, the variance 
explained about 9%, 10% for depression, 40% for schizophrenia and 30% for bipolar 
disorder. These percentages would increase with sequencing data. Polygenic risk scores 
can be calculated. Genetic correlation can be conducted between common disorders 
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and traits and Mendelian randomisation, which detects the causality of the association 
as well as the direction.  
 
There is well-known comorbidity between depression and genetically correlated disorders. 
Obesity, body fat and triglycerides are associated at a genetic level with depression, and 
the direction is from BMI to depression. The direction is opposite in relation to the 
correlation between smoking and depression (i.e. depression triggers smoking). Not only 
substance use disorders are genetically associated with alcohol dependence, but also 
depressive disorder, major depressive disorder, ADHD and PGC cross-disorder, which 
includes schizophrenia. One of the major findings of the GWAS study was that psychiatric 
disorders, in contrast to neurological disorders, have large genetic commonality with 
substantial sharing of variant risk.  
 
With respect to disentangling genetic commonalities and specificities, in categorical 
diagnosis of schizophrenia and bipolar disorder a specific number of symptoms have to 
be fulfilled over a predetermined time period in order to obtain a positive diagnosis, but 
this approach is somewhat arbitrary. In this process, clinical symptoms that are pertinent 
to the diagnosis of schizophrenia do not overlap with the clinical symptoms of bipolar 
disorder. However, all clinicians know that this is not the case; for example, 50% of 
schizophrenia patients show depression before the onset of the disorder, but these 
symptoms are not used to diagnose schizophrenia.  
 
In a diagnosis of schizophrenia, with a high load of manic symptoms as defined by the 
polygenic risk score, there will be many manic paranoia symptoms. If the polygenic risk 
score is low, there will be many negative symptoms associated with schizophrenia. In the 
case of bipolar disorder with a high score for schizophrenia risk variance, there will be 
many psychotic symptoms. Bipolar disorder can be subdivided into bipolar 1 and bipolar 
2. Until recently, it was thought that bipolar 2 was only a minor variant compared with 
bipolar 1. However, while bipolar 1 and bipolar 2 share a number of genes, bipolar 1 has 
more commonalities with schizophrenia than bipolar 2, and bipolar 2 has more 
commonalities with major depressive disorder. Large multiplex families with bipolar 
disorder were recently analysed and the same pattern was found. It was found that in the 
same family, bipolar 1 patients have a higher risk score for schizophrenia, and bipolar 2 
patients have a higher risk score for major depressive disorder. These findings have 
shattered concepts that had been held for many decades. It is thus important to scrutinise 
not only clinical symptoms but all other symptoms.  
 
AUDIT is one of the most common screening measures for alcohol use disorder. It is a 
composite questionnaire that also measures frequency and quantity of alcohol drinking 
as well as binge drinking. While alcohol frequency and quantity share about 50% of the 
genetic underpinnings in alcohol use disorder, opposing genetic correlations have been 
found with disorders and traits, e.g. frequency as opposed to quality is correlated to 
overall better health, socio-economic factors and cognitive functioning. Animal studies 
show that the amount of drinking but not the frequency predicts the response to 
nalmefene.  
 
Comprehensive phenotyping is recommended and should be longitudinal and respond 
to intervention, relapse and course among specific populations. Comprehensive 
phenotyping should take into account environmental factors (socio-demography, 
education, violence, abuse, emotional support, green space, poverty, nutrition and 
locomotor activity), disorder-associated symptoms (clinical symptoms, neuro-
psychological features, behaviour, endophenotypes [brain imaging] and side-effects) 
and biological features (transcriptome, proteome, epigenome, microbiome and hair 
cortisol). Ecological momentary assessment can be done in real time by means of apps 
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(which could measure neuropsychology, mood/emotions, cognition, volition and 
craving), smart watches (which could measure locomotion, light, temperature, heart rate, 
body posture and pressure) and smart garments (which could measure ECG and heart 
beat monitor, heart rate variability, effort and fatigue assessments, QRS events, breathing 
rate, minute ventilation, activity intensity, peak acceleration, and track sleep). 
Comprehensive phenotyping would begin with prenatal monitoring and continue 
through birth, high risk identification, course of the disorder and intervention). 
 
Phenotyping has been done in population-based samples in the German national cohort 
of 200,000 longitudinally assessed population-based individuals with expert and self-
ratings. Examination modules entail the content of the face-to-face interview, self-
completion questionnaires offered as touch-screen modules, and physical examinations. 
 
Genetic approaches enhance the understanding of underlying biological processes and 
the identification of new drug targets, and help with disentangling heterogeneity and 
comorbidity, biologically guided diagnoses, individualised therapies, prediction of onset 
and course of the condition, as well as prevention. 
 
 
Priorities of mental health public policy in Portuguese-speaking countries from Africa and 
South America: how to build nationwide care systems in contexts of social inequalities, 
vulnerability and scarcity (Prof Pedro Gabriel Delgado, Institute of Psychiatry, Federal 
University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) 
  
The presentation can be summed up by the central question ‘How are developing 
countries facing the thorny problem of the mental health treatment gap?’ This question 
unfolds into others, including how to set clear priorities for mental health policy, and in 
what way is it possible to build sustainable responses at national level. Brazil is taken as an 
example in answering these questions, taking into account innovations implemented in 
the last 35 years, and prospects for the future brought about by drastic political change 
that the country has faced since 2016. A workshop for representatives from Portuguese-
speaking countries was held in Lisbon recently (January 2019) to discuss the challenges 
posed by the targets of Agenda 2030. This workshop coincided with the launch of the 
Lancet Commission’s report on mental health. The central theme of the workshop was the 
strategies developed by very populous countries such as Mozambique, Angola and Brazil 
with the aim of building nationwide service networks in the context of social inequality, 
scarcity and vulnerability. Mozambique is a successful example of innovation through 
task-shifting in personal mental health. 
  
The 2030 Agenda for Sustainable Development includes mental health and well-being 
among its goals. The Lancet Commission report of October 2018 explicitly recommends 
that mental health be included in all the SDGs. Inclusive education, gender equality, 
sustained peace and opportunities for decent work are all conditions for achieving well-
being. In that sense, the scenarios of social inequalities, violence in all its forms and 
vulnerability are challenges for mental health policy. 
  
The process of psychiatric reform in Brazil will be examined in more detail, taking into 
account geographic and socioeconomic data. Brazil has a population of 206 million 
inhabitants and GDP of US$1,960 trillion. Since 2001, Brazil has experienced significant 
improvement in the indicators of infant mortality (13.12%) and life expectancy at birth 
(76.2 years). The human development index (2017) is 0.759, which is the 79th position in the 
world. 
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The components of psychiatric reform include transformation from the hospital-centered 
system to community psychiatry, in a balanced care model; the radical internalisation of 
mental health services to regions previously not covered by care; strong integration 
between community-based specialised services and primary care; the challenges of the 
institutionalisation of long-stay patients; the promotion of health and well-being in social 
contexts of inequity and vulnerability; how to build a sustainable mental health network in 
a large country with scarce financial resources; and the challenge of the single health 
system (SUS) and its goal of universal health coverage. The programme to downsize beds 
in psychiatric hospitals was the first challenge. Until 2001, the hospital component 
comprised almost 90% of mental health expenditure. The steady reduction of beds since 
2001 was interrupted in 2017. The beds have been reduced in order to progressively 
transform hospitals with more than 500 beds into smaller micro hospitals, ensuring safe 
transition of the care model. Residential services were created in order to receive long-
stay patients. For the same purpose, the country has created a major innovation, namely 
the ‘return home’ programme, which has been approved in national law and provides 
financial support directly to long-term patients who are discharged from hospital and 
treated in the community, where they can become full citizens in the society. 
  
The second major component of the psychiatric reform process was the establishment of 
community-based mental health services throughout the country, called psychosocial 
care centres (CAPS), which have grown steadily from 295 in 2001 to 2209 by 2014, ensuring 
the internalisation of mental healthcare. Facing the challenge of the mental health gap 
and the barriers to access to treatment, these centres have modalities for adults, children, 
adolescents and youth and patients with problems associated with the consumption of 
alcohol and other drugs. 
  
In order to ensure access to treatment, mental health has been articulated with primary 
healthcare in the form of collaborative care or inclusion of mental health teams. 
Community health agents began to receive training in mental health cases and situations. 
Unfortunately, in 2017 the expansion of this programme was interrupted by the federal 
government that took over after the removal of President Dilma Rousseff. 
  
The coverage of family health teams has been expanded to the current figure of 39,000 
teams. This is one of the main achievements of the unified health system and the gateway 
to the whole system. The care setting has changed completely with the extension of the 
primary care themes throughout the country. In 2019, the new government extinguished 
the ‘More Doctors’ programme and made changes to the family health programme, 
which means a threat to primary healthcare coverage. 
  
The changes in funding should also be highlighted. There has been a shift in the destination 
of financial and human resources from mental health so that the community component 
(i.e. community-based mental healthcare, residential services and primary care) has 
surpassed the hospital component since 2006. More than 85% of funding is earmarked for 
the community service network, with a real increase in mental health financial resources, 
although still insufficient at around 2.6% of total health expenditure compared with the 
WHO recommendation of at least 5%. The demographic and socioeconomic 
characteristics of Brazil constitute a challenge for mental health and for the promotion of 
well-being in accordance with the sustainable development agenda. 
  
The main problems include: 
• Extreme socioeconomic inequality, which is one of the most serious in the world, 
with a high concentration of income aggravated by the neoliberal agenda of the 
current government; 
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• Decrease in overall financing for health and public policies since 2016; 
• High unemployment of around 13%; 
• Serious problems of urban violence, with territories occupied by armed groups 
linked to drug trafficking or paramilitary militia groups; 
• Increased mortality from homicide (56 per 100,000 per year); 
• Explosive penitentiary situation, with the third-largest prison population in the world; 
• Racial and gender discrimination. 
  
Brazil has made a safe transition from the hospital-centred psychiatric model to the 
community mental healthcare model of balance. There are still several challenges to 
overcome in the consolidation of a psychosocial care network capable of overcoming 
the care gap, but the existing evaluations and studies maintain that the direction is 
correct. However, there are two enormous challenges to be faced: firstly, the worsening 
of social tension, vulnerability, unemployment and inequity, especially in 2019; and 
secondly, the political challenge represented by the funding restrictions of the fiscal 
adjustment agenda of the governments implemented in the country after 2016. There is a 
real risk to the unified health system and intersectoral public policies. 
  
Prof Delgado expressed his solidarity to all countries that are pursuing the goals of Agenda 
2030. 
  
  
Adolescent substance abuse trends: the need for early identification (Prof Arvin Bhana, 
Chief Research Specialist, Health Systems Research Unit, South African Medical Research 
Council) 
 
The association between adolescent substance use and the emergence of future 
substance abuse, including mental health issues, is quite strong. Accelerated neuronal 
development takes place in adolescents together with advanced pruning. This group is 
vulnerable because of the use of substances. Due to pruning, the vulnerability to 
dependence has greater effects on some parts of the brain. Harmful alcohol use in early 
adolescence predisposes to damage in the brain in some cases. While the abuse of 
substances can disrupt the potential for higher cortical functioning, it should also be borne 
in mind that the shorter period of use is less likely to lead to entrenched patterns of abuse. 
There are some good reasons why adolescent substance use needs to be looked at.  
 
Repeated cross-sectional data will be presented, because the research involved 
respondents being surveyed at successive time points. This allows disaggregation for 
examining trends in some populations. The disaggregated data help provide more robust 
estimates of emerging or developing trends and useful information about overall patterns 
of abuse over time and take away the notion of a particular substance being abused 
more at a particular point in time forming a new trend. When the data are considered 
over time, the apparent trends even out, given that variations may spike over a short 
period of time. 
 
The data have been collected from 78 inpatient and outpatient treatment centres by the 
South African Community Epidemiological Network on Drug Use. This network has been 
collecting this type of data for a long time. This is currently the only data on substance use 
provided to the DoH, not only among adolescents but also among adults. The data are 
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facility based (i.e. from people who visit treatment centres for substance abuse issues, not 
data from the general population or communities). The data cover the whole of South 
Africa (with Mpumalanga and Limpopo combined as the Northern Region, and Free 
State, Northern Cape and North West combined as the Central Region). The data reflect 
trends in substance use among adolescents in treatment aged between 10 and 19. The 
data were collected every six months between 2009 and 2013.  
 
The most populous region in terms of young people aged 10 to 19 is KwaZulu-Natal (KZN) 
(about two million in total), followed by the Eastern Cape and Gauteng. Over the period 
under investigation, Eastern Cape presented 7.7% of the data and KZN 9.4%. Two 
provinces, the Western Cape and Gauteng, have over one third of young people aged 
10 to 19 in treatment, with averages far above the norm and out of proportion to the 
number of young people in the province.  
 
The data bear out the perception that substance abuse is more prevalent among males. 
On average, four-fifths of the population in treatment is male. The Eastern Cape follows 
that trend, with 20% of those in treatment being girls and young women. In the Western 
Cape and Northern Region by comparison, far higher percentages are female. Gauteng 
also had a substantial number of young women in treatment. The age of vulnerability 
peaks in mid to late adolescence, generally between 16 and 17 years of age. Every 
population group apart from Black Africans is overrepresented in the data in relation to 
the size of the respective population.  
 
In the overall data set for the period January 2016 to December 2018, the data for the 10–
19 age group are predominant. Substance abuse appears to be a phenomenon of young 
people. A very small percentage of those treated during the five-year period are returning 
patients; most are new patients.  
 
Most of the cohort in the data set were treated on an outpatient basis. This begs the 
question of whether this is an effective approach to treating substance use among young 
people. However, this is the treatment that is available. Most of this treatment is provided 
by an NGO, not by the state.  
 
The profile of the major substances abused has changed over time. Methamphetamine 
and heroine, the top drugs of use in 2009, began to decline.The most significant 
substances that are currently abused are marijuana and alcohol. Multiple substance use 
is often a factor (including also heroine, nyaope and methamphetamine). A second series 
of data, from 2013 to the present, might further exemplify the change in pattern. Between 
2009 and 2013, there was a steady increase in drug use among early and mid-adolescents 
but not late adolescents.  
 
Data on mental health started to be collected recently. The data are not sufficiently 
granular to provide details of the type of mental health issues that the patients present 
with. The data already show a direct relationship between mental health and substance 
use. Early identification is critical. Given the age of greatest vulnerability, efforts to identify 
early abuse are possible. Substance abuse needs to be identified at school, in the 
community and at primary healthcare level, but the tendency is to focus exclusively on 
adults. Young people are not receiving enough attention because the problem is 
overlooked and they are generally not considered to be individuals in need of help. From 
a prevention perspective, if young people are not targeted, the prospects of treatment 
for this age group are not good.  
 
39 
 
Screening tools that are fit for purpose are required and may help in addressing the 
challenge through early identification and referral to treatment; however, there is not 
much treatment available.  
 
The research gaps include the fact that most research on these issues has been done in 
high-income countries. The applicability of the findings to a country such as South Africa 
is uncertain. It is not known whether the treatment modalities that are offered, or the 
relationships shown between substance use and various characteristics, are applicable to 
South Africa. There is severe underrepresentation of research in low-resource contexts. 
Much of the work is exploratory rather than explanatory (i.e. basic survey-oriented 
research that is not particularly useful in planning interventions or preventing substance 
use). Robust research is required, using sophisticated methodologies and statistics to 
provide better-quality evidence of what works, for whom, and in what context. Currently 
this data does not exist.  
 
Systems-based research that focuses on issues of implementation is required and should 
form the bedrock of sustainable and effective research efforts. If interventions are 
implemented without considering the context in which the problems occur, the 
interventions are likely to be unsustainable, incapable of scaling up and ineffective.  
 
Early identification is important in the interests of prevention. Research is required into 
adaptations, the development of valid and reliable measures, and the most appropriate 
type of intervention for a particular type of substance abuse problem in a given context 
(e.g. interventions for the same population group might differ between a school, a primary 
healthcare environment or a community). It is likely that in some provinces the issues might 
not be related to the substances that are abused, but social determinants could play a 
significant role in some communities engaging more in substance use than others).  
 
What systems and processes need to be in place to ensure continued care from early 
identification to intervention? In high-income countries as well as middle- and low-income 
contexts, the evidence for effective treatment for adolescents does not inspire 
confidence. Early identification to prevent the problem from becoming chronic (i.e. 
associated with dependence) is thus even more critical.  
 
Discussion 
 
Ms Scott (Wits): As a psychologist who sees people from both outside and inside the 
university, there are signs even among students of problems that will emerge more fully 
later, such as very high levels of anxiety, withdrawal and avoidance of reality, and low 
self-esteem. These are early indicators that suggest the potential for later alcohol 
dependence. The interventions need to focus on anxiety. 
 
Prof Bhana (SAMRC): Some practitioners feel uncomfortable to ask patients how much 
they drink, especially if the patient is a young person, but this question needs to be asked 
to put the patient’s health into context. From a certain cultural perspective in South Africa, 
high alcohol consumption is considered normative, so the answer to the question could 
indicate existing or potential problems and risks.  
 
Ms Scott (Wits): Alcohol usage tends to increase into adulthood, and high levels of alcohol 
use may be normative among students, usually in a social context. Avoidance of reality 
may be seen along with alcohol use among many students. Anxiety and high levels of 
punitive self-talk are another form of avoiding facing a part of the self. These key factors 
among adult alcoholics can already be seen in students. High normative social drinking 
among students could become alcoholism in later life.  
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Prof Sinha (All India Institute of Medical Sciences): Is the approach to following the 
metabolome and the microbiome longitudinal? Is the microbiome expected to remain 
stable, and what are the components? How do you distinguish between the stable and 
unstable components of the microbiome? 
 
Prof Rietschel (Central Institute of Mental Health, Germany): Research suggests that a 
microbiome pattern remains relatively stable after the age of 3 years, albeit it may change 
thereafter due to many factors. The microbiome is only starting to be researched for 
psychiatric disorder. In our research the microbiome of four-year-olds was investigated. 
Associations were found with cognition, which have been reported before. These findings 
are associated with smoking by the mother during pregnancy. The significance of these 
associations is not yet understood. Follow-up research will be required.  
 
Dr Zungu (HSRC): Are you seeing an increase in the number of young people that present 
at clinics since the ruling that made dagga legal for personal use?  
 
Prof Bhana (SAMRC): It is still too early to establish whether the change in legislative 
regulations for marijuana have made a difference in usage patterns. It is also difficult to 
make a direct association between people who are likely to use marijuana and whether 
they are now likely to use it more frequently than before. However, the changes in 
regulations are unlikely to improve the situation among users.  
 
Prof Petersen (UKZN): The DoH is introducing screening into primary healthcare facilities, 
and also wants to introduce screening for community healthcare workers. The 
presentation focused on the measures. Will you also interrogate ‘how’ in order to provide 
balanced data? The question of ‘how’ is important from the perspective of the provider 
(i.e. who is doing it), what training they would need, and how best to introduce screening 
(e.g. in a screening room or consultation room), how it is integrated into other screening 
processes, as well as the patient’s perspective. South Africa has a low medical literacy 
rate, and patients do not understand what they are being screened for. Psychoeducation 
may thus also need to be introduced. 
 
Prof Kagee (SU): The data raised some concerns about the utility of routine screening, 
which needs to be borne in mind. Screening might seem to be an easy solution; screening 
is certainly required, but we need to be more circumspect about the potential gains from 
routine screening. Perhaps our expectations are somewhat inflated with respect to the 
health outcomes, including mental health outcomes, that can occur as a consequence 
of screening. In other contexts, such as the USA for example, there is mixed evidence that 
routine screening leads to optimal mental health outcomes. These considerations need to 
be taken into account in the debate about the potential benefits of screening. We should 
not give up on screening, because we need to be able to identify people who require 
mental health services. It will be important to consider ways to integrate local idioms of 
distress as items on measures that pertain to people’s lived subjective experience. This will 
probably be the next step in this line of work.  
 
With respect to the question of where and how screening should be conducted, 
screening could not be conducted in clinic waiting rooms for example. Screening has to 
be done under more controlled conditions where nurses are screening patients for other 
conditions as well. A possible approach would be to try to identify a minimum number of 
items on a screening instrument that could lead to a stepped approach in which people 
who endorse items in a scorable direction are referred for additional assessment. 
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Prof Domschke (University of Freiburg): Congratulations on the data showing comorbidity 
of HIV patients with mental disorders. There is a tendency not to look at categorical 
disorders any longer. There has been considerable work on transdiagnostic psychometric 
instruments. There are research consortia looking at genetic data that point towards a 
common biological trunk for several disorders. At the diagnostic level, there seem to be 
common intermediate phenotypes and genotypes. This mirrors efforts in treatment; David 
Barlow’s transdiagnostic unified protocol for emotional disorders, for example, pointed 
towards targeting intermediate phenotypes of mental disorders. This is especially 
interesting in the context of global mental health. If it is necessary to use resources 
economically, one might want to focus on interventions that are economical in targeting 
many disorders at the same time. This also applies to therapy. 
 
Prof Kagee (SU): There are debates whether a mental health condition is a continuous or 
binary phenomenon. In a Lancet paper of which Prof Crick Lund was an author, there was 
a strong statement that mental health conditions should be considered as a continuum, 
which seems to be true. The issue is to manage this in a public health context. How do you 
make decisions about who to refer, who to treat, how that process should take place, 
and what markers to take into consideration in making such decisions? Even though 
mental health conditions exist on a continuum, as a heuristic approach to making quick 
decisions, we probably need to think about mental health conditions both in terms of a 
continuous variable and a binary variable for ease of decision-making. 
 
Dr Allen (Lentegeur Psychiatric Hospital): It is not clear how to make sense of some of the 
data presented. The presentation emphasised that Gauteng and the Western Cape have 
higher numbers of young people using substances, but it was also noted that these are 
the provinces with the highest numbers of facilities for treatment. The lower numbers of 
people presenting for treatment in other provinces could result from the fact that there 
are fewer facilities. This could thus be an issue of poor case detection.  
 
If the data show that there has been a problem of substance use among adolescents as 
well as older people since 2009, should we not consider testing and screening pre-teens? 
 
Prof Bhana (SAMRC): It is not clear whether the higher numbers of treatment centres in the 
Western Cape and Gauteng were established in response to the drug issues. The facilities 
are not operated by the state but by an NGO, which provides services on the basis of the 
demand.  
 
Young people are usually brought into treatment by family members following a period 
of trying to deal with issues of substances use, or they will be referred by the school. The 
public health service is the least efficient channel for referring them, except in cases of 
overdose or attempted suicide. Even if children were identified early, the services for 
treating them are lacking. The young people thus enter treatment centres for adults, 
which are not adolescent friendly or equipped to deal with adolescent issues. Often the 
issues are related to the families of the adolescents who are referred for treatment also 
being caught up in the spiral of alcohol and drug use. There are thus social determinants 
that are difficult to fix. The availability of services is one of the factors that determines 
whether and when adolescents will receive treatment. Most of the adolescents who 
receive treatment do so as outpatients, which calls in question the quality of the services. 
If an adolescent receives treatment for just a few hours and then returns to the same 
environment that gave rise to the problem, nothing will have changed. The success of 
such treatment is highly questionable. Early intervention alone would not be effective. 
What is required is evidence-based interventions to mitigate the issues surrounding the 
treatment of young people.  
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Some of the evidence related to the treatment of young people from good studies 
conducted in high-income countries with the necessary resources is not particularly 
encouraging. Treatment is very expensive, time-consuming and requires specialists. The 
South African health system cannot cope with any of these conditions.  
 
Early intervention is required but should perhaps not focus on substance use, but rather on 
wellness. South Africa needs research that does not necessarily focus on the pathology or 
the negative aspects but on what would make adolescents well within the context of 
toxic environments.  
 
Dr Allen (Lentegeur Psychiatric Hospital): In the Western Cape, the management of the 
affairs of children under the age of six years is the responsibility of the Department of Social 
Development, while the Education Department is responsible for the management of the 
affairs of children aged between seven and 18; however, the mandate for substances 
belongs to the Department of Social Development. These factors complicate the issues of 
where patients are seen, and which party intervenes. There is a need for policy integration 
in order to avoid part of the system having to take responsibility for issues that they do not 
have the capacity to manage effectively.  
 
Unidentified speaker: Is there any correlation between mental health and socioeconomic 
conditions? One would expect a higher proportion of mental health cases in the poorer 
provinces. 
 
Prof Bhana (SAMRC): The South African Community Epidemiology Network on Drug Use 
(SACENDU) does not collect such data, and it is thus not possible to make associations 
between mental health and socioeconomic conditions in the data set. Other data, 
however, show strong and clearly established patterns of socioeconomic problems 
contributing directly to the extent of drug and alcohol problems within communities, but 
the links between socioeconomic conditions and substance use are not exclusive.  
 
Prof Petersen (UKZN): It would be important to take into account data on the number of 
treatment centres per region. Did you record this data? It might be assumed that Gauteng 
and the Western Cape have more treatment centres because they are more affluent. 
The Eastern Cape is one of the poorest provinces and has among the lowest incidences 
of adolescents receiving treatment, but the prevalence of adolescents who need 
treatment for substance abuse in that province is not known.  
 
Prof Bhana (SAMRC): The data came from 76 treatment centres overall, but the number 
of treatment centres per region was not explicitly singled out. The number of treatment 
centres per region is not related to affluence. SACENDU does not collect data on the 
prevalence of substance abuse. The number of treatment centres established in the 
various regions is probably based on a business model rather than a healthcare model. 
 
Prof Nöthen (University Hospital of Bonn): The limitations of clinical studies with respect to 
generalisability of the results to the general population have been mentioned. It is 
important for healthcare systems to establish resources for data from the general 
population (e.g. on prevalence) to assess the effect of certain parameters that are 
measured in distinct clinical populations. Germany has established the national cohort for 
this purpose and there are endeavours in other countries worldwide. Has South Africa 
considered establishing such a resource? 
 
Prof Stein (UCT): The suggestion to establish a resource for population-wide data (e.g. on 
prevalence of mental disorders) in order to be able to compare data from certain clinical 
populations could be a recommendation of the workshop. Such initiatives are not limited 
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to high-income countries but are being done in some developing countries (e.g. Vikram 
Patel in India). 
 
Prof Lund (UCT): There are several demographic surveillance sites in South Africa (e.g. in 
rural KwaZulu-Natal and Mpumalanga), which enumerate the entire population of a 
particular catchment area, capture data over time, and establish data on births, 
mortality, in-migration and out-migration). Many of the surveillance sites are focused 
specifically on HIV. Very little work is being done on mental health in these catchment 
areas. South Africa does not have nationally representative data. There is one nationally 
representative survey in South Africa, which Prof Dan Stein conducted in 2002–2003.  
 
Prof Stein (UCT): Other related initiatives include the Birth to Twenty study, but these are 
not integrated across disciplines. Some are demographic studies. An Agincourt study 
looked at ageing. South Africa does not have resources such as the UK biobank or the 
national cohort in Germany with a range of data that can be analysed from different 
perspectives and then integrated.  
 
Prof Bhana (SAMRC): The National Income Dynamic Study collects data on mental health 
using a depression screening tool. This is perhaps a model for collecting national data on 
other issues. Birth to Twenty is a cohort study but does not provide data on the extent of 
issues in the general population. 
 
Prof Stein (UCT): The South African National Health and Nutrition Examination Survey 
(SANHANES-1) collects data among other things on blood pressure. 
 
Dr Zungu (HSRC): The HIV/AIDS national household survey also includes a measure for 
substance use called the Audit and the later survey includes the Kessler 10 for Depression. 
This study has been done since 2002 and has been repeated five times.  
 
Prof Bhana (SAMRC): These initiatives are driven from the perspective of particular interests 
rather than being strategic. There is no emphasis on the ongoing collection of data on a 
national basis that covers key areas that are important for minimising or reducing the 
extent of health burdens.  
 
The lack of policy integration is an issue (e.g. the Department of Social Development 
being responsible for young people, but not working together with the Department of 
Health). These issues need to be debated and approached in a sensible way.  
 
Prof Stein (UCT): The discussion also raises issues of governance. The National Drug Master 
Plan is driven by the Department of Social Development but is cross departmental. The 
plan speaks to the need for a regular survey of substance abuse in communities across 
the country. However, the plan is not financed. South Africa has policy that is not 
implemented. Due to the lack of implementation, there is a lack of data, and policy 
cannot be implemented because of the lack of data. The National Drug Master Plan is 
centrally highly regulated, but not properly implemented. 
 
Prof Bhana (SAMRC): Recognising substance use as part of neurological disorders and 
treating it as different from mental health places the conditions in different compartments. 
Substance use thus becomes a moral issue rather than a mental health issue.  
 
Prof Stein (UCT): Perhaps this is why data collection on substance use has not been funded. 
The USA, for example, does an annual survey of substance use in which substance use is 
not seen as a moral issue but as a mental health issue. 
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Prof Nöthen (University Hospital of Bonn): Prof Rietschel pointed out that there are new 
technologies and methods of data collection to counter the impression that data 
collection is necessarily expensive. Much cheaper methods could be considered to 
obtain data that were previously costly because of the extensive examinations required 
at a central examination centre. New studies could make use of new technologies to 
collect data in more efficient and cost-effective ways. This is a matter of design and the 
phenotypes that researchers wish to concentrate on. 
 
Prof Stein (UCT): Mxit was an example of a free instant messaging application used by 
adolescents from widely varying socioeconomic groups, which could be used to conduct 
surveys, for example, on their preferences. Surveys on social media would cost 
government very little. 
 
Prof Rietschel (Central Institute of Mental Health, Germany): Methodologies developed for 
other studies could be repeated to collect new data in such a way that the data sets 
would be comparable with data that have already been collected in other surveys. For 
example, researchers could go back to a specified subgroup to collect biomaterial and 
compare this with a particular phenotype, thus producing data that would be 
comparable with other countries. 
 
Cell phones are widely used among different socioeconomic groups and offer the 
opportunity to collect data (e.g. even beggars are using cell phones to collect money 
rather than accepting cash).  
 
Wrap-up of Day 1 
 
Prof Frank Rösler, Senior Professor, Biological Psychology and Neuropsychology, 
University of Hamburg 
 
It is difficult to sum up the broad scope in a few brief statements. The topics covered in 
the various presentations ranged from public health issues, to basic research and genomic 
psychiatry. Some of the presentations triggered thoughts that deserve further discussion.  
 
The GWAS were mentioned, and their relationship to psychiatric diseases, but there is a 
basic psychophysiological mapping problem. The key question is how to establish 
relationships between basic molecular findings on the one hand, and very broad 
categories of psychiatric syndromes on the other hand. In order to fill the gaps between 
these areas, we need more knowledge about how genes express in certain physiological 
functions, and how this is mapped to behaviour, otherwise we will remain stuck with 
genome associations and correlations that are not causal explanations. This area is open 
for research. 
 
There are certain critical periods during the life span (e.g. some effects might work on 
gene expression during pregnancy). Environmental factors that might play a role in the 
expression of psychiatric diseases due to existing predispositions during these critical and 
sensitive periods, or that might help to strengthen resilience, are not well understood. This 
research area needs more effort to be invested. 
 
The bottom line in relation to health is raising money, which means convincing politicians 
to invest. Mental diseases from which hundreds of millions of people suffer are a pressing 
problem. One of the main reasons why significantly larger sums of money are spent on 
research on cancer and heart disease than on mental health seems to be that politicians 
are more easily convinced to invest in diseases from which they could potentially suffer 
and that are life threatening. Mental diseases are not immediately life threatening. We 
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need different ways to convince politicians, one of which might be the economic burden, 
which needs to be translated into terms that politicians readily understand. 
 
Prof Crick Lund (Alan J Flisher Centre for Public Mental Health, Department of Psychiatry 
and Mental Health, University of Cape Town) 
 
The presentations showcased a broad range of research, from basic genetic research to 
applied public-health oriented research.  
 
It was interesting to hear the priorities listed by Dr Yogan Pillay (DDG: Health Programmes, 
DoH), an influential policymaker. The priorities were heavily focused on operational 
research in South Africa and how to bridge the treatment gaps.  
 
Five key points stood out from the presentations: 
1. It is important to develop the field in interdisciplinary ways. Researchers tend to work 
in silos. In order to bridge the gaps from basic genetic science through to the way in 
which symptoms present themselves behaviourally, we need more conversations such 
as those at this symposium in order to consider how social epidemiological data could 
be built into genomic studies, for example.  
2. Obtaining and following population representative data is important. Snippets of data 
from South Africa and other sub-Saharan African countries are often facility based 
rather than representative. There is a general lack of nationally representative data 
that are adequately powered to answer the questions we need to answer. We often 
have cross-sectional data but are not able to follow cohorts over time. The idea of 
establishing a nationally representative population cohort from which biological 
samples could be gathered as well as a range of psychological and socioeconomic 
data is very compelling. Collecting such data could potentially inform the future 
research agenda. 
3. In order to answer many of the questions in which we are interested, we need large 
samples. This was identified very strongly in the genomics research in particular. We 
cannot rely on studies with small samples from a single country. There is huge 
untapped potential in African populations. Most of the current genomic research is 
conducted on European populations. Prof Sinha made a compelling case for the 
potential of looking at endogenous groups in Indian and African populations to take 
this kind of research forward.  
4. We also need longer follow ups. 
5. We need international collaboration. It is hoped that this symposium will be the start of 
work involving the pooling of data sets and the development of common measures 
despite socioeconomic and cultural diversity.  
 
The intention on Day 2 of the symposium is to distil some of these thoughts in order to 
identify a set of research priorities that could be recommended to ASSAf, Leopoldina and 
academies in India, Brazil and China in order to start to shape the direction of funding for 
public benefit in the short and long term.  
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DINNER 
Facilitator: Dr Khutso Phalane-Legoale, Programme Officer: Health and Related Sciences, 
Academy of Science of South Africa 
 
Provider core competencies for improved mental healthcare of the nation: a consensus 
study (Prof Rita Thom, University of the Witwatersrand, South Africa) 
 
The consensus study on ‘Provider core competencies for improved mental healthcare of 
the nation’ is the first mental health-related project to be conducted by ASSAf. The study 
is still under way. 
 
South Africa has a significant burden of MNS disorders and a large treatment gap. The 
National Mental Health Policy Framework and Strategic Plan (2013–2020) clearly outlines 
a strategy to reduce the burden of disease posed by MNS disorders. A fundamental 
principle and strategy in the plan is task-sharing/shifting (i.e. generalists and lay providers 
providing some of the interventions that might be provided by specialists in other more 
developed countries). There is thus a need for clarity on the core competencies for each 
level of provider in order for task-shifting/sharing to work. The US Institute of Medicine (IOM) 
convened a meeting in Uganda in 2012 at which core competencies for treating MNS 
disorders in sub-Saharan Africa were proposed.  
 
ASSAf took this matter up, and convened a workshop in 2014 that considered the question 
‘How could these core competencies be implemented in South Africa?’ The ASSAf 
consensus study was then commissioned in 2015 with Prof Rita Thom (Wits) as chairperson 
and the following expert panel members approved by the ASSAf Council: Dr Robin Allen 
(DoH), Associate Prof Eve Duncan (UCT), Prof Crick Lund (UCT), Prof Bronwyn Myers 
(SAMRC), Prof Solomon Rataemane (Sefako Makgatho Health Sciences University), Prof 
Inge Petersen (UKZN), Ms Bharti Patel (South African Federation for Mental Health) and Dr 
Gayle Langley (Wits). ASSAf was represented by Prof Roseanne Diab and Dr Khutso 
Phalane-Legoale, and Mr Robin Hamilton was the researcher for the study.  
 
The rationale for the study was to establish whether providers are adequately equipped 
with the necessary competencies to implement the plan. There is a need for a consensus 
view on the education and training needs of healthcare workers and other providers in 
South Africa in MNS disorders. 
 
The aims of the study were to: 
• Interrogate core competencies developed by the IOM and ASSAf workshops, and 
agree on ‘ideal’ core competencies; 
• Provide baseline data on current training programmes; 
• Map these data against core competencies identified by the panel and identify gaps 
in current training programmes; 
• Consult with key stakeholders to contribute to the report; 
• Make recommendations to address gaps and improve the capacity to provide 
comprehensive services for people with MNS disorders; 
• Disseminate recommendations to the Health Professions Council of South Africa 
(HPCSA), the DoH and other training and regulatory bodies.  
 
The panel identified core functions and core competencies for each provider group. 
Baseline data were collected with respect to curricula and existing core competencies 
for provider groups (although there were many gaps in the required information). A 
mapping exercise was done to identify appropriate training and highlight gaps. The final 
report is being drafted. 
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It needs to be acknowledged that mental healthcare is multisectoral and 
multidisciplinary. The study focused mainly on public sector formal health services for 
adults. The predominant focus was on the district health service, taking primary healthcare 
(PHC) re-engineering and the National Health Insurance (NHI) into account. It was not 
possible to include other sectors (education, police, justice, correctional services) and 
informal services (traditional healers and faith-based organisations) due to resource and 
time constraints, although it is recognised that these sectors are important players in 
relation to mental healthcare.  
 
The vision of care for MNS disorders in South Africa is that it should be a district-based, 
comprehensive and integrated mental health service using a task-sharing and task-
shifting approach with specialist support. Such care is based on a recovery model and a 
disability-inclusive approach in which the human rights of all individuals are respected. 
Each individual is assisted to reach their potential within the restrictions of their illness or 
level of disability. Services should be provided in the least restrictive setting possible, as 
close to home as possible. The emphasis is on ambulatory care and voluntary care. 
Community care needs to be defined very broadly and be inclusive of other sectors and 
NGOs that play a role. Admission to hospital should only be for acute episodes of severe 
mental illness. Long-term institutional care should be provided only for those who cannot 
be cared for in the community. There needs to be a balance between outpatient and 
inpatient services. 
 
The district mental health specialist team organises services in the district. People should 
enter the system through primary care including PHC clinics and ward-based outreach 
teams (WBOT), which visit patients in their homes and are ideally placed for screening and 
assessment for MNS disorders. Primary care interventions include referral to providers at 
primary care level (counsellors, allied health professionals, doctors for medication) or 
referral to specialist providers (including family physicians) for consultation or for inpatient 
treatment. The clinical multidisciplinary specialist team, for patients who cannot be dealt 
with by PHC practitioners, comprises a psychiatrist, psychiatric nurse, psychologist, 
specialised social worker and occupational therapist. Apart from the district mental 
healthcare specialist team, there should be clinical teams with the relevant disciplines 
within the district, but not hospital based. The consensus study report emphasises the 
importance of these clinical teams.  
 
Inpatient treatment at district hospitals is managed by generalist doctors, nurses and allied 
health professionals. Seventy-two-hour assessments are conducted with appropriate 
facilities. Patients may be referred to secondary level care at acute psychiatric units (with 
specialist teams), or to tertiary level care at central academic hospitals and specialised 
psychiatric hospitals. Patient stays should preferably be short, and patients should be 
discharged back to the community, with post-discharge referral back to the clinical 
specialist team, and down-referral to PHC for ongoing management of stabilised patients, 
which should include engagement with other sectors and liaison with community-based 
psycho-social rehabilitation services. Specialists should provide support for PHC services. 
 
The consensus study looked at the following service provider categories: community 
health workers; nurses, general medical practitioners (including emergency medical 
practitioners and clinical associates); the psychosocial rehabilitation team comprising 
psychologists, social workers, occupational therapists; and medical specialists (including 
family physicians, neurologists and psychiatrists). 
 
The consensus study made several key findings with respect to the various categories of 
providers: 
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• Community health workers (CHWs): This category developed during the HIV/AIDS 
epidemic prior to ARVs as a cadre employed in the public sector who form part of 
ward-based outreach teams. There is also a category of community caregivers. Ward-
based outreach teams could play a pivotal role in screening, referral and providing 
adherence support for MNS disorders. Current training equips CHWs with generic 
competencies, but it is unclear whether there is sufficient content training in MNS 
disorders for them to be able to screen appropriately and provide adherence support. 
Ongoing support, training and mentoring from professional nurses is critical. It is not 
clear what kind of training caregivers receive. If any training is provided, it does not 
seem to be regulated in any way. 
 
• Nurses: They form the backbone of the health service in South Africa and often 
perform an expanded role. Over the years they have taken over many roles that 
medical practitioners would play in other countries, including assessment and 
treatment of medical conditions. South Africa is facing a critical shortage of nurses, 
which is likely to worsen. There seems to be underutilisation or lack of posts for auxiliary 
and staff nurses. The restructured nursing curriculum largely excludes psychiatry. The 
current training in the four-year degree and diploma and the Advanced Diploma in 
Psychiatric Nursing covers the required competencies but has been criticised for not 
preparing practitioners adequately to deal with MNS disorders. There is concern that 
the new curriculum contains less psychiatry and mental health than the current 
curriculum. This needs to be raised with the South African Nursing Council and the DoH, 
because primary care nurses are expected to provide primary mental healthcare. A 
positive aspect has been the development of the Adult Primary Care (APC) 
approach, which provides training and resources for nurses including essential areas 
of primary mental healthcare. 
 
• Medical and associated professions:  
o Emergency medical services are being rationalised. Generic competencies for 
managing emergencies are taught, but there is insufficient content on 
emergency presentations of mental disorders in order to manage them safely.  
o Clinical associates are a new category of professionals that were developed to 
support general practitioners and perform some of the roles of general 
practitioners. Their roles are still quite fluid and their competencies are not clearly 
defined. At present clinical associates do not seem to be properly utilised. Clinical 
associates could play an important role in assessment, psychoeducation and 
monitoring of people with MNS disorders, but there is insufficient attention to MNS 
disorders in the curriculum.  
o Doctors: South Africa is relatively well-supplied with doctors compared to other 
SADC countries. However, there is maldistribution of doctors, with 60% of doctors 
working in the private sector and a concentration in the urban areas. South Africa 
has instituted community service for doctors, which has gone some way towards 
alleviating the shortages in rural areas. However, community service doctors are 
junior and need support and supervision, which are often lacking. Doctors trained 
in South African medical schools generally receive sufficient training in core 
competencies to manage MNS disorders at primary care level, including district 
hospitals. Other barriers play a significant role, including competing health 
priorities, lack of specialist support, time constraints, and in some situations a lack 
of medication. 
 
• Psychological services:  
o Behavioural health counsellor: This category of behavioural health counsellor has 
evolved from initiatives such as the PRIME and is being proposed to the DoH as a 
provider for structured counselling interventions for conditions such as depression. 
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Currently there are very few posts available in the public sector for these providers. 
They could play a useful role at primary care level, including supervising 
behavioural health counsellors. 
o Psychometrists: They play an important role in assessment, especially for children 
and adolescents. 
o Registered counsellors: South Africa has developed training for this category in the 
form of the four-year BPsych. There are various categories of psychologists at 
master’s level. The findings related to psychologists and other practitioners in this 
category is that there is a need for training in evidence-based psychological 
interventions, including psychoeducation, specific manualised and structured 
interventions, counselling and psychotherapy in a stepped approach, in which 
health counsellors provide much of the psychoeducation and manualised 
interventions, and psychologists provide more specialised psychotherapy. The 
emphasis in providing services should primarily be on ambulatory care in the 
district, with some services in inpatient settings. Clinical psychologists work primarily 
in specialised settings, which are not necessarily hospitals. 
o There is a maldistribution of skilled professionals as for doctors, a lack of posts for 
registered counsellors, lack of standardisation of training and curricula across 
training institutions, and a need for more specialised clinicians to play a greater 
mentoring and training role with respect to primary care. 
 
• Social work services: These include auxiliary social workers and professional social 
workers (as well as youth workers). Social workers are a scarce resource in the public 
sector, especially in health services. They are skilled in providing individual and group 
interventions. Current social workers have received some training in substance use 
disorders. Only a few institutions offer training in clinical social work, which equips social 
workers to work in specialist mental health teams. 
 
• Occupational therapy: This category is the most highly trained and skilled in functional 
and vocational rehabilitation and provides guidance to teams in encouraging 
recovery and a disability-inclusive approach. As in several other categories, there is a 
maldistribution of resources, with most working in private healthcare and urban 
settings. Related categories of providers and training programmes have developed, 
including community rehabilitation workers (CRWs). No training is currently provided 
for occupational therapy assistants (OTAs) or technicians (OTTs). There is concern 
about the lack of recognition for occupational therapy in the PHC reengineering 
plans. 
 
• Medical specialists: Family physicians lead the district health service. They are 
responsible for planning, organising and evaluating services in the district. General 
practitioners with a Diploma in Mental Health can serve as a ‘specialist’ resource in 
the district. Neurologists are primarily hospital-based and interact very little with the 
district health service. Psychiatrists and sub-specialist psychiatrists are also primarily 
hospital based, although some are district based. All medical specialists undergo 
standardised final exit examinations through the Colleges of Medicine of South Africa 
(CMSA). For psychiatry, the CMSA has developed core competencies, and 
examinations are aligned with these. There should be greater emphasis on specialists 
providing training and mentoring to district PHC and other staff. 
 
The consensus study identified a number of cross-cutting issues and gaps: 
 
• Substance use disorders: There is an epidemic in South Africa. The social context in 
which people live and the drivers of substance abuse must be taken into account in 
any interventions. Judgemental and punitive attitudes are unfortunately prevalent in 
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the health sector and are unhelpful. There is a lack of adequate training in 
interventions for people with substance use disorders across all providers. Harm 
reduction approaches are the most useful. Integrating some of the WHO work on brief 
interventions into curricula would be important. 
• Child and adolescent mental health: Thirty-four per cent of the total population in 
South Africa is under 18 years of age (2014). MNS disorders often begin in childhood 
and adolescence, and early intervention is most effective at this stage. Further 
research is required to focus on developing competencies for acute care in PHC for 
children and adolescents and in school health services. 
• Promotion of mental health and prevention of mental disorders: It will be important to 
identify specific competencies in these areas and to integrate these into curricula. 
Hopefully the current symposium will help to identify research priorities. 
• Other sectors and alternative health practitioners: Traditional health practitioners are 
often the first site of consultation for parallel treatment. Further research is needed on 
competencies in screening, identification and management of MNS disorders in these 
sectors by alternative health practitioners. 
• Ageing population: 8.1% of the population is over the age of 60 years and this 
percentage is increasing, with an associated high burden of non-communicable 
diseases as well as an increasing burden of neurocognitive disorders requiring specific 
competencies at all levels of providers. 
• Intellectual disability: The severely and profoundly intellectually disabled are a highly 
vulnerable group. They often have associated physical disabilities that require greater 
levels of supervision and physical care, and this needs to be taken into account in 
relation to the providers who care for this group. There is very limited training across all 
categories of providers in caring for this group of individuals. 
 
Other recommendations of the consensus study included: 
• There is a need for evidence-based implementation research to test and evaluate the 
envisaged system of care. 
• Inter-sectoral liaison needs to occur at national, provincial and district levels. 
• Posts are needed for new cadres, registered counsellors, psychiatrists and other 
mental health specialists in district health services 
• Scope of practice issues exist in relation to new cadres, supervision and accountability 
(e.g. if nurses are allowed to prescribe anti-depressant medication, as suggested, who 
would be accountable if things go wrong, and how would appropriate supervision 
take place). 
• With respect to training for district-based services, academic platforms should be more 
district and community-based. 
 
DAY 2: 31 MAY 2019 
 
SESSION 4: INTERVENTION RESEARCH 
Facilitator: Prof Ashraf Kagee, Co-Director, Centre for Public Mental Health, University of 
Stellenbosch, South Africa) 
 
Using intervention research to drive evidence-based integration of mental health into 
primary healthcare settings in South Arica (Prof Inge Petersen, Centre for Rural Health, 
University of KwaZulu-Natal, South Africa) 
 
The presentation will take a systems focus to intervention research over the last eight years. 
The research looked at how to increase access to mental health services in the PHC 
system for people with common mental disorders that are comorbid with chronic 
conditions. Comorbidity of common mental disorders with conditions such as HIV and 
other non-communicable diseases impacts negatively on treatment adherence. This is a 
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significant issue in South Africa due to the high burden of HIV and the size of the investment 
in ARV treatment.  
 
The research began in 2012 with the PRIME. Formative and piloting work were done in 
North-West province at the request of the DoH, which was engaged in piloting NHI science 
as well as an integrated chronic disease model. Initial evaluation was done using an 
experimental approach and two trials. The work was then scaled up with additional 
funding and extended to districts in KwaZulu-Natal and Mpumalanga. The scale-up is 
currently being evaluated using implementation science methods. 
 
The SAMRC framework for complex interventions was used. The work began with 
development in the Dr Kenneth Kaunda district municipality in North West province. The 
team engaged in a series of theory of change workshops as well as formative research in 
order to develop a collaborative package for treating common mental disorders 
comorbid with chronic conditions. The research team made use of what was available in 
the system. Primary healthcare nurses form the backbone of the healthcare system in 
South Africa; their capacity was strengthened to identify common mental disorders. 
Referral systems were also strengthened by training behavioural health counsellors in the 
vicinity (initially these were HIV counsellors) to provide psychoeducation and depression 
counselling as well as adherence counselling. The capacity of doctors was strengthened 
to diagnose and review complex severe cases and prescribe psychotropic medication. 
PHC nurses in South Africa have not been able to initiate psychotropic medication. The 
intention was also to train psychologists to provide training supervision to counsellors as 
well as the referral service for more complex cases in line with the task-sharing approach.  
 
With respect to feasibility, the research team engaged in extensive piloting, resulting in 
some adaptations, in particular the need for change management processes to orientate 
nurses and other providers to all the systems changes and to person-centred care that 
looks at the patient holistically, as opposed to the historical task-centred vertical 
approach. This required role clarification and training in skills to provide person-centred 
care. Central to this approach is clinical communication skills as well as self-management 
for stress and burnout, since they were expected to engage in emotional labour. Other 
changes included the introduction of a psychoeducation talk because of the low mental 
health literacy in the country, existing PHC workers were used in the piloting phase, but 
the research team was then informed that they could not continue to use them because 
the requirements of the research were beyond the scope of what they were paid to do.  
 
South Africa was one of five countries engaged in the PRIME programme, which was led 
by Prof Lund. The initial research was done under the auspices of PRIME, applying a 
method that was used across all five countries. A facility-detection survey was carried out 
to establish whether there was any improvement in the detection of depression and 
alcohol use disorder (AUD) by the PHC providers, in this case nurses. As part of the 
intervention evaluation, a cohort study was conducted to establish the impact on patients 
who were referred for care according to the model. A case study was used to try to 
understand the factors that contributed to the outcomes found in both of the studies. This 
work has been published. 
 
The findings showed a significant increase in identification by the nurses of about 10% for 
depression and 14% for AUD. Among patients referred for treatment, at the three-month 
follow up those receiving treatment were twice to three times more likely to have a 50% 
reduction in depression scores compared to the controls. There were similar findings 
related to remission.  
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These results showed that the intervention was working. It was then tested in two 
pragmatic cluster randomised control trials. One trial focused on depression comorbid 
with hypertension, and the other on depression comorbid with HIV patients on ARTs; the 
latter was a CoBalT trial responded by NIH. The PRIME trial was conducted in a single 
district, and the CoBalT trial in two districts. In PRIME there were 20 clinic randomised 
intervention sites, and in CoBalT there were 40. Approximately 1000 patients were involved 
in the PRIME trial and approximately 2000 in the CoBalT trial. The results are still under 
analysis.  
 
With respect to implementation, funding was obtained from the US Centers for Disease 
Control and Prevention to assist in the scale up of the integrated model in collaboration 
with the University of Washington and an NGO. The scale up was done in Dr Kenneth 
Kaunda district municipality (North West province) as well as Amajuba district municipality 
(KwaZulu-Natal) and Ehlanzeni district municipality (Mpumalanga). There have been 
continual adaptations to the scale-up package.  
 
At provincial level, project-employed counsellors were used for PRIME but it was not 
possible to do this during scale-up. The initiative thus used HIV counsellors, enrolled nurses 
or other people that the DoH or clinics consider to be suitable for counselling and health 
promotion. Continuous quality improvement, which is data driven, was used as the vehicle 
for implementation in order to try and embed this within the services. The two key 
indicators for mental health at PHC level in South Africa, namely number screened and 
number treated, were used. The research team engaged with the DoH to increase the 
number of indicators. Clinical communication skills training was integrated into the adult 
PHC mental health module. The research team referred to the integrated chronic care 
guidelines used in the DoH for PHC nurses.  
 
At facility level, the team worked with a brief mental health screening tool, which is 
currently being introduced. Facilities were using anything available; the tools were 
unstandardised and unvalidated, and sometimes healthcare providers would just look at 
a patient and say that the patient had been screened. The team engaged in a 
collaborative study with the DoH to consider how best the tool should be introduced, and 
developing a standard operating procedure.  
 
The PRIME project did not have a community-level intervention. A major addition was at 
the community level, because of low rates of identification as well as evidence of the 
need to work on growth by improving both demand and supply. The community 
interventions were to improve mental health literacy and identification. The core 
community mental health detection tool is being adapted for the context at the request 
of the DoH. The community health initiatives will be implemented by community health 
worker outreach, who will take a psychoeducation approach and also get people to self-
identify. The process of tracing and linking patients to care is being strengthened due to 
the fallout from care of about 20% of patients who are HIV positive.  
 
An operational manual was developed using continuous quality improvement as the 
vehicle for implementation. The manuals and toolkits for integrating mental health into the 
PHC system for trainers as well as those who are being trained can be freely accessed on 
the website of the Centre for Rural Health. A further initiative is a two-year capacity 
building programme among the KZN provincial directorate as well as all district mental 
health coordinators in the province. The Centre for Rural Health co-designed the 
curriculum, which entails how to do situational analysis using the Mental Health Theory of 
Change workshops to develop the district mental health plans; how to use continuous 
quality improvement to drive the implementation process; monitoring and evaluation; 
and dissemination.  
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As regards evaluation of the scale-ups, the Southern African Research Consortium for 
Mental Health Integration (S-MhINT) involves Mozambique, Tanzania and South Africa. The 
presentation focused on uptake, implementation, effectiveness and sustainability of an 
existing scale-up of an integrated mental health package for chronic disorders project at 
primary healthcare level in two different districts (Amajuba in KwaZulu-Natal and Ehlanzeni 
in Mpumalanga) in South Africa. S-MhINT uses the RE-AIM framework to measure reach, 
effectiveness, adoption, implementation and maintenance.  
 
The preliminary results included: 
• Reach: The initiative started in October 2017 in a rural subdistrict with 13 facilities in 
Newcastle, ten in Dannhauser and two in Emadlangeni and many mobile points. The 
reach was only about 2%, but these people would not have received any services 
without the intervention, since there are only two psychologists in the district to service 
between 500,000 and 600,000 people. The psychologists reported that the referrals 
they were receiving were far more appropriate. 
• Adoption: A PhD student linked to the project investigated adoption, looking at 
predictors of nurse detection and referral of chronic care patients with depressive 
symptoms. This work was embedded in the CoBalT study and found that nurses were 
identifying 50% of the patients screened by the research team as positive for 
depressive symptoms. This was a considerable improvement on the results for Dr 
Kenneth Kaunda district municipality. However, the nurses did not refer all of these 
patients, even though referral pathways were strengthened. Only 30% of those 
identified as having depressive symptoms were referred to treatment, resulting in an 
overall referral rate of 18%. The nurses tended to identify patients with more severe 
symptoms, thus adopting a more targeted approach, but they did not necessarily 
refer those with more severe symptoms.  
• Effectiveness: The three-month results of the cohort study show that there are three 
different arms among patients: not diagnosed; diagnosed and not referred; and 
diagnosed and referred. Those who were diagnosed and referred showed significantly 
better reduction in symptoms than those who were not diagnosed, or were diagnosed 
but not referred. 
 
Key lessons from this work included: 
• Implementation science can be a useful vehicle for driving the scale-up of mental 
health services. Researchers should adopt and funders should support the 
implementation of future programmes. The NIH is forward thinking in this regard, and 
required the inclusion of capacity building using implementation science for 
implementers and managers in the health system.  
• This approach allows for the development of middle-range theories of what works, for 
whom and under what conditions in order to inform further studies. The PRIME study, 
for example, found that patients have to attend five to eight sessions in order to be 
effective. The case studies also found that the counselling intervention was less 
effective for patients in lower socioeconomic groups (i.e. patients with food insecurity 
needed something more). The findings need to be explored in more depth to establish 
why the nurses are not referring many of the patients.  
• Strong collaborative relationships built on trust are required with the DoH and other 
sectors. 
• This kind of research requires long-term funding and flexibility to respond to DoH needs, 
which also helps to build trust (e.g. responding to the need of the DoH for validated 
screening tools).  
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Providing screening, brief intervention and referral to treatment (SBIRT) for substance use 
disorders into South Africa’s primary healthcare services: lessons from local research 
(Prof Bronwyn Myers, Chief Specialist Scientist: Alcohol, Tobacco and Other Drug 
Research Unit, South African Medical Research Council) 
 
There is a considerable treatment gap for substance use disorder, as for other mental 
health disorders. Only 2–3% of people who meet the diagnostic criteria for substance use 
disorder and need treatment are able to access treatment on an annual basis. Treatment 
is reaching those with severe and chronic problems, but the vast number of people who 
use substances generally do so either unproblematically or at hazardous and harmful 
levels. There is a need to focus on reaching them as well as a way of preventing further 
progress to more chronic and severe problems, but services are not available to do so. 
The WHO has recommended that interventions for substance use disorders are integrated 
into primary healthcare services as a means of detecting people who are at risk for future 
problems and providing brief or early interventions to reduce the risk of harm.  
 
Screening, brief intervention and referral to treatment (SBIRT) consists of several steps, 
starting with universal screening of patients as they enter healthcare service. Those who 
are not at risk would be congratulated on their healthy behaviour and encouraged to 
continue along that path. Those who are screened as being at risk would be offered a 
brief or extended brief intervention. Those with severe problems, or who do not respond 
to the brief intervention would be referred upward to more specialised services. This is a 
step towards narrowing the treatment gap and reaching people in a window of 
opportunity in which their use of substances can be discussed and they can be provided 
with access to services. It is also a strategy for reducing the harmful effects of substance 
use on health. For those who are using substances at hazardous and harmful levels to their 
health but do not meet diagnostic criteria, it is an opportunity to provide brief counselling 
and advice to reduce their use in order to prevent chronic diseases and future health 
problems.  
 
South Africa has a National Drug Master Plan, as part of which the DoH has been tasked 
with implementing screening and brief interventions within primary healthcare services, 
particularly in emergency departments, services that reach pregnant women and in 
chronic diseases instances. However, the plan has not been properly implemented. In 
2018, there was considerable energy in considering how to scale-up SBIRT and introduce 
it to primary healthcare facilities. There was a large meeting, a report has been produced, 
and training has taken place for primary care providers and NGOs working in primary care 
facilities.  
 
The presentation will argue that we should not rush from training to attempted 
implementation without considering key scale-up questions such as ‘What is the package 
of care? Who is going to deliver each component of the package? What resources do 
we need to support delivery of this package? What kind of environmental factors do we 
need to ensure are in place to support implementation?’ These questions have not been 
adequately addressed, but we can draw on local research findings to begin to answer 
these questions. This would give the opportunity for evidence for informed decision-
making around how to start implementing these services.  
 
The presentation draws on lessons from SBIRT intervention research in various parts of the 
country including HIV services, emergency departments, MoUs with pregnant women and 
chronic disease services. Some of these projects are ongoing and others have been 
completed. There are some shared lessons and learnings across the projects that will be 
presented: 
 
55 
 
• Screening:  
o We have learnt that screening should be universal. At present, screening often 
involves case detection by appearance (e.g. if a patient smells of alcohol or is 
visibly intoxicated). A single question may be asked about alcohol use, but if the 
patient says they do not drink, there is no further investigation. Participants in the 
studies have said that screening is a very useful process; that before screening 
they did not think about their alcohol use and that it might be problematic for their 
health.  
o Brief versions of validated screens that are widely used in research studies can be 
very useful for detecting people who might benefit from a brief intervention (i.e. 
people with hazardous or harmful use, or mild to moderate symptoms, but not 
necessarily with severe problems). Tools that comprise three to four questions 
about alcohol use, such as the Alcohol Use Disorders Identification Test (AUDIT-C 
or AUDIT-PC), or even a single question on drug use in the past month can be 
useful for detecting people who might benefit from intervention.  
o We have learnt lessons about who should do the screening. Most providers and 
patients themselves have said that they would like screening to be completely 
integrated into the history-taking process, so that it is not seen as a separate 
process but forms part of their entry into the health system. Nurses who work in 
observation rooms and take the patients’ history as they present for service should 
thus do the screening.  
o Screening should not be a once-off event. There should be multiple opportunities 
for screening because people who visit a clinic for the first time might not feel 
comfortable disclosing alcohol or other substance use and may only become 
more comfortable over time once they have developed a relationship with their 
healthcare provider. Some of the trial data show that screening results change 
over time, as people become more comfortable about disclosing the actual 
extent of their alcohol use. 
o Patients are very open to screening and consider that it would be a valuable 
process. Those with other physical health comorbidities, in particular, would like to 
know everything about their health and how they can act appropriately and 
timeously to avoid future problems.  
 
• Brief and extended brief interventions: 
o A brief intervention is generally a once-off session of feedback about screening 
results, advice and counselling or motivational counselling to encourage and build 
readiness to change. An extended brief intervention would add several more 
sessions to the initial session in order to help the person to build some skills for 
implementing changes and working towards the goals they have developed for 
themselves.  
o Providing information is key. Participants have said that information about what a 
standard drink is, and how many drinks are contained in containers is useful, as they 
previously did not know how much they were drinking or what a sensible or safe 
drinking limit was. Knowing this information made them aware of the need to 
change and the fact that their alcohol use was potentially harmful.  
o As part of this health education, goal-setting and self-monitoring were also seen as 
very helpful. Participants are encouraged to diarise their drinking so that they 
become aware, at least in the first month, about how much they actually 
consume. Often this is very illuminating to patients. Patients like to be able to keep 
track of their drinking and record progress towards their goals.  
o Participants found it useful to learn strategies for coping with stress and other 
triggers. Stress and stressors in people’s lives are often a reason why people drink in 
order to avoid the problems. Having alternative strategies for coping with these 
issues helps them to manage the urge to use alcohol. Across all the studies, 
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boredom was identified as a big risk factor for drinking. Elements of behavioural 
activation therapy have therefore been incorporated into the interventions so that 
people can consider strategies for managing boredom and positive leisure 
activities that are alcohol free.  
o Brief interventions are acceptable to patients, and are efficacious.  
 
 
 
• Intervention delivery: 
o The duration of the intervention should be flexible. The number of sessions should 
depend on the patient and their needs. There is a fine line between over-treating 
and under-treating. Some participants do very well with just one or two sessions, 
but others need more sessions to cement the skills that they have learnt. Optional 
booster sessions have been added to the interventions so that participants can 
receive additional sessions if they need to.  
o Much has been learnt about the delivery agent. It has been demonstrated that 
interventions can be task-shared with facility counsellors and community health 
workers. We are starting to learn about peers. Peers are not widely used as delivery 
agents in this setting, but participants are starting to say that they would like to 
receive the intervention from someone who has themselves struggled with 
substance use issues or reduced their alcohol use. Peer recovery coaches are 
widely used in other settings and could perhaps be considered for this setting.  
o We have learnt about the competencies and qualities that are required for 
effective intervention delivery. Some of these are core competencies, while others 
are treatment specific. The qualities of being passionate, committed and highly 
ethical are important. We have also learnt about training. Initially in these 
interventions, we started training only those who would be responsible for 
screening and for the intervention delivery. We have since learnt that everybody 
in the healthcare setting needs to be trained so that the person delivering the 
intervention is supported, there is a backup, and the referral path is clear. 
o Clinical supervision and debriefing are an important element of the package of 
care. We have started to strengthen the supervision and debriefing part of the 
package. This is particularly important in a task-sharing context. Clinical supervision 
goes beyond standard fidelity checking to using supervision as an opportunity for 
booster training to role play difficult cases. It is also used as an opportunity to 
debrief the person delivering the intervention about potentially difficult situations 
that have been personally challenging for the participants. Counsellors have 
appreciated debriefing and supervision. 
 
• Referral to treatment: 
o This is a critical but often neglected part of the SBIRT process. The current way of 
providing referrals is often problematic for various reasons: there is a lack of 
awareness of where to refer people to; there are structural barriers to accessing 
services; substance use treatment services are not to the person’s liking; and the 
provider who refers does not get feedback. These protocols need to be developed 
for SBIRT implementation. 
 
• Other lessons about implementation: 
o SBIRT cannot be implemented without ensuring that the environment into which it 
is to be implemented is conducive for implementation. We have learnt through 
more than 300 hours of observation at 26 primary care facilities that the core 
elements that need to be present for implementation preparedness are person-
centred care, therapeutic environment, sufficient human resources, good 
leadership and infrastructural resources.  
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o Stigma-reduction interventions are needed to support SBIRT implementation. 
Providers continue to be highly stigmatising towards people who use alcohol and 
drugs; patients feel judged and are wary of disclosing their substance use when 
asked. To encourage uptake of SBIRT when it is implemented and offered, it needs 
to be accompanied by interventions to reduce stigma among providers. 
 
The resources required to support the implementation of SBIRT include training materials 
and resources, screening protocols, providers with appropriate competencies, 
intervention manuals and protocols, a referral protocol, supervision and debriefing 
protocols, and supervisors with appropriate competencies. 
 
Evidence-informed implementation of SBIRT is required. Healthcare managers who are 
responsible for overseeing the implementation of these new services say that many new 
programmes that have been introduced have failed at the point of implementation 
because there is a rush towards implementation without careful planning or consideration 
of what might work in a particular setting, and what will not work. They call for careful 
testing and tailoring or the protocols for each facility. This should be borne in mind, but 
there is an opportunity to use this information to inform implementation. 
 
Overcoming trauma and violence: from individual trauma narratives to community-
based intervention in war-torn regions (Prof Thomas Elbert, Professor of Clinical 
Psychology and Neuropsychology, University of Konstanz, Germany) 
 
Violence, both domestic and organised, remains the major driver of mental suffering and 
mental disorders. The research priority is thus how to prevent violence, and to develop 
and test interventions on an individual and a community or social level (i.e. in families, 
homes, schools and gangs, as well as violence at an organised level). The policy priority is 
to raise awareness about the devastating consequences of domestic violence, and to 
support the poor and downtrodden living on the hopeless, hungry side of town. Violence 
is never ending, and conflicts and organised violence can be enumerated throughout 
many parts of the world.  
 
Violence operates in cycles: the victims of violence may develop a range of 
psychopathological conditions such as post-traumatic stress disorder, anxiety, depression 
or dissociation, and may in turn respond with reactive aggression. Early childhood 
problems create the likelihood for depression. Post-traumatic stress disorder is not the result 
of one life-threatening event, but of ongoing repeated threats to life and fitness. Ultimately 
through many such experiences, a person may build up an associative memory of sensory 
information (e.g. of fire, bombs, explosions, beatings), the cognition of helplessness, 
negative emotions centred on anxiety and physiological defence responses. If the 
individual loses the realisation that activation of this associative memory refers to the past 
and perceives it as present perceptions, threat gets triggered by many cues and 
becomes omnipresent.  This leads to suffering from post-traumatic stress and other trauma-
related disorders. Another cycle of violence is fuelled by appetitive aggression. This intrinsic 
enjoyment of violence, the lust to kill is so to say, “in our blood”. In peaceful times it is taboo 
and exists only as a latent state; though it may become apparent during hunting and 
killing animals, during war and crises it can be “easily called  into play and raised  to the 
power of a collective psychosis” as Albert Einstein has put it. The neural circuitry is quite 
different between reactive aggression in which people are trying to defend themselves, 
and appetitive aggression in which people participate to achieve a combat high and 
satisfy their blood lust. Appetitive aggression may thus give rise to a cycle of violence that 
is different but interconnected with the reactive cycle: in a violent environment, symptoms 
of psychopathy and antisocial behaviour may emerge (e.g. the stimulus of blood can 
become a stimulating signal for fighters in combat).  
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Boys who have been exposed to severe violence during their development are likely to 
fight back at some point.This reactive violence then fuels the appetitive aggression and 
with-it criminal behaviour.  Girls who have been exposed to violence are more likely to 
become self-injurious.   
 
There is evidence of massacres going back as far as the early Holocene hunter-gatherers. 
Pre-historic evidence of massacres comes for instance from sites at the Tukana Lake in 
Tanzania, and massacres continue to the present. In the Rwandan genocide in 1994, 
800,000 people were hunted and killed by hundreds of thousands of perpetrators, which 
indicates that it is not a rare form of personality disorder but rather a latent trait of humans 
to be able to kill and to even enjoy it. What conditions will call this trait into play and would 
cause someone to kill? Of the victims of the Rwandan genocide, 40% were killed with 
machetes, 17% were killed with batons, 15% were shot, 9% were beaten to death, 4% were 
drowned and 3% were burnt. The statements of many of the perpetrators of the Rwandan 
genocide have been documented, for example “The more we killed, the more we got 
the taste to go on. If you can enjoy the craving without punishment, it will get hold of you. 
It was an unforeseen public entertainment.” Evidence from as far afield as Colombia, 
Afghanistan and Africa shows that the more violence in which a person engages and the 
earlier they start, the more likely they are to become addicted to violence as a form of 
pleasure, without necessarily any intention to rob or to rape. Sometimes robbery becomes 
an excuse for engaging in killing.  
 
In violent environments, appetitive aggression can be a resilience factor. Repeated 
exposure to traumatic stressors leads to trauma-related mental disorders, while appetitive 
aggression may delay their development. Fighters experience tension between the 
negative and positive connotations of their associative memory of live-threatening 
events. US combatants in the Vietnam war perceived themselves positively as heroes in 
the fight, but when they returned home society at large blamed them for terrible deeds. 
The Vietnam veterans began to suffer from PTSD and started to consume drugs. Drug 
prevention intervention would only succeed if the network of memories is adjusted such 
that cues that trigger the memory are clearly distinguished from actual threat and 
combat situations. Once people are caught up in the bi-cycle of reactive and appetitive 
aggressive, it is very difficult to stop. The best measure is to prevent this situation from 
arising.  
 
Research was conducted by sampling saliva, and differences were found in the 
expression of the proopiomelanocortin precursor protein and in endorphin regulation. 
Changes in opioids contribute to becoming addicted to violence. There is a sensitive 
period between the ages of 12 and 17 when appetitive aggression may become most 
addictive.  
 
Research was conducted by sampling saliva, and differences were found in the 
expression of the proopiomelanocortin precursor protein and in endorphin regulation. 
Changes in opioids contribute to becoming addicted to violence. There is a sensitive time 
between the ages of 16 and 17 when this can be modified.  
 
The research undertaken among gang members in the townships of Cape Town identified 
traumatic stressors in the community; 77% had witnessed killings, 90% knew someone who 
had been killed, and 73% had been shot at. Participants had also committed a number 
of criminal offences: 90% had attacked other humans, 75% had hurt someone with a 
weapon, and 53% had seriously injured someone. This indicates that both the reactive and 
appetitive cycles of aggression were in operation. Typically, gang members in Cape Town 
do not have a father present; the mother struggles to provide as a single parent; and 
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around the age of 11 or 12 they start to join a gang and are exposed to early experience 
of violence through gang fights. During a flight they become totally immersed in the 
hunting mechanism and do not consider that they could die. They crave to participate in 
violence as an addiction. Drugs are essential to facilitate aggression, leading to a dual 
cycle of drug abuse and aggression.  
 
Gangsters can be helped if their associative memory is properly organised during 
narrations of the most arousing past events. The sensory memory of killing someone brutally 
at a young age, the associated emotions, cognitions and physiological responses at the 
time have to be contrasted with the feelings and thoughts here and now, when the 
events, each at a single time are remembered. This is not an easy task for the guiding 
psychotherapist, as the therapist has to fully accept the emotions that the person 
experienced at the time, including their positive feelings of killing someone. Traumatic 
events can be processed in a similar way. Restructuring through narrative exposure not 
only reduces PTSD symptoms, but also reduces appetitive aggression, whereby social 
inclusion rather than exclusion is essential.  
 
Research was also conducted in the Kivu regions of the DRC, where state authority has 
collapsed and there is ongoing criminal activity. Of the ex-combatants who were 
interviewed, 90% had been involved in armed attacks, 75% in looting, 72% in physical 
assaults against civilians, 25% in massacres and 12% in sexual assaults and rape, and many 
had even eaten human flesh. Trauma symptoms can be treated with narrative exposure 
therapy as well as substance abuse, because survivors frequently use substances to 
reduce their symptoms and suffering; depression symptoms will also reside; and the 
likelihood of re-joining another armed group can be reduced. In this way, people can be 
extricated from the cycle of violence. Actual aggression can be reduced among both 
men and women. Women in civil society have very little drive for competitive aggressive 
actions, but if women are exposed to a violent environment at a sensitive age they 
become highly competitively aggressive, with little differences from men.  
 
However, in areas such as the DRC, there are too many people to be treated on an 
individual basis, and other ways have to be considered. South Africa’s Truth and 
Reconciliation process provides an example that can be improved upon. The process that 
is followed is that anonymised narratives from perpetrators and victims are developed 
(including not only what was experienced but how the person felt). The community is 
informed about the facts derived from narratives (thus breaking avoidance and reducing 
stigmatisation) and completes them. Facts from the narratives and community sessions 
are archived as a part of the history of the community. Individuals with severe symptoms 
are referred to local counsellors trained in narrative exposure treatment. Briefing is used as 
prevention in subclinical cases.  
 
Aggression (but not necessarily violence) is part of human nature. Violence is the major 
source of mental ill-health. It is driven by the failure of state monopoly of power, extreme 
poverty (looting and fighting for survival) in circumstances in which there are no other 
sources of well-being (insufficient nutrition, no healthcare, no family/erotic relationships), 
drug abuse (consumption to reduce trauma) and gangs (hunting in groups offers more 
safety and more fun). The policy priority should be to prevent violence, both domestic 
and organised, working at both the individual and the social or community level.  
 
Discussion 
 
Prof Stein (UCT): How could the model developed by the Centre for Rural Health be 
introduced in the Western Cape without research funding? How could those responsible 
be persuaded to buy into a collaborative care model? 
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Prof Petersen (UKZN): Eden district municipality in the Western Cape has already adopted 
the model. The Centre for Rural Health has been supporting Eden district with training. They 
had sent a psychologist to participate in training for trainers, supervisors and mentors 
presented to psychologists in KZN. Eden district had identified people to be trained in 
facilities. A team from the Centre for Rural Health recently visited Eden district to present 
a facility manager’s training workshop in order to orientate facility managers to the model. 
The district municipality had been taking this initiative with their own financial resources, 
but was developing a proposal for support from the provincial government for the model. 
It is possible to implement the model without large resources. 
 
Prof Stein (UCT): The message of the presentation on SBIRT was that expert interventions 
do not work without implementation. The implication is that the Addiction Technology 
Transfer Programme (ATTC) of education in the Western Cape is not effective.  
 
Prof Myers (SAMRC): The ATTC has raised awareness of SBIRT. This was the reason for the 
initial meeting about scaling-up SBIRT. The ATTC has presented national training on SBIRT 
and associated screening tools. The way in which the ATTC has raised literacy related to 
issues of addiction has been very valuable, which has helped break down stigmas and 
barriers to discussing these issues with patients. The presentation attempted to convey 
some caution that it cannot be assumed that implementation will take place just by 
training people on evidence-based practice. Implementation of a new practice is unlikely 
to happen without the necessary support, especially given the challenges in the South 
African healthcare system. There is an opportunity for the DoH to engage on the basis of 
what is known from substance use research, but the opportunity should not be wasted by 
rushing to implement without properly thinking through what is required. 
 
Prof Stein (UCT): Perhaps we should encourage children to play rough and tumble games 
and participate in martial arts, thereby becoming skilled at expressing aggression in a 
natural way and possibly making them resilient to mental illness. However, perpetrators 
would still be at risk, since the South African Stress and Health (SASH) data show that 
perpetrating violence is a risk factor for PTSD. Is this explained in the bi-cycle theoretical 
model?  
 
Prof Elbert (University of Konstanz): This is an interesting proposal which could and maybe 
should be tested. In addition, reasons why people use drugs have to be considered. The 
data show in principle that success cannot be achieved without a sound aetiological 
model for the causes of drug use. In South Africa, the major reasons for drug use are 
trauma and poverty, although these are not the only reasons. It should be a research 
priority to find ways of getting boys out of criminal environments. There is no universal 
solution, but if the causes are known it is possible to consider ways of changing them. If 
young people have no way to obtain social status in society, they will look for other ways 
of earning status such as in a gang. From a high-income country perspective, the solution 
would be to give them a job, but this is difficult in a country with high rates of 
unemployment. Without progress in that regard, addressing the problems is very difficult. 
 
Prof Myers (SAMRC): I believe that all substance abuse treatment, especially for more 
severe problems, has to be trauma focused. We need structural interventions that address 
the drivers of why people are using substances. The current focus is to respond to the 
problem rather than preventing it, but in order to be effective, we need to address both 
prevention and treatment.  
 
Dr Pretorius (Wits): Would it be possible to collaborate with traditional healers in developing 
integrated primary healthcare, especially in rural areas? 
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Prof Petersen (UKZN): The integration of traditional healers would be important not only in 
rural but also in urban areas. This has not yet been done because the Centre for Rural 
Health is working with the formal healthcare system provided by the DoH. There would be 
an opportunity to do so with the development of the community platform. In addition to 
the work on mental health, the Centre for Rural Heath is also working with the DoH to 
strengthen community-oriented primary healthcare. This entails working with ward-based 
outreach teams and with community structures, which would include community health 
workers and traditional healers. The intention is to empower community members to be 
more in control of their own health as well as the health of the community. 
 
Ms Lunsky (Wits): The University of the Witwatersrand is rolling out a mental wellness 
strategy together with several partners and as many stakeholders as possible. There are 
enormous challenges. Part of the initiative involves capacity building with students and 
staff. How did the Centre for Rural Health get the buy in of nurses? Were they voluntarily 
trained or was participation mandatory? 
 
Prof Petersen (UKZN): Unless nurses are required to report on mental health cases, they will 
generally not do so. The healthcare system runs on a series of tick boxes. We therefore 
have to engage all the way from provincial to district, subdistrict and primary healthcare 
facility manager levels to ensure that people are involved at all levels, and that it becomes 
clear to primary healthcare workers that mental health issues are part of their work on 
which they have to report. Performance appraisal systems are important. The indicators 
of the numbers screened and treated for mental health in primary healthcare has helped. 
The indicators and continuous quality improvement are used to get the buy in and will of 
primary healthcare providers to provide the service.  
 
Prof Lund (UCT): What are the links between endemic poverty and scarcity in relation to 
violence as drivers of population mental health? How is the bidirectional relationship 
between violence and mental health influenced by conditions of poverty and scarcity? 
 
Prof Elbert (University of Konstanz): The presentation emphasised that humans can get into 
a hunting mode in which they enjoy violence. The factors that cause someone to enter 
into the hunting mode, especially during development, are very complex. Prof Lund’s 
presentation showed that plasticity occurs when pruning takes place during adolescence 
and early adulthood. It is possible to recruit child soldiers and turn them into ferocious 
fighters. This is one of several drivers. A prerequisite for a solution for South Africa would 
appear to be creating enough jobs for people. 
 
Prof Lund (UCT): How do we reach men who drink, since men tend not to visit clinics? 
 
Prof Myers (SAMRC): The health system is struggling to attract more men into the health 
services, especially HIV services. For alcohol-related interventions, emergency 
departments provide an access point within the current health services to reach to men 
after they have been in fights and have been injured. Ward-based outreach teams 
(WBOTs) provide another opportunity to identify men who are drinking and possibly 
intervene at a community level, and perhaps link the men with facility-based services. It 
will be necessary to address the configuration of WBOTs so that they are not just women 
run, and men feel that the services are not just for women and children. There are 
perceptions that health services are for women and children. 
 
Prof Petersen (UKZN): The idea behind the community mental health detection tool is to 
get a household member to identify someone who might display symptoms and to ask if 
they want help. This would be a possible way of involving men. Another opportunity for 
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community-wide interventions might be through community structures, led by community 
leaders who are often men, on which community health workers would sit and discuss 
problems in the community.  
 
Prof Myers (SAMRC): The community should be seen as an extension of the health system. 
There might be an opportunity in this environment to use peers; for example, a man who 
has had a history of drinking heavily and has stopped could identify with other men who 
are drinking. 
 
 
SESSION 5: BREAK-AWAY: IDENTIFYING POLICY AND RESEARCH PRIORITIES IN MENTAL 
HEALTH 
Facilitator: Dr Siyavuya Bulani, Senior Liaison Officer, Academy of Science of South Africa 
 
Many of the presentations included recommendations for advancing research and policy 
priorities in mental health. The intention of the breakaway sessions was to compile a set of 
recommendations for inclusion in the proceedings, which would be shared with the DoH.  
 
Group 1: Neuroscience and Genetics (Rapporteur: Prof Dan Stein, UCT) 
 
1. There is concern about the negative connotations of the term ‘precision public 
health’. The term ‘potentiating public health through prevention and patient-centred 
care’ is recommended instead. It is important to be consistent with public health 
principles, consistent with patient-focused care, and consistent with prevention.  
2. We need to do this because of local health inequities, because local population 
diversities will cause the health inequities to grow over time, and because of the need 
for locally based pharmacogenetics. Germany and certain other countries are 
already using genetic methodologies for diagnosis and treatment (e.g. in the field of 
intellectual disability, and in using CNVs to establish preventive practices). South Africa 
is not doing this locally.  
3. To do this requires capacity development, ethics, improving health literacy, 
decreasing stigmatisation, instituting training and equipment: 
a. Capacity development: South Africa has very little capacity development. The 
Human Heredity and Health in Africa (H3Africa) initiative provides a good 
example. 
b. Ethics: It must be taken into account that much of the decision-making in South 
Africa is communitarian. 
c. Improving health literacy: The generally low health literacy in South Africa needs 
to be addressed, including low mental health literacy and low genetics literacy. 
d. Training: Training in genetic counselling is required. The recommendations of the 
ASSAf report ‘Proceedings of a workshop on the implementation of core 
competencies for mental, neurological and substance use disorders’ need to be 
extended in order to address how genetics, especially neurogenetics, will be 
addressed in the future. More training is also needed in bioinformatics. Genetics 
should form part of all health curricula. 
e. Equipment: Infrastructure is required for freezers, for microchipping and for 
sequencing. South Africa does not have infrastructure of this nature. 
4. Funding will be required. H3Africa, which is funded by the NIH and Wellcome Trust, 
provides an example of bringing together collaborative funding in order to advance 
the field. Ways of encouraging European funding for similar initiatives could be 
considered. 
5. Consideration needs to be given to what needs to be biobanked. The suggestions 
ranged from whole exome sequencing of every new-born baby, to more targeted 
biobanking (e.g. all clinical research should have a biobanking component). Routine 
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questioning is done on factors such as gender and age, and it was argued that routine 
questioning on genetics is also required.  
6. There was a strong proposal for a population-level cohort, taking into account several 
key points:  
a. Genetics and environment both need to be taken into account. 
b. If the aim is prevention and person-centred care, genetics should take into 
account the comorbidity of mental health with communicable and non-
communicable disease. 
c. In the context of populations in Africa being young, a neurodevelopmental 
population cohort would be required. 
d. Any proposal for such a cohort would need to be supported by the new 
professional field of health economics with specialisation in genetics. ICER 
(incremental cost analysis ratio) analysis was proposed.  
 
Group 2: Public Mental Health and Epidemiology (Rapporteur: Ms Ravhengani Machaka, 
Sefako Makgatho University) 
 
1. Epidemiological research needs to be strengthened, especially having better incident 
data. 
2. Data collection systems should be strengthened by linking them with existing surveys 
and other data. 
3. Strategies are required to look at high-risk populations such as the early childhood 
development phase, adolescents and young people who are affected by the high 
rate of unemployment and substance abuse.  
4. Research is needed on how well the healthcare system is working in order to 
implement mental health strategies. 
5. Mapping the minimum community resources for mental well-being is required in order 
to establish how well communities are doing with respect to social cohesion and social 
capital (e.g. how functional school governing bodies are; the extent to which 
communities are integrated; whether there are sports groups and religious groups to 
foster social cohesion). 
6. Technology needs to be harnessed for data collection. 
 
Group 3: Intervention Research (Rapporteur: Dr Gayle Langley, University of the 
Witwatersrand) 
 
1. With respect to policy and research priorities, does the DoH have an agenda for 
mental health research? There does not seem to be a robust model. Gaps were 
identified. There was no evidence-based model for working in South Africa.  
2. At community level, subsystems need to be strengthened to address issues of poverty 
and violence. 
3. Prevention and promotion should start early right from pregnancy, and continue 
through infancy, schools, teenagers and early adulthood. 
4. In order to develop human resources in the community, it is first necessary to know 
what exists in the community. Very little is known in this regard, and we tend to work in 
silos.  
5. We need to work through ward-based outreach teams, NGOs and non-profit 
organisations, and less formal support resources.  
6. The systems, problem areas, supportive structures and social and capacity building 
assets inherent in communities need to be mapped, with a focus on health and 
wellness rather than technology. 
7. The group was enthusiastic about a systems approach, using methodologies such as 
appreciative inquiry, and using youth desks of political parties and faith-based 
organisations, which would require a change in the research paradigm.  
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8. Longitudinal studies are required in order to measure change, using community 
indicators set by communities themselves. An action research approach is 
recommended.  
9. The DoH does not seem to have an agenda for mental health research. Interest and 
funding thus tend to direct and lead research, resulting in uncoordinated efforts. 
Power rests to a large extent with provincial authorities, which is problematic. 
Coordination between universities and provincial authorities is recommended, which 
would place pressure on provincial governments. There is also a role for the DoH to 
place pressure on provincial authorities.  
10. The impediments to research include governance issues such as ethics committees 
and provincial committees. There is a need to facilitate and simplify permission issues. 
11. Health is not vertical; intersectoral mapping is required.  
12. The higher education space was pointed out, as there has been a burgeoning of 
mental health issues among student populations with respect to both incidence and 
severity. The need for resources to deal with mental health issues among students was 
raised, including depression, violence, substance abuse and suicidality.  
13. With respect to mental health literacy, the life-span approach was suggested 
extending from maternal health through the trajectory of childhood, schooling, 
teenagers and young adults. 
14. Destigmatisation is required in relation to issues of gender and sexuality in schools and 
in education generally, including teachers, educators and parents. It is important to 
consider the whole environment. This is an issue for research attention. 
15. Mentoring of students could be considered as a means to facilitate mental health. 
16. Support, advocacy and referral are required. 
17. Group work and group strategies could be considered. 
18. There was a suggestion to start in a catchment area and develop indicators, look at 
promotion and track outcomes over time, and in that specific context consider 
children, teachers, mental health indicators and a cohort study in a bounded space 
in early childhood development. 
19. Large amounts of data are available but are not being mined. Systematic reviews are 
required of services, and meta-analysis of systems over the life course. 
20. Issues that require urgent attention include substance abuse, violence, severe mental 
illness, chronic diseases of lifestyle, quality of life, lifestyle follow up, and resources for 
maintaining wellness after discharge or intervention. 
 
Discussion 
 
Dr Siyavuya Bulani (ASSAf) invited further comments. He noted that multidisciplinary 
approaches had been mentioned in the discussions and asked for suggestions on how 
the three sets of recommendations from the three breakaway groups could be brought 
together. 
 
Prof Lund (UCT): Does the Neuroscience and Genetics group (Group 1) have any 
suggestions related to a population cohort, as the Intervention Research group (Group 3) 
had similar ideas from the intervention perspective? Would there be any possibility for or 
interest in developing joint proposals following a cohort over time within a given 
catchment area, collecting both biological and social epidemiological data, potentially 
nesting targeted prevention and promotional treatment interventions in the catchment 
area, and looking at longitudinal effects over time?  
 
Prof Chiliza (UKZN): The possibility of a longitudinal catchment study was considered, but 
it would be very expensive. The main message from the Neuroscience and Genetics 
group (Group 1) was that every study that is conducted in South Africa should make use 
of a biobank and collect genetic data through blood and saliva.  
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Prof Lund (UCT): One possibility would be to approach the organisers of the National 
Income Dynamics Study (NIDS) and ask them to collect blood samples during the next 
wave of the study. NIDS already has data from five waves over ten years from a nationally 
representative cohort.  
 
Prof Thom (Wits): There have been recommendations for a longitudinal study in a given 
catchment, as well as for nationally representative samples. What exactly is being 
recommended: a catchment study, or a national study, or both?  
 
Prof Lund (UCT): Some nationally representative data are already available, but if 
population-level interventions are considered, it would make more sense to adopt a 
catchment area approach.  
 
Prof Bhana (SAMRC): The Public Mental Health and Epidemiology group (Group 2) 
recommended the need for better understanding of the burden of disease nationally. 
NIDS could be a platform for asking a variety of questions. We are not recommending 
another South African Stress and Health (SASH) study related specifically to mental health. 
We recommend that the understanding of mental health should be linked to social 
determinants. Adding a genetic component could be interesting. Perhaps what is 
required is a national study, with a cohort study of vulnerable populations as a sub-
component. Because of the expense of research of this nature, studies have to be 
carefully designed.  
 
Prof Stein (UCT): Most recent nationally representative epidemiological studies of mental 
health have included DNA. The presentation by the DDG of the Department of Health 
emphasised the need for operational research as a priority, but South Africa also needs 
to be aware of the kind of research being done in other parts of the world, including India 
and China. 
 
SESSION 6: RESEARCH SUPPORT: FUNDERS 
Facilitator: Mr Stanley Maphosa, International and National Manager, Academy of 
Science of South Africa 
 
NRF funding opportunities for mental health research (Ms Tracy Klarenbeek, Director: 
Knowledge Advancement and Support, National Research Foundation, South Africa) 
 
The National Research Foundation (NRF) was established to facilitate the creation of 
knowledge, innovation and development in all fields of science and technology, 
including indigenous knowledge. The funding instruments of the NRF are therefore not 
generally discipline-specific. Most of the NRF’s funding instruments are open to all 
disciplines. It is not easy to mine the data specifically for mental health, with some 
exceptions. NRF funding instruments may be developed in one of three ways: top-down, 
bottom-up, and bilateral or multilateral.  
 
Top-down instrument development is informed by the policies, strategies and priorities of 
government in relation to the two main sources of income of the NRF. Approximately 80% 
of the NRF’s income comes from contracts with government departments, primarily the 
Department of Science and Technology (DST), as well as the departments of Trade and 
Industry, and Higher Education and Training. Approximately 20% of the NRF’s income 
comes from Parliamentary grant baseline funding to support the mandate of the 
organisation as outlined in the National Research Foundation Act (No. 23 of 1998), as 
amended.  
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Bottom-up instrument development emanates from research groups and research 
associations in order to support vulnerable disciplines (e.g. capacity development in 
nursing) or emerging disciplines. The NRF operates almost exclusively in higher education 
institutions and with science councils to facilitate strategic initiatives, infrastructure and 
flagship programmes. 
 
A host of different players operate in the space of bilateral or multinational instrument 
development, including: 
• Government departments, including the Department of International Relations and 
Cooperation; 
• International partners through formal country-to-country, or funding agency-to-
funding agency bilateral agreements; 
• NRF through international partnerships (e.g. Belmont Forum for environmental 
sustainability;) 
• Individual researchers; 
• Research groups and research associations; 
• Higher education institutions and science councils. 
 
The NRF supports the range of phases of a research career, with several instruments that 
are not discipline specific for the next-generation, emerging and established researchers, 
namely: 
• Thuthuka: PhD, Post-PhD and NRF Rating Tracks; 
• Competitive Support for Rated and Unrated Researchers; 
• Incentive Funding for Rated Researchers; 
• Knowledge Interchange and Collaboration; 
• Infrastructure or Equipment Funds; 
• Freestanding Bursaries and Fellowships. 
 
When the NRF dataset was filtered for support for mental health, psychology and 
psychiatry between 2013 and 2017, 30,538 awards were identified (excluding student 
bursaries) amounting to R720 million, which represented 32% of the NRF budget over this 
period. Forty-seven per cent of these awards were for inventive funding, and almost 10% 
for international engagements, including travel.  
 
NRF contract funding currently supports 198 research chairs through the South African 
Research Chairs Initiative (SARChI), 40 of which are in health (representing 20% of the total) 
including: 
• Post-traumatic Stress Disorder  
• Enabled Environments for Assisted Living  
• Clinical Neurosciences Research  
• Brain Imaging  
• Health and Wealth in South Africa  
• Health Systems, Complexity and Social Change. 
 
NRF contract funding also currently supports 15 Centres of Excellence, three of which are 
in health, namely Epidemiological Modelling and Analysis, HIV Prevention, and Biomedical 
Tuberculosis Research. 
 
NRF funding can be accessed via university research offices or online submission. There 
are opportunities to shape the research agenda at various levels by partnering with the 
NRF and/or other potential stakeholders to shape funding instruments, identifying 
international initiatives and lobbying for South African inclusion and/or funding. 
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SAMRC funding for mental health research (Prof Rachel Jewkes, Executive Scientist: 
Research Strategy, South African Medical Research Council) 
 
The SAMRC is a complicated funder. Funding for the field of mental health is available 
from the SAMRC in both formal and less obvious ways. There are four key avenues for 
SAMRC funding: 
 
• Intramural units and departments, four of which work on mental health, namely:  
o Alcohol Tobacco and Other Drugs Unit (ATODRU), which deals with substance 
abuse and other mental health issues as they overlap with the substance abuse 
agenda. 
o Gender and Health Research Unit, which does considerable work in mental health 
because the its core area is gender-based violence, a large part of which is to 
study the medical health impact of gender-based violence, and the ways in 
which mental health and substance abuse may impact on the risk of gender-
based violence. Mental health interventions for preventing gender-based 
violence are considered as well as the implications for health services. The Gender 
and Health Research Unit houses the Sexual Violence Research Initiative (SVRI), 
which is a small-scale grant maker. The SVRI/World Bank mechanism extends one-
year grants of about US$10,000 annually. Work at the interface of mental health 
and gender-based violence is potentially fundable through this mechanism. The 
call is advertised each year. Anyone interested in this field is advised to become 
a member of the SVRI, which sends out a bimonthly mailing, including funding and 
conference opportunities and new publications. The SVRI convenes an annual 
conference. The Gender and Health Research Unit has also been managing large 
DFID funds and supporting large grants for intervention evaluations, including 
interventions at the interface of mental health and violence. The work from the 
first funding mechanism is being completed, and it is not known if there will be 
another opportunity. 
o Health Systems Research Unit, which has a long history of collaboration with the 
Division of Child and Adolescent Psychiatry at UCT.  
o Violence and Injury Prevention Research Unit, which is embedded in the 
community psychology work with the aim of developing data-driven prevention 
initiatives and transferable solutions for issues of injury and violence, including the 
promotion of safety and peace. 
o Biostatistics Unit, which has a cross-cutting mandate and provides a source of 
biostatistics expertise and support to the SAMRC’s network of medical and health 
researchers as well as government departments and national and international 
research bodies. It is an interdisciplinary unit with expertise in biostatistics, 
geographic information science, data management and food science. 
o Cochrane South Africa, which is part of the global, independent Cochrane 
network of researchers, professionals, patients, carers and people interested in 
health. Cochrane is a non-profit organisation that prepares and disseminates 
information in the form of systematic reviews on what works and what does not in 
healthcare. These reviews enable policymakers, health service providers and the 
public to make informed decisions about healthcare. The Cochrane Centre has a 
variety of training mechanisms in the systematic review field ranging from 
workshops over several hours to programmes over several days. Webinars are 
posted on the website as a resource for researchers and students. Cochrane 
provides support in response to queries on how to conduct meta-analysis. 
o Research Capacity Development: The SAMRC funds PhDs, master’s degrees and 
postdoctoral fellowships, and hosts the Bongani Mayosi National Health Scholars 
Programme.  
 
68 
 
• Extramural units (EMUs) located in universities or research institutions, only one of which 
is in the field of mental health, namely the Risk and Resilience in Mental Disorders Unit 
at UCT. The SAMRC usually advertises a call once a year for new extramural research 
units. Since mental health is underrepresented, the SAMRC would welcome strong 
applications for mental health units. EMUs are built around the scientific excellence 
and leadership of the unit director. The goals of EMUs are to generate knowledge using 
SAMRC seed funding, develop nodes of research excellence, and develop the next 
generation of research leaders. EMUs are supported for up to 15 years. Continued 
funding is based on progress measured by peer review every five years. The baseline 
funding is R1 million. Incentivised funding is based on the previous year’s publications. 
The unit’s total budget may not exceed R2.5 million. 
 
• Self-initiated grants which are advertised each year. The grants are for R200,000 per 
year for three years. Early career researchers are funded, as well as mid-career and 
established researchers in a different category with capacity development as one of 
the criteria. The grants are moved to different priority areas year. Mental health was 
not a priority area in 2018, and it is not yet known if it will be in 2019. Priority is given to 
quality proposals from women researchers, and researchers from historically 
disadvantaged groups or historically disadvantaged institutions (HDIs). Researchers 
from other institutions could consider collaborating with HDIs. Advantages in EMU 
applications include being based in an HDI or collaborating with an HDI, the gender 
and race of the unit director, and geographical location outside the Western Cape 
(where most of the EMUs have historically been located). 
 
• Ad hoc mechanisms, which are normally but not exclusively advertised and managed 
through the SAMRC's Grants, Innovation and Product Development Unit (GIPD). The 
SAMRC occasionally funds large studies with big budgets in important areas; for 
example, in response to a particular need. The SAMRC is planning to fund the National 
Survey of Mental Health and Suicide in Higher Education Institutions. GIPD manages 
joint funding mechanisms between the SAMRC and other funds, which are usually 
international, including the Swedish Research Council for Health, Working Life and 
Welfare (Forte), UK Medical Research Council, Wellcome Trust, and Bill and Melinda 
Gates Foundation. 
 
A co-funded SAMRC/NIH call for proposals is out for collaborative research between South 
African and US institutions involving HIV as a component of the work. Work on the interface 
between mental health and HIV would fall within the remit of the call.  
 
Janssen/J&J global public health support for mental health programmes in South Africa 
(Ms Abeda Williams, Senior Director Technical and Medical Affairs, Janssen 
Pharmaceutica, South Africa) 
 
The approach of Janssen/J&J is commercial, philanthropic and self-sustaining: 
• Commercial model: Janssen/J&J’s core business is profit-driven through Janssen 
Pharmaceutica, J&J Medical Devices and J&J Consumer Healthcare. The first 
responsibility is to doctors, nurses, patients, mothers and fathers, and everyone who 
uses the products. Every day, the products touch over a billion people worldwide. 
• Philanthropic approach: Global Community Impact (GCI) is the social responsibility 
group, which seeks to strengthen frontline health workers and sustain healthy 
communities. GCI has a strong presence in Africa. GCI partners include bilateral and 
UN agencies (including USAID, UNICEF and WHO), international NGOs, professional 
associations, Ministries of Health, global collaboratives, youth and innovators. 
• Self-sustainable approach: Global Public Health provides cross-sector product- and 
solution-centric innovations that improve patient and social outcomes in resource-
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limited settings via sustainable access models and partnerships. The intention is to be 
in a position to deliver healthcare to the entire spectrum of patients. The four core 
focus areas are TB, HIV, mental health and soil-transmitted helminths. Other areas of 
interest and supporting platforms include vector-borne diseases (dengue, malaria), 
vaccines (an Ebola virus has been developed and will be delivered to the DRC), 
essential surgery and trauma, and myopia. The cross-cutting approach to the four 
focus arrears or pillars entails: 
o Building R&D capacity in Africa, including clinical trial sites and fellowships 
o Strengthening health systems and enabling frontline healthcare workers 
o Private sector roundtable leadership on global health security  
 
Some examples of J&J global public health support for mental health include: 
• In Rwanda, determining the prevalence and burden of disease to inform policy 
decision-making; increasing access to mental healthcare within communities; and 
accelerating access to innovative, life-saving and transformational schizophrenia 
medicines. The accomplishments include undertaking the first nationwide mental 
health survey in the country; providing remote training to 65,000 healthcare workers 
on mental health counselling and support; leveraging digital technology; and dosing 
the first patients with long-acting injectables as part of a pragmatic study. 
• In South Africa: 
o A consensus study has been funded on provider core competencies for the 
improvement of mental healthcare. 
o The DoH has approached J&J to develop an investment case for mental health to 
determine the costs and returns of a prioritised package of system and service-
level interventions to reach important targets related to South African mental 
health services. 
o The current community-based mental health services model has been reviewed to 
determine the input costs for implementation of the model and develop guidelines 
to guide provinces in the development and provision of community-based mental 
health services. 
o Training is provided with a focus on public sector nurses in Gauteng. The capacity 
of registered nurses at peripheral sites has been developed to diagnose, treat and 
where required refer patients who present with a range of commonly occurring 
mental health conditions.  
o Patient-level support is provided through the Spring Foundation Lentegeur market 
garden. This is a flagship programme of the Spring Foundation with the aim of 
providing rehabilitation, food security, mentoring and training opportunities for 
patients at the hospital and in the surrounding community.  
 
Discussion 
 
Prof Lund (UCT): To what extent can this ASSAf symposium on mental health influence the 
priority-setting processes of the NRF and the SAMRC? How are potential research priorities 
for mental health established? Do the NRF and SAMRC have a strategic vision for mental 
health funding? 
 
Prof Jewkes (SAMRC): The SAMRC does not have a strategic vision specifically for mental 
health funding, but the SAMRC will be embarking on strategic planning over the next six 
months and focusing the vision for various research areas should form part of that process. 
The SAMRC is inviting comments and input from a wide range of stakeholders. The 
outcome of this symposium should help inform the SAMRC’s strategic planning. The 
SAMRC recently decided to prioritise selected areas for self-initiated grants each year. The 
SAMRC should perhaps invite suggestions to influence the selection of these areas. A case 
could be made for prioritising mental health in a future round of self-initiated funding or 
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establishment of extramural research units. The SAMRC wants to be positioned as an 
organisation that listens to advice and demands for funding to move to particular areas.  
 
Ms Klarenbeek (NRF): The NRF and the SAMRC work quite similarly. Many NRF initiatives 
come from the bottom-up. It is encouraging that this symposium has started to identify 
priority areas for research and policy. Some of the suggestions would meet the criteria for 
NRF funding instruments. Before applying to large funding instruments such as SARChI or 
the Centres of Excellence, engagement with the DoH is recommended in order to get 
political buy in. Important considerations in awarding grants include innovation (in line 
with the DST’s recent White Paper on Science, Technology and Innovation), societal 
benefit, multidisciplinarity and transdisciplinarity, and community engagement that 
involves the development of research questions and the co-creation of knowledge. One 
of the priorities identified by this symposium, namely harnessing technology for data 
collection, would have enormous societal impact.  
 
Ms Williams (Janssen/J&J): Mental health is a key priority among the focus areas of J&J. 
The company is committed not only to supporting drugs and medicines, but also 
strengthening health systems and addressing the research required for that purpose.  
 
Prof Jewkes (SAMRC): Researchers are encouraged to put their ideas forward. The SAMRC 
responds to the demands of stakeholders and invites quality grant proposals. 
 
Ms Klarenbeek (NRF): The NRF offers opportunities outside of research grants, including 
freestanding student bursaries and early career development funding tracks, which 
strongly address the transformation agenda. The NRF partners with the Department of 
Higher Education and Training for capacity development initiatives (e.g. successful 
training in mathematics and statistics in 2018). The NRF National Equipment Programme 
funds research infrastructure. Researchers need to advocate for support in order to 
successfully win research grants. 
 
Wrap-up and closure of symposium 
 
Prof Crick Lund (Alan J Flisher Centre for Public Mental Health, Department of Psychiatry 
and Mental Health, University of Cape Town) 
 
Prof Lund thanked ASSAf for their work and support in convening the symposium. It was 
encouraging that an institution with the stature of ASSAf within South Africa was focusing 
on mental health. He also thanked Leopoldina for their role in planning and organising the 
symposium and the opportunity to meet colleagues from Germany. A basis has been 
established for ongoing collaboration and exchange of ideas. He thanked the 
participants for sharing their thoughts, expertise and wisdom so freely, and contributing to 
interesting and stimulating discussions. 
 
ASSAf would compile a report of the symposium documenting not only the presentations, 
but also the recommendations with respect to research and policy priorities. The report 
would be sent to the South African Department of Health, which was interested in 
identifying research priorities. Research often takes place on a fairly ad hoc basis around 
researchers’ individual interests and on the basis of available funding. The symposium had 
identified the need for national leadership to identify research priorities for mental health. 
 
The intention was to develop an agenda for mental health research in the national 
interest, especially in order to cater for the needs of those who are most disadvantaged 
in society. South Africa is a classic example of the inverse care law, in that people who 
have the least access to care have the most mental health needs. Historically, South 
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Africa’s services have focused on psychiatric hospitals which continue to dominate the 
budgeting landscape but are not necessarily the most conducive space for mental care. 
Research is especially needed around prevention and promotion for mental health. It is 
important to take a life course perspective, including early interventions, from pregnancy 
through to old age. 
 
It was encouraging to hear from the SAMRC and the NRF about the potential for national 
priority-setting processes to inform funding. 
 
Prof Frank Rösler (Senior Professor, Biological Psychology and Neuropsychology, 
University of Hamburg) 
 
The symposium covered a broad range of topics, from basic to applied research. 
Research effort is required for integration of the various initiatives in this wide-ranging field. 
Many of the problems of South Africa were presented in some form during the symposium, 
and provided valuable insights that could be used to promote mental health research in 
low- and middle-income countries.  
 
The symposium provides further evidence of the success of the cooperation between 
Leopoldina and ASSAf. Prof Rösler thanked colleagues from both organisations and 
looked forward to the next symposium. 
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APPENDIX 1: LIST OF ABSTRACTS  
 
Addressing Mental Health Disorders in the African Region 
Steven Shongwe, Non-communicable Diseases, Wold Health Organisation (WHO) 
Regional Office for Africa. 
Email: shongwes@who.int   
Abstract 
Mental disorders include a range of mental and behavioural disorders such as depression, 
bipolar affective disorders, schizophrenia, anxiety disorders, dementia, substance use 
disorders, intellectual disabilities, and other disorders. Globally, 14% of the global burden 
of disease is attributed to these disorders. Seventy-five per cent of the people with these 
disorders in many low-income countries do not have access to the treatment they need. 
Determinants of mental health and mental disorders include social, cultural, economic, 
political and environmental factors. Certain individuals may be at higher risk of mental 
disorders – those with chronic conditions such as human immunodeficiency virus 
(HIV)/acquired immunodeficiency syndrome (AIDS), cardiovascular diseases, cancer, 
people exposed to substance use, people experiencing discrimination and human rights 
violations, and those in conflict, natural disasters and humanitarian situations. The overall 
goal of the WHO Mental Health Action Plan 2013 – 2020 is to promote mental well-being, 
prevent mental disorders, provide care, enhance recovery, promote human rights and 
reduce mortality, morbidity and disability for persons with mental disorders. In line with this 
global action plan, WHO has advocated for prioritisation of mental health in countries, 
provided technical support for the development and implementation of mental health 
policies, plans and legislation. WHO has also provided technical support towards the 
implementation of the WHO Mental Health Gap Action Programme (mhGAP), and the 
provision of psychosocial support and care during disasters and humanitarian 
emergencies. Progress in implementing the WHO global action plan has been slow due 
to several challenges including inadequate funding for mental health, insufficient 
numbers of trained health workers, inadequate mental health facilities, stigma and 
discrimination against people with mental disorders. This presentation recommends that 
countries in the African region should mobilise financial, human and material resources to 
scale up mental health programmes, services and interventions and accelerate the 
development and implementation of mental health policies, plans and legislation. It also 
recommends scaling up the training of mental health workers and promoting task shifting 
and sharing among health workers and integrating mental health, alcohol and substance 
use disorders into primary health care. 
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Global Mental Health and the Sustainable Development Goals: Aligning the Research and 
Policy Agendas 
Crick Lund, Alan J Flisher Centre for Public Mental Health, Department of Psychiatry, 
University of Cape Town. 
Email: crick.lund@uct.ac.za   
Abstract 
The past 20 years have seen an unprecedented growth in the field of global mental 
health. Beginning with early research efforts in the 1990s, we have seen key policy 
commitments from the WHO, national governments and the United Nations Sustainable 
Development Goals (SDGs). There have also been large new investments in research 
funding, generating substantial evidence regarding the global burden of mental illness, 
and cost-effective interventions. Yet the SDG era challenges us, as mental health 
researchers and practitioners, to think differently about mental health: to understand 
mental health from a life-course perspective, to develop a more dimensional approach 
to the construct of mental illness in diverse cultures, and to protect and promote the 
human rights of people living with mental illness. This talk will present a framework for the 
social determinants of mental health and the SDGs and propose an agenda for future 
research and policy priorities in the SDG era. 
 
Mental Health Research Priorities in South Africa:  Should We Include Neurogenetics? 
Dan Stein, Department of Psychiatry and Mental Health, University of Cape Town, South 
Africa. 
Email: dan.stein@uct.ac.za   
Abstract 
Several mental health research priority exercises have taken place, both locally and 
globally.  Epidemiological and implementation research has been viewed as particularly 
important for low and middle-income countries.  More recently, attention has been paid 
to the relevance of discovery research in these contexts. Given advances in 
neurogenetics and possible clinical implications, there are good reasons for including 
genetics research as part of such discovery efforts. Still, to maximise potential, an 
integration of neuroscience with global mental health research is needed. 
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Breakthrough in Understanding the Molecular Causes of Psychiatric Disorders 
Markus Nöthen, Institute of Human Genetics, University Hospital of Bonn, Germany. 
Email: markus.noethen@ukbonn.de  
Abstract 
A long-established hypothesis is that genetic factors contribute to the development of 
psychiatric diseases, including common illnesses such as schizophrenia and the affective 
disorders. However, reliable molecular identification of these factors represents a far more 
recent innovation. This has been rendered possible by technological advances in the 
individual characterisation of the human genome, and the combining of large genetic 
datasets at the international level. For the first time, the results of genome-wide analyses 
provide researchers with systematic insights into disease-relevant biological mechanisms. 
Here, the integrated analysis of different omics-level data generates important insights in 
terms of the interpretation of the genetic findings (e.g. the national IntegraMent 
consortium). The results of genetic studies also demonstrate the degree of etiological 
overlap between differing psychiatric disorders, with the greatest commonality having 
been observed to date between schizophrenia and bipolar affective disorder. Although 
the translation of genetic findings into routine clinical practice is being pursued at various 
levels, elaborate follow-up studies are typically necessary. The diagnostic investigation of 
rare genomic deletions/duplications (so-called copy number variants) in patients with 
schizophrenia is likely to represent one of the first examples of routine clinical application. 
The necessary prerequisites for this are currently being defined, for example at the 
European level within the COST action EnGagE. 
 
China Brain Project and Macaque Models for Biomedical Research 
Mu-ming Poo, Institute of Neuroscience, Chinese Academy of Sciences.  
Email: guyixi@ion.ac.cn    
Abstract 
After years of discussion and planning, China Brain Project (on Brain Science and Brain-
inspired Technology) is officially initiated this year.  This project consists of basic research 
on the neural circuit basis of cognition, as well as the development of new diagnostic and 
therapeutic approaches in treating brain disorders and brain-inspired machine learning 
methods and computing devices.  Non-human primates will play a prominent role as the 
animal model for both basic and applied research in the China Brain Project.  In particular, 
the project proposes the mapping of mesoscopic connectome of the macaque monkey, 
a long-term project that requires extensive international collaboration. The project also 
calls for the generation of macaque models of brain disorders and the development of 
intervention and therapeutic approaches using these models. For preclinical animal 
studies, it is desirable to have monkeys with a relatively uniform genetic background. I will 
summarize our recent efforts in cloning macaque monkeys using somatic cell nuclear 
transfer (SCNT) and showed that this approach could be used in generating macaque 
monkey clones carrying identical gene-editing.  As an example, we first performed 
CRISPR/Cas9 editing on in vitro fertilised macaque embryos to knockout Bmal1, gene 
encoding a core transcription factor for circadian rhythm, and obtained a group of 
moneys with either complete or mosaic knockout of BMAL1 expression. To varying extent, 
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these monkeys showed circadian disorders in locomotive activity, sleep pattern and 
circulating hormones, as well as anxiety/depression and schizophrenia-like psychosis 
phenotypes.  We then took the skin fibroblasts of one young male monkey that showed a 
complete BMAL1 knockout and most severe circadian disorder phenotypes for SCNT and 
generated five monkey clones with identical BMAL1 knockout genotype. Thus, gene-
edited macaque monkeys with uniform genetic background will soon be available for 
studying primate neurobiology and for developing therapeutics for human diseases.  
 
Family Studies from Endogamous Groups Enable the Elucidation of Distinct Predisposing 
Pathways in Dyslexia 
Subrata Sinha, All India Institute of Medical Sciences, New Delhi, India. 
E-mail: sub_sinha@hotmail.com  
Abstract  
Dyslexia is a specific learning disability that manifests as difficulty in reading despite 
adequate intelligence or opportunity. It is a complex disorder, which has a strong heritable 
component. While these are several genes that have been implicated in the 
pathogenesis of dyslexia, none of these account for a significant proportion of the 
disability across populations. 
We have studied three extended families with from distinct endogamous groups who had 
a high proportion of dyslexia. All these families had distinct patterns of inheritance. One of 
these had an autosomal dominant pattern of inheritance. A set of 17 polymorphisms on 
Chromosome 5p31.3 that encompassed a 1.9 Mb region comprising mainly the 
Protocadherin G (PCDHG) cluster, was strongly associated with dyslexia in this family. 
Seven of the risk-associated variants are ancestral variants preponderant Neanderthal 
and Denisovan sequences, while the non-risk associated variants are preponderant in 
modern humans. The other families had different inheritance patterns; one was autosomal 
recessive, while the third had an association with Attention Deficit Hyperactive Disorder 
(ADHD), a known co-morbidity condition of dyslexia. 
Endogamous groups are common in the developing world and are of great help in 
identifying disease pathogenesis and the molecular sub-classification of disease 
phenotypes. Because of genetic similarities, especially during family studies, they provide 
a better opportunity to identify pre-disposing mutations and pathways. While the exact 
pathways thus identified may not be generalised to the population at large, they provide 
vital clues for endophenotyping and pathogenesis. However, it is important that such 
studies have to be pursued with sensitivity and within clear ethical guidelines, so that they 
do not increase the vulnerability of the populations being studied. An important 
component of this work was done at the National Brain Research Centre, Manesar, India. 
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Common Mental Disorders Among Individuals Seeking HIV Testing 
Ashraf Kagee, Centre for Public Mental Health, University of Stellenbosch, South Africa. 
Email: skagee@sun.ac.za   
Abstract  
The presentation will have two parts. In the first part, the prevalence of mental health 
conditions among persons seeking an HIV test will be discussed. In the second part, the 
utility of screening for common mental health disorders will be examined. Much of the 
literature assumes that the receipt of an HIV-positive test results precipitates a mental 
health condition, such as depression, anxiety or posttraumatic stress. I will present data on 
the prevalence of common mental disorders among persons seeking an HIV test, i.e. prior 
to receipt of their test results. Using the Structured Clinical Interview for the DSM (SCID) 
among 500 persons seeking HIV testing, my studies found the following prevalence of 
14.2% for major depressive disorder; 5.0% for generalised anxiety disorder; 4.9% for 
posttraumatic stress disorder; and 19.8% for alcohol use disorder. These findings imply the 
need to integrate mental health assessment and referral trajectories in the context of 
voluntary HIV counselling and testing.  
Considerable literature has also indicated that screening for common mental disorders 
will assist in case detection and consequent treatment. We administered a battery of self-
report screening instruments to test their accuracy in determining caseness for the 
disorders mentioned above. Receiver operating characteristic curve analysis was used to 
determine the ability of these measures to discriminate between caseness and non-
caseness as determined by the SCID. We found the ability of screening instruments to 
predict caseness for common mental disorders was limited. Persons screening positive for 
a common mental disorder may still require evaluation with a clinical interview by a 
trained professional to be diagnosed with a common mental disorder, which raises 
questions about the resource utilisation in the public health system. 
 
Addressing the Challenge of Mental Disorders: Genetic Approaches to Nosology, Etiology, 
and Treatment 
Marcella Rietschel, Department of Genetic Epidemiology in Psychiatry, Central Institute of 
Mental Health, Germany. 
Email: Marcella.Rietschel@zi-mannheim.de   
Abstract 
Genetic factors are implicated in the etiology of all mental disorders. Unravelling these 
factors on the molecular level will generate insights into biological mechanisms and the 
interplay between genetics and environment. This in turn will guide future intervention and 
prevention strategies on both the individual and population level. An ever-increasing 
number of genetic variants are being identified via high-throughput genome-wide 
association analyses (GWAS). The majority of these variants are common and make only 
a limited contribution to the respective mental disorders. However, such variants can shed 
light on genes and pathways of etiological significance. Furthermore, joint analyses 
generate insights into the genetic architecture of mental disorders, as well as overlap with 
(co-morbid) diseases and traits. GWAS data on different mental and somatic disorders 
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can be compared using approaches such as polygenic risk score and linkage-
disequilibrium score regression analyses. To date, important findings from such analyses 
include a wide-spread cross-disorder sharing of common risk variants. Future steps in 
mental disorder research will include a disentangling of the communalities and 
specificities of the different mental disorders, elucidation of the impact of environmental 
factors on mental disorder risk, and the establishment of biologically guided diagnoses. 
This is a challenging undertaking, since no objective measure or biological marker – 
comparable to blood pressure monitoring in hypertension, or glucose measurement in 
diabetes – is yet available to assist the diagnostic process or predict the course of mental 
disorder and disease risk. This endeavour will require new approaches, including novel 
methods of phenotyping. Use of new cost-efficient devices, such as smartphones and 
actigraphs, will allow active and passive real-time assessment of many phenotypes of 
interest. These phenotypes will include: psychological parameters (e.g. emotion, 
cognition, volition, craving); physiological parameters (e.g. heart rate variability, 
locomotor activity, breathing rate); behaviour (e.g. fluid intake, social interaction); and 
environmental conditions (e.g. geolocation, surroundings). Longitudinal monitoring of 
these phenotypes can be performed over extended time periods in both patients and 
subjects from the general population. Combining these data with the results of parallel 
neuroimaging and multi-omics analyses will generate information concerning the 
biological mechanisms of traits underlying the development and course of the various 
mental disorders. The clinical utility of these ecological assessments in terms of predicting 
and preventing mental disorder relapse has already been demonstrated. 
 
Priorities of Mental Health Public Policy in Portuguese-speaking Countries of Africa and 
South America: How to Build Nationwide Care Systems in Contexts of Social Inequalities, 
Vulnerability and Scarcity  
Pedro Gabriel Delgado, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de 
Janeiro, Brazil.   
Email: p.g.godinhodelgado@gmail.com   
Abstract 
The sustainable development agenda (United Nations (UN) 20/30) recommends that 
middle and low-income countries face barriers to access to mental health care in order 
to achieve adequate health care coverage by 2030. In addition to the general guidelines 
and measures, such countries should develop innovations that address and include local 
peculiarities, especially in contexts of socioeconomic inequity, vulnerability and scarcity 
of resources. The present study analyses the experience of expanding access to treatment 
in Brazil, in the period of 2001 – 2015, and presents and discusses the strategy developed, 
i.e, replacing hospital-centred care for the internalisation of community-based services 
and mental health actions in the primary care level. We describe the model change, and 
the results obtained in the expansion of access. In order to dialogue with the 
recommendations of Agenda 20/30, the strategies for expanding coverage in mental 
health of two Portuguese-speaking African countries, equally marked by inequity, 
vulnerability and scarcity, in very diverse socio-cultural and economic contexts, are 
summarily discussed. The aim is to identify strategies that constitute local innovations and 
can be effective ways to address the mental health gap in countries of an international 
community, the Community of Portuguese Speaking Countries (CPLP). 
78 
 
 
Adolescent Substance Abuse Trends: The Need for Early Identification 
Arvin Bhana, Health Systems Research Unit, South African Medical Research Council, 
South Africa 
Email: Arvin.Bhana@mrc.ac.za  
Abstract  
The presentation focuses on adolescent substance abuse trends using data collected 
over a five-year period from treatment facilities in South Africa through the South African 
Community Epidemiology Network (SACENDU). The spotlight is falls on a number of 
individuals in treatment in the country, key demographic characteristics and the major 
substances abused by adolescents. Implications of these trends are discussed in relation 
to mental health in general and in relation to neurobiological vulnerabilities. Suggestions 
for future research are discussed in advocating for early identification and treatment. 
 
Epigenetics in Psychiatry and Psychotherapy – At the Crossroads between Risk and 
Resilience 
Katharina Domschke, Department of Psychiatry and Psychotherapy, University of Freiburg, 
Germany. 
Email: katharina.domschke@uniklinik-freiburg.de   
Abstract 
After identification of the genetic architecture of complex genetic mental disorders, there 
is burgeoning evidence for epigenetic mechanisms such as DNA methylation or histone 
modifications to crucially shape risk and resilience towards mental disorders at the 
crossroads between the genetic and the environmental level. Epigenetic patterns might 
furthermore govern treatment response and/or constitute temporally dynamic biological 
correlates of treatment success. Finally, pharmacological targeting of epigenetic 
mechanisms carries promising potential to augment treatment efficacy in mental 
disorders. The present talk will focus on recent advance in epigenetic research from basic 
mechanisms to treatment options exemplarily for anxiety, affective and stress-related 
disorders and will provide a forum to discuss future developments as well as limitations in 
the field. Despite some pitfalls, such as a variety of confounders, the difficulty to translate 
peripheral findings to central processes in humans and open questions relating to stability 
and transgenerational transmissibility of epigenetic marks, progress and perspectives in 
the field of epigenetics carry great promise to take us closer to clinical application 
comprising resilience-increasing indicated preventive measures in high-risk groups, as well 
as more targeted, personalised and innovative treatment options for mental disorders. 
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Using Intervention Research to Drive Evidence-based Integration of Mental Health into 
Primary Health Care Settings in South Arica 
Inge Petersen, Centre for Rural Health, University of KwaZulu-Natal, South Africa. 
Email: PETERSENI@ukzn.ac.za   
Abstract 
While there is research evidence on the effectiveness of integrating mental health into 
primary health care using task sharing in low and middle-income countries; there is a 
paucity of knowledge of how to scale up such models in real-world settings. Using the 
Medical Research Council framework for complex interventions, this presentation will track 
the development, implementation, evaluation and scale up of a collaborative care 
model for the integration of care for common mental disorders into the chronic primary 
health care platform in South Africa in real-world settings.  Through the Programme for 
Improving Mental Health Care (PRIME), an initial programme theory for integrated mental 
health care for adults with common mental disorders was co-developed with local 
stakeholders in one district in the North West province, using Theory of Change workshops. 
The resulting collaborative care model was piloted, refined and then initially evaluated 
using a quasi-experimental design comprising a repeat facility detection survey to assess 
changes in detection, a cohort study to assess individual-level changes in symptoms and 
functioning, and a case study to examine the process of implementing the plans. This 
implementation study was followed by a pragmatic cluster randomised control trial of 
patients with comorbid hypertension depression and hypertension. Process indicators, 
collected alongside the trial, were analysed using qualitative comparative analysis to 
understand the configurational effects of these indicators on trial outcomes across the 
cascade of care. Through the Mental Health Integration (MhINT) project, this collaborative 
model has been scaled up in the KwaZulu-Natal province starting with the Amajuba 
district using continuous quality improvement as the vehicle of implementation, resulting 
in differentiated refined scale-up packages for different contexts. This scaled-up package 
is being evaluated using implementation science methods by the Southern African 
research consortium for Mental Health IntegraTion (SMhINT). Findings from these various 
studies will be reported.     
 
Providing Screening, Brief Interventions and Referral to Treatment (SBIRT) for Substance Use 
Disorders into South Africa’s Primary Health Care Services: Lessons from Local Research 
Bronwyn Myers, Alcohol, Tobacco and Other Drug Research Unit, South African Medical 
Research Council, South Africa 
Email: Bronwyn.Myers@mrc.ac.za  
Abstract  
In recent years, the South African Department of Health has expressed commitment to 
scaling up the provision of screening, brief intervention, and referral to more intensive 
treatment (SBIRT) for harmful substance use within primary health care services.  To ensure 
that the provision of SBIRT for harmful substance use moves from a service plan to 
successful implementation requires evidence-based tools for SBIRT to be identified and 
questions related to the process of delivering SBIRT within current health services to be 
addressed. This presentation will describe findings from studies of SBIRT for harmful 
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substance use conducted within emergency departments, HIV, and chronic disease 
services. First, we will present findings related to screening tools and brief intervention 
materials. Next, patient, health system, and contextual barriers to SBIRT implementation 
that require consideration when developing a national implementation strategy will be 
reviewed. Finally, provider and patient recommendations for how to enhance the 
acceptability of SBIRT, feasibility of implementation, SBIRT adoption, and the fidelity with 
which SBIRT is implemented will be presented. If used, lessons from these local studies could 
support the successful implementation of SBIRT within primary health care services. 
 
Overcoming Trauma and Violence – From Individual Trauma Narratives to Community-
based Intervention in War-torn Regions 
Thomas Elbert, Sabine Schmitt, Katy Robjant, Maggie Schauer, & Anke Köbach, University 
of Konstanz, Germany. 
Email: Thomas.Elbert@uni-konstanz.de   
Abstract 
Experiences of adversities and stressors are stored in an associative memory.  With regards 
to social and physical threats for life and integrity, this trauma network becomes enlarged, 
with ever more cues being able to trigger alarm or dissociative responses. Ultimately this 
will lead to forms of trauma-related suffering, including post-traumatic stress disorder 
(PTSD) and depression. Narrative Exposure Therapy (NET), an evidence-based 
psychotherapy, assists survivors to reorganise their memory and thus initiates a healing 
process.  In NET, the client, with the assistance of the counsellor, constructs a chronological 
narrative of her/his life story with a focus on the traumatic experiences. Within a 
predefined number, usually about 4 – 12, of 90 – 120 min sessions, the fragmented reports 
of the traumatic experiences will be transformed into a coherent narrative. Empathic 
understanding, active listening, congruency, and unconditional positive regard are key 
components of the therapist’s behavior and attitude. For traumatic stress experiences the 
therapist explores sensory information, resulting cognitions, affective and physiological 
responding in detail and probes for respective observations. The patient is encouraged to 
relive these experiences while narrating, while consciously contrasting them to the “here 
and now”. Using permanent reminders that the feelings and physiological responses result 
from activation of (hot) memories, the therapist links these mnemonic representations to 
episodic facts, that is, time and place (cold memory). For survivors of violence, the 
testimony can be recorded and used for documentary purposes.  
While this treatment has helped thousands of survivors in war and crisis regions to find ways 
back to a life with social relations and occupational functioning, individual therapy can 
only be one component for healing. Another one is acceptance and support by the social 
group. Therefore, we have developed NETfacts, a feasible intervention on the community 
level.  NETfacts combines ongoing provision of trauma therapy with delivery of a 3 to 4-
week trauma-informed community intervention. It includes the development of a 
community lifeline symbolising shared highly affective experiences. It is constructed in a 
meeting with community members followed by a 2-week period in which traumatic events 
of traumatised individuals (with subclinical symptom severity) are recorded in single 
exposure sessions according to the NET logic. The narratives of traumatic experiences that 
are found critical for the continuation of violence will be presented to community 
members during the next two session. In the fourth and last community session, an anti-
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violent action schemes is developed by the community. All members of a 
community/village are encouraged to actively participate. 
We have first tested the feasibility and then demonstrated the efficacy of NET facts in 
villages of the war-stricken Kivu regions of Eastern Democratic Republic of the Congo 
(DRC). An example of a community lifeline is presented in Figure 1. It is our hope that this 
approach can be scaled up to support larger numbers of survivors of war and violence, 
and even contribute to a sustainable peace-building process. 
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